Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036481	p-korsol	nmol/l (nmol/l)	19233	41963	0.10%
3036481	s-korsol	nmol/l (nmol/l)	17198	35924	0.00%
3036481	s-korsol	— (—)	2717	3628	100.00%	Distribution not available
3036481	p-korsol	— (—)	2194	3038	100.00%	Distribution not available
3036481	p-kortisoli	nmol/l (nmol/l)	159	198	0.00%
3036481	fs-korsol	nmol/l (nmol/l)	23	25	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Finngen Rheumatological endpoints

6762

23188

1.74

320.97

2.1

2.3

354.90

383.54

nmol/l

24.65

6250

21372

Nerve, nerve root and plexus disorders

7308

27710

1.69

318.91

2.2

362.78

377.04

nmol/l

7.16

6699

25558

Liquid cancers, helper endpoint

2650

10621

2.36

316.29

3.1

1.8

379.74

365.26

nmol/l

3.12

2515

9606

Other disorders of urethra and urinary system

4919

19995

1.88

314.06

2.2

366.05

380.99

nmol/l

5.12

4504

18435

L04AA Selective immunosuppressants

1961

8110

2.74

313.83

2.5

2.2

313.94

372.99

nmol/l

37.76

1871

7461

Disorders of mineral metabolism

856

2195

4.81

313.69

2.5

2.3

373.56

364.54

nmol/l

0.58

804

2015

Bleeding

5537

22968

1.81

312.45

2.3

372.51

372.23

nmol/l

0.03

5128

21100

Iron deficiency anaemia

3122

15294

2.18

311.34

2.3

2.2

363.28

379.38

nmol/l

3.23

2851

13980

Behavioural syndromes associated with physiological disturbances and physical factors

6527

28285

1.72

309.56

2.0

2.2

374.59

375.39

nmol/l

0.12

5961

26149

Non-small cell lung cancer, including Hilmo

1212

3640

3.58

308.68

5.4

1.8

427.28

366.03

nmol/l

16.44

1168

3241

Fibromyalgia

990

2847

4.25

308.46

2.2

2.1

343.80

383.03

nmol/l

7.87

908

2623

Non-selective monoamine reuptake inhibitors

2570

11422

2.34

308.14

2.2

2.3

350.51

378.20

nmol/l

9.07

2338

10564

Gastrointestinal diseases

4309

10681

2.13

307.65

2.2

2.1

368.48

388.55

nmol/l

7.59

3995

9854

Exclusions for E4_PCOS_CONSORTIUM

6402

19510

2.24

307.65

3.0

1.9

362.51

378.95

nmol/l

6.94

5937

17911

Mood disorders

8922

27096

2.31

307.65

2.1

2.3

371.81

376.37

nmol/l

1.16

8103

25121

Asthma-related pneumonia or sepsis

2707

12526

2.35

307.65

2.5

2.2

321.51

386.78

nmol/l

50.98

2507

11405

Bacterial infection, other or unspecified

4685

16941

2.57

307.65

2.7

2.2

375.67

375.63

nmol/l

0.00

4412

15468

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7583

27982

1.97

307.65

2.5

2.1

362.86

376.11

nmol/l

5.44

7022

25834

Other specific joint derangements/joint disorders

5522

19314

1.96

307.65

2.2

2.3

362.92

385.55

nmol/l

13.92

5067

17825

Hypothyroidism and >3 levothyroxin purchases

2946

2401

8.13

307.65

2.7

1.6

370.64

382.01

nmol/l

1.49

2708

2251

Any reimbursement code in KELA

4659

9016

2.79

307.65

2.3

1.7

369.89

387.48

nmol/l

6.10

4327

8265

Viral Sepsis

1863

6047

3.57

307.65

2.4

2.2

348.49

378.52

nmol/l

7.13

1725

5524

Other nutritional deficiencies

5873

24943

2.44

307.65

2.1

2.2

345.20

379.64

nmol/l

32.09

5333

23111

Other bacterial diseases

7898

26125

2.05

307.65

2.6

2.1

365.59

374.32

nmol/l

2.67

7394

23992

Diarrhoea and gastroenteritis of presumed infectious origin

7434

28394

1.82

307.65

2.2

364.57

377.35

nmol/l

5.64

6846

26169

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5156

21411

2.35

307.65

2.8

2.2

369.48

375.05

nmol/l

1.03

4823

19592

Certain infectious and parasitic diseases

7155

19844

1.90

307.65

2.3

2.1

371.95

378.71

nmol/l

1.64

6604

18260

Other symptoms and signs involving the nervous and musculoskeletal systems

3245

15843

2.23

307.65

2.2

354.77

375.47

nmol/l

7.69

3037

14524

Asthma

6308

13756

2.60

307.65

2.3

2.1

338.05

386.72

nmol/l

59.17

5834

12704

Persons encountering health services for specific procedures and health care

8720

26845

2.08

307.65

2.6

2.1

374.36

373.10

nmol/l

0.20

8148

24635

Septicaemia

3176

12818

2.54

307.65

2.5

2.2

374.20

376.76

nmol/l

0.21

2963

11671

Implicit viral Sepsis

1861

6031

3.58

307.65

2.4

2.2

348.46

378.64

nmol/l

7.18

1723

5509

Asthma (only as main-diagnosis)

5745

13756

2.61

307.65

2.3

2.1

337.44

386.72

nmol/l

56.45

5313

12704

Explicit Sepsis

3352

13637

2.51

307.65

2.5

2.3

374.23

375.94

nmol/l

0.13

3127

12503

8122

24986

1.76

307.65

2.3

2.1

356.90

384.93

nmol/l

26.68

7470

22991

Pneumonia, organism unspecified

7089

25731

2.07

307.65

2.6

2.2

359.57

375.95

nmol/l

7.47

6550

23740

Nutritional anaemias

3582

17495

2.13

307.65

2.3

2.2

366.22

378.81

nmol/l

2.45

3267

15999

Intestinal infectious diseases

8403

28189

1.79

307.65

2.2

366.46

377.33

nmol/l

4.47

7736

25997

Complications of surgical and medical care, not elsewhere classified

7243

28527

1.84

307.65

2.4

2.2

365.44

376.25

nmol/l

3.68

6723

26231

ILD differential diagnosis

5864

13872

2.25

307.65

2.3

2.1

367.29

386.81

nmol/l

8.89

5384

12807

Pain in limb

6200

21468

2.06

307.65

2.2

360.13

383.11

nmol/l

15.21

5721

19815

Acute renal failure

1711

6356

3.04

307.65

2.3

389.96

374.88

nmol/l

1.64

1592

5779

Condition for Implicit Sepsis (Organ dysfunction codes)

6986

22887

2.33

307.65

2.2

2.3

373.94

372.78

nmol/l

0.16

6419

21087

Bacterial Sepsis

3764

12710

2.80

307.65

2.4

2.3

371.60

374.69

nmol/l

0.29

3472

11634

Diabetes mellitus

7671

25406

1.87

307.65

2.2

369.70

373.66

nmol/l

0.81

7025

23492

Implicit Sepsis

6379

20678

2.55

307.65

2.2

2.3

373.20

373.86

nmol/l

0.08

5854

19004

Intestinal infectious diseases

7053

30416

1.86

307.65

2.4

2.2

365.24

376.95

nmol/l

4.47

6514

28035

Asthma, hospital admissions , main diagnosis only

6025

30624

1.84

307.65

2.3

2.2

337.61

382.08

nmol/l

57.16

5576

28195

Anxiety disorders

7746

25915

2.26

307.65

2.1

2.2

372.10

374.43

nmol/l

0.42

7052

24025

Asthma, hospital admission 2, infections

4748

22401

2.25

307.65

2.4

2.2

332.53

384.29

nmol/l

59.07

4398

20573

Other systemic involvement of connective tissue

2291

9755

2.63

307.65

2.1

350.37

381.82

nmol/l

8.66

2137

8862

Implicit bacterial Sepsis

3399

11154

3.02

307.65

2.3

371.24

376.04

nmol/l

0.48

3128

10204

Pneumonias (Asthma/COPD co-morbidities)

7827

28081

1.99

307.65

2.5

2.1

362.83

376.42

nmol/l

5.85

7248

25924

Benign neoplasm: Adrenal gland

1229

2305

8.33

307.65

2.3

2.2

244.23

372.18

nmol/l

53.05

1127

2117

Type 2 diabetes

7005

23852

1.81

307.65

2.2

2.3

362.83

374.27

nmol/l

4.21

6391

22037

Asthma (mode)

6172

13872

2.57

307.65

2.3

2.1

338.82

386.81

nmol/l

57.07

5702

12807

Symptoms and signs involving cognition, perception, emotional state and behaviour

7404

27226

1.97

307.65

2.1

2.3

374.31

373.75

nmol/l

0.08

6783

25158

Autoimmune diseases related-to ILD

6689

29714

2.06

307.65

2.2

350.62

380.39

nmol/l

25.39

6179

27363

Complications of procedures, not elsewhere classified

5689

27477

1.81

307.65

2.4

2.2

365.97

376.09

nmol/l

3.00

5280

25267

Benign neoplasm of other and unspecified endocrine glands

2763

4126

12.24

307.65

3.9

2.1

304.67

375.45

nmol/l

36.62

2619

3786

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7127

20914

2.21

307.65

2.5

2.1

364.70

382.44

nmol/l

8.29

6584

19277

Complications of medical and surgical care

5245

27339

1.87

307.65

2.4

2.2

368.88

375.50

nmol/l

1.36

4863

25121

Symptoms and signs involving the digestive system and abdomen

7292

19626

1.96

307.65

2.2

362.99

379.93

nmol/l

9.32

6730

18118

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6964

26951

1.77

307.65

2.3

2.2

360.46

376.98

nmol/l

8.37

6455

24863

Benign neoplasms

6896

22550

1.76

307.65

2.6

2.0

358.07

384.00

nmol/l

20.96

6389

20809

Hyperfunction of pituitary gland

871

1500

9.27

307.65

3.9

1.8

372.25

378.74

nmol/l

0.44

831

1383

Autoimmune diseases excluding thyroid diseases, strict definition

7628

20172

2.20

307.65

2.2

2.0

356.83

385.28

nmol/l

23.39

7066

18641

Other functional intestinal disorders

3654

15020

2.46

307.65

2.3

2.2

372.52

377.95

nmol/l

0.74

3365

13809

3641

16935

2.33

307.65

2.4

2.1

330.59

382.55

nmol/l

47.39

3380

15567

Asthma, excluding more controls

6155

12977

2.68

307.65

2.3

2.1

338.01

385.25

nmol/l

54.53

5701

12004

Diseases of oesophagus, stomach and duodenum

8082

26490

1.94

307.65

2.2

362.85

376.54

nmol/l

6.66

7418

24483

Cerebrovascular diseases (FINNGEN)

2161

5985

2.77

307.65

2.3

2.4

368.60

376.57

nmol/l

0.96

1990

5566

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6757

23397

1.83

307.65

2.2

2.3

373.37

372.06

nmol/l

0.18

6189

21639

Hypertension

6181

16512

2.27

307.65

2.3

352.10

374.25

nmol/l

12.63

5734

15311

Hypertensive diseases

6183

16531

2.27

307.65

2.3

352.18

374.22

nmol/l

12.54

5736

15325

General symptoms and signs

9867

18736

2.89

307.65

2.3

2.1

367.41

378.18

nmol/l

4.80

9157

17210

Hypertensive diseases (excluding secondary)

4534

9956

2.91

307.65

2.3

351.31

374.38

nmol/l

10.43

4206

9272

Excluding asthma or asthma-COPD overlap

5896

13895

2.26

307.65

2.3

2.1

367.11

386.63

nmol/l

8.94

5410

12831

Neurotic, stress-related and somatoform disorders

7690

25731

2.27

307.65

2.1

2.2

371.93

374.24

nmol/l

0.42

6997

23860

Sleep apnoea, including avohilmo

7801

24690

2.10

307.65

2.1

2.3

343.06

381.88

nmol/l

50.05

7167

22856

Asthma, hospital admissions 3, pneumonia

2707

12526

2.35

307.65

2.5

2.2

321.51

386.78

nmol/l

50.98

2507

11405

Recurrent or chronic depression

3666

8416

3.42

307.65

2.0

2.4

366.46

378.11

nmol/l

2.52

3325

7872

Type 1 diabetes

2192

8601

2.85

307.65

2.0

2.3

401.46

369.74

nmol/l

8.93

2031

7960

General examination and investigation of persons without complaint and reported diagnosis

5015

11169

2.51

307.65

2.3

2.2

360.54

382.33

nmol/l

9.15

4636

10394

Anaemias

2510

2318

8.38

307.65

2.4

1.7

359.77

376.18

nmol/l

2.33

2339

2176

Fever of other and unknown origin

5064

15231

3.30

307.65

2.7

2.1

357.55

379.91

nmol/l

10.52

4772

13948

Adrenocortical insufficiency

968

1009

28.76

307.65

6.2

1.9

217.63

376.90

nmol/l

47.49

915

930

All pneumoniae

7866

28175

1.99

307.65

2.5

2.1

362.81

376.43

nmol/l

5.90

7279

26017

Hyperprolactinaemia

575

1044

8.52

307.65

3.5

1.8

367.85

379.35

nmol/l

0.75

557

970

Dorsopathies

7193

22054

1.73

307.65

2.1

2.2

361.85

384.77

nmol/l

17.33

6592

20415

COPD differential diagnosis

5865

13877

2.25

307.65

2.3

2.1

367.20

386.84

nmol/l

9.00

5385

12811

Osteoporosis

2382

7878

3.28

307.65

2.4

2.1

315.04

392.64

nmol/l

38.95

2173

7095

Secondary hypertension

794

1677

5.69

307.65

2.8

2.3

327.03

376.24

nmol/l

8.28

744

1558

7127

20914

2.21

307.65

2.5

2.1

364.70

382.44

nmol/l

8.29

6584

19277

Hypertension, essential

6191

15920

2.38

307.65

2.2

2.3

354.28

374.65

nmol/l

11.11

5735

14754

Low back pain

5924

21130

2.16

307.65

2.2

360.97

385.71

nmol/l

15.38

5403

19550

Abnormal findings on diagnostic imaging of lung

3560

15486

2.41

307.65

3.0

2.2

367.19

376.76

nmol/l

1.82

3340

14152

Other CVD (FINNGEN)

1086

1822

5.51

307.65

2.2

2.5

380.57

387.78

nmol/l

0.42

993

1684

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1933

6869

3.16

307.65

5.6

1.8

403.96

364.33

nmol/l

11.27

1873

6184

Dyspnoea

7495

26300

2.28

307.65

2.3

2.2

353.42

379.60

nmol/l

20.79

6888

24255

Mood disorders, excluding more controls

8212

20988

2.55

307.65

2.1

2.3

371.33

375.13

nmol/l

0.83

7447

19539

Examination and observation for other reasons

4344

11112

2.42

307.65

2.3

2.2

369.72

382.46

nmol/l

3.56

3983

10347

Persons encountering health services in other circumstances

3061

14555

2.26

307.65

2.2

2.1

362.71

380.89

nmol/l

4.97

2856

13285

Care involving use of rehabilitation procedures

4724

22335

2.08

307.65

2.3

2.1

366.61

369.60

nmol/l

0.39

4424

20466

Persons encountering health services in other circumstances, wide

8778

25215

1.89

307.65

2.3

2.2

363.07

379.37

nmol/l

10.15

8205

23101

Other medical care

3473

14050

2.43

307.65

3.5

2.1

403.16

374.96

nmol/l

9.71

3304

12753

Other special examinations and investigations of persons without complaint or reported diagnosis

4746

11187

2.28

307.65

2.2

367.83

382.37

nmol/l

4.17

4380

10404

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8076

25140

1.84

307.65

2.3

2.2

361.35

379.27

nmol/l

11.66

7559

23053

Medical observation and evaluation for suspected diseases and conditions

5538

11186

2.74

307.65

2.4

2.2

365.63

382.37

nmol/l

6.52

5010

10404

Antihypertensive medication - note that there are other indications

5052

11795

2.44

307.65

2.2

369.28

385.69

nmol/l

6.00

4669

10943

Codeine or tramadol medication

8506

26216

1.88

307.65

2.3

2.2

356.14

383.83

nmol/l

26.76

7834

24130

First line medication for Crohn's disease

10869

21530

3.02

307.65

2.8

1.8

341.68

398.11

nmol/l

122.33

10141

19681

Pain in joint

4584

12381

2.55

307.65

2.2

2.3

363.28

387.39

nmol/l

11.97

4200

11463

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1498

1585

31.13

307.65

5.4

2.0

351.15

374.93

nmol/l

2.62

1456

1451

Asthma, unspecified (mode), excluding more controls

4256

11991

2.91

307.65

2.3

2.1

337.34

384.55

nmol/l

41.95

3937

11078

Codes for special purposes

4041

20896

2.08

307.65

2.3

2.2

368.94

378.01

nmol/l

2.02

3782

19161

Provisional assignment of new diseases of uncertain etiology

4030

20871

2.08

307.65

2.3

2.2

368.96

377.90

nmol/l

1.97

3773

19136

Hypogonadotropic hypogonadism

628

740

18.08

307.65

2.9

2.2

346.87

362.96

nmol/l

1.15

582

690

Disorders of the thyroid gland

8227

24250

2.40

307.65

2.6

2.1

367.50

380.14

nmol/l

5.63

7531

22375

Disorders of thyroid, IBD co-morbidities

1606

2567

4.97

307.65

2.3

2.6

377.61

400.92

nmol/l

3.77

1477

2389

Neoplasms

5663

15808

2.00

307.65

2.8

1.6

363.67

380.68

nmol/l

7.96

5272

14500

Any mental disorder

8495

21431

2.11

307.65

2.1

2.3

373.34

374.37

nmol/l

0.16

7739

19949

Type 1 diabetes, wide definition, subgroup 1

1884

7055

3.02

307.65

2.0

2.3

408.32

367.83

nmol/l

11.83

1744

6524

Intracranial trauma

3948

13359

2.20

307.65

2.1

2.3

371.20

385.89

nmol/l

3.94

3636

12432

Symptoms and signs involving the nervous and musculoskeletal systems

4438

22555

2.13

307.65

2.2

2.3

360.66

376.25

nmol/l

5.80

4138

20695

Symptoms and signs concerning food and fluid intake

1171

2559

5.70

307.65

2.2

2.1

393.47

381.80

nmol/l

0.94

1085

2337

Syncope and collapse

3246

11152

2.70

307.65

2.2

376.76

383.67

nmol/l

0.83

2948

10182

Drug-induced adrenocortical insufficiency

543

533

51.76

307.65

6.7

2.1

175.27

366.19

nmol/l

55.92

521

495

Other anaemias

3215

13586

2.46

307.65

2.3

2.2

369.76

378.91

nmol/l

1.41

2957

12365

Pain, not elsewhere classified

2300

7974

3.22

307.65

2.4

2.1

354.10

381.28

nmol/l

5.94

2123

7293

COPD/asthma related infections

7663

20923

1.94

307.65

2.3

2.1

362.56

382.50

nmol/l

12.18

7064

19286

Aplastic and other anaemias

3460

14522

2.43

307.65

2.3

2.2

369.56

378.20

nmol/l

1.37

3189

13228

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8642

26895

2.42

307.65

2.4

2.2

364.09

375.95

nmol/l

4.93

8026

24750

Symptoms and signs involving the circulatory and respiratory systems

7950

19687

2.15

307.65

2.2

364.21

383.74

nmol/l

12.48

7330

18211

Depression medications

2558

2525

5.65

307.65

2.0

1.6

371.52

383.46

nmol/l

1.65

2342

2368

Diabetes, varying definitions

7611

25392

1.86

307.65

2.2

369.55

373.64

nmol/l

0.84

6975

23478

Pain in throat and chest

6481

18826

2.21

307.65

2.2

360.53

383.29

nmol/l

14.54

5938

17409

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2633

4137

3.42

307.65

2.1

2.0

372.67

385.66

nmol/l

2.05

2428

3809

Symptoms and signs involving the urinary system

5282

22627

1.88

307.65

2.3

366.34

375.04

nmol/l

2.07

4793

20879

Diabetes medication

7424

26394

1.75

307.65

2.1

2.2

373.11

373.12

nmol/l

0.00

6786

24406

Oedema, not elsewhere classified

2516

8689

3.18

307.65

2.5

2.2

352.28

381.23

nmol/l

9.02

2309

7915

Obesity and other hyperalimentation

5434

24434

2.35

307.65

2.1

2.2

340.42

379.75

nmol/l

39.77

4931

22634

Convulsions, not elsewhere classified

1750

6460

2.94

307.65

2.3

2.2

382.79

381.01

nmol/l

0.10

1607

5912

Abnormalities of breathing

7962

19619

2.56

307.65

2.3

2.2

354.58

383.76

nmol/l

25.05

7341

18148

Nausea and vomiting

2603

8427

3.46

307.65

2.6

2.1

371.70

385.07

nmol/l

2.17

2406

7692

Abdominal and pelvic pain

7141

19623

1.92

307.65

2.2

361.19

379.97

nmol/l

10.66

6604

18115

Hypothyroidism, other/unspecified

7898

22977

2.47

307.65

2.6

2.0

366.44

380.61

nmol/l

6.60

7233

21194

Abnormalities of heart beat

2715

11199

2.59

307.65

2.1

2.2

373.34

387.66

nmol/l

3.01

2505

10300

Malaise and fatigue

5651

12159

4.37

307.65

2.3

2.2

377.01

381.34

nmol/l

0.67

5196

11113

Other disorders of adrenal gland

1110

1305

20.46

307.65

6.0

1.9

228.86

378.89

nmol/l

50.49

1047

1196

Hypothyroidism, strict autoimmune, 3 medication purchases required

6427

22708

2.04

307.65

2.2

2.0

373.48

380.83

nmol/l

2.07

5831

20903

Exclusions for E4_PCOS_BROAD

4155

5709

14.14

307.65

4.6

2.0

322.60

373.03

nmol/l

27.94

3940

5251

Dizziness and giddiness

5444

23264

1.97

307.65

2.2

2.3

372.56

375.02

nmol/l

0.39

4959

21458

All kidney diseases

7708

27980

2.01

307.65

2.4

2.2

370.72

375.39

nmol/l

1.02

7171

25743

All chronic kidney diseases

4075

15474

2.33

307.65

2.4

2.3

363.43

376.38

nmol/l

3.33

3821

14150

Endocrine, nutritional and metabolic diseases

7492

11715

3.58

307.65

2.3

2.0

369.90

382.15

nmol/l

4.42

6879

10932

Headache

5790

17358

2.93

307.65

2.3

2.1

358.47

379.62

nmol/l

12.23

5340

15924

All anxiety disorders

5459

19495

2.42

307.65

2.0

2.2

377.61

373.68

nmol/l

0.70

4960

18123

Hypokalaemia

1377

3179

5.48

307.65

2.6

2.2

384.84

369.81

nmol/l

1.14

1273

2889

Migraine

4094

15061

2.40

307.65

2.1

370.62

386.26

nmol/l

5.00

3773

13913

Panhypopituitarism

473

497

30.07

307.65

6.3

1.8

244.11

373.37

nmol/l

9.96

441

455

Osteopathies and chondropathies

4379

19780

2.24

307.65

2.4

2.2

336.18

382.23

nmol/l

32.86

4033

18143

Azathioprine

1426

4543

3.67

307.65

2.7

2.1

311.46

386.91

nmol/l

30.62

1339

4153

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4405

12375

4.48

307.65

3.7

2.0

351.80

375.66

nmol/l

9.69

4147

11323

Parasetamol

5667

13392

2.28

307.65

2.2

2.1

366.63

391.74

nmol/l

13.57

5218

12391

Other dorsopathies, not elsewhere classified

7330

21866

1.84

307.65

2.1

2.2

363.19

385.44

nmol/l

15.66

6697

20231

Renal failure

3514

13095

2.62

307.65

2.3

373.94

377.13

nmol/l

0.34

3288

11928

Tramadol

6361

17260

2.45

307.65

2.3

2.0

351.81

383.30

nmol/l

23.78

5834

15888

Concussion

3400

13121

2.25

307.65

2.1

2.3

364.79

385.54

nmol/l

6.74

3132

12212

Opioids

7835

19517

2.23

307.65

2.3

2.0

363.50

386.91

nmol/l

17.16

7219

17971

Benzodiazepine use

8242

28632

2.13

307.65

2.2

368.39

376.88

nmol/l

3.00

7467

26517

Pain (limb, back, neck, head abdominally)

4996

12836

2.05

307.65

2.2

2.3

362.12

386.18

nmol/l

12.57

4607

11862

Oxycodone

3501

10157

3.55

307.65

3.6

2.1

374.56

386.25

nmol/l

2.15

3279

9319

Selective serotonin reuptake inhibitors

7380

19481

2.10

307.65

2.1

2.3

370.65

378.88

nmol/l

2.50

6697

18089

Any gastric operation

6469

13814

2.52

307.65

2.4

1.8

365.49

387.52

nmol/l

11.91

5954

12682

Episodal and paroxysmal disorders

8875

22166

2.18

307.65

2.1

2.2

360.74

385.80

nmol/l

21.42

8144

20507

Other disorders of fluid, electrolyte and acid-base balance

4683

8458

7.10

307.65

2.3

401.84

369.04

nmol/l

14.13

4320

7728

Oral corticosteroids

10532

23853

2.91

307.65

2.5

2.1

336.69

392.34

nmol/l

125.58

9820

21893

Codeine

7289

19170

2.21

307.65

2.3

2.0

357.31

386.48

nmol/l

24.19

6730

17659

L04AX Other immunosuppressants

4489

22246

2.19

307.65

2.3

2.2

335.39

377.19

nmol/l

38.43

4221

20450

Anxiety (asthma-related co-morbidities)

5367

17626

2.59

307.65

2.0

2.2

377.03

373.05

nmol/l

0.69

4878

16401

Hypothyroidism, strict autoimmune

5961

16011

2.66

307.65

2.2

1.9

374.30

390.50

nmol/l

7.09

5432

14711

Other pulmonary diagnosis

5865

13895

2.25

307.65

2.2

2.1

365.54

386.63

nmol/l

10.29

5377

12831

Used for control exclusion in common control thyroid runs

9523

18288

2.88

307.65

2.5

1.9

364.33

386.28

nmol/l

16.79

8794

16854

Asthma (diagnoses ohter than nonallergic)

6744

30251

1.97

307.65

2.3

2.2

336.14

383.65

nmol/l

71.09

6238

27859

Other soft tissue disorders, not elsewhere classified

7591

22108

2.16

307.65

2.2

358.43

383.24

nmol/l

20.61

7000

20419

Renal tubulo-interstitial diseases

6792

26084

2.08

307.65

2.3

2.2

374.95

375.68

nmol/l

0.09

6305

23974

Asthma, unspecified (mode)

4336

12704

2.81

307.65

2.3

2.1

337.72

386.50

nmol/l

45.39

4007

11715

Sleep disorders (combined)

8633

24150

1.99

307.65

2.1

2.3

359.96

385.02

nmol/l

22.37

7883

22361

Lower back pain or/and sciatica

7801

29358

1.83

307.65

2.2

361.20

379.67

nmol/l

11.79

7119

27118

Psychiatric diseases

7237

18793

2.04

307.65

2.1

2.3

370.76

373.93

nmol/l

0.59

6604

17532

Other antidepressants

8612

19328

2.47

307.65

2.1

2.3

366.73

379.38

nmol/l

5.75

7851

17944

Type 2 diabetes, wide definition

5730

19028

2.06

307.65

2.2

2.3

367.15

374.13

nmol/l

1.48

5242

17566

Bronchitis

7641

29331

1.72

307.65

2.3

2.2

356.50

381.07

nmol/l

19.51

7069

26985

Disorders of lipoprotein metabolism and other lipidaemias

5251

17530

1.96

307.65

2.2

2.3

370.17

365.06

nmol/l

0.91

4783

16165

Dorsalgia

7471

21778

1.94

307.65

2.2

360.85

385.50

nmol/l

18.20

6833

20146

Depression or dysthymia

5442

11925

2.73

307.65

2.1

2.5

366.53

378.26

nmol/l

3.31

4907

11167

Spondylopathies

5317

17667

1.89

307.65

2.2

2.3

350.92

381.61

nmol/l

20.56

4854

16318

Polyarthropathies

4844

16976

1.98

307.65

2.1

2.3

349.50

383.18

nmol/l

23.93

4514

15637

Non-invasive ventilation

1655

4942

3.28

307.65

2.2

2.6

388.79

373.57

nmol/l

1.90

1537

4638

GASTRO-related operations

6469

13814

2.52

307.65

2.4

1.8

365.49

387.52

nmol/l

11.91

5954

12682

Asthma-related infections

4748

22401

2.25

307.65

2.4

2.2

332.53

384.29

nmol/l

59.07

4398

20573

Other bacterial diseases

7485

25007

2.16

307.65

2.6

2.2

367.91

373.06

nmol/l

1.08

6990

22957

Other heart diseases

3633

10151

2.53

307.65

2.3

365.45

376.05

nmol/l

1.95

3362

9448

COPD/asthma/ILD related infections

7663

20923

1.94

307.65

2.3

2.1

362.56

382.50

nmol/l

12.18

7064

19286

Cardiac arrhythmias

4429

13927

2.21

307.65

2.1

2.3

366.50

372.68

nmol/l

1.09

4099

12937

Neurological diseases, wide definition

2593

3729

3.82

307.65

2.1

2.4

370.77

394.63

nmol/l

5.63

2414

3482

Obesity related asthma

2967

12293

2.71

307.65

2.3

2.2

319.57

380.43

nmol/l

55.49

2726

11321

Depression

8482

26249

2.39

307.65

2.1

2.3

372.89

375.83

nmol/l

0.60

7710

24353

Hypothyroidism, drug reimbursement

1191

1421

6.72

307.65

2.2

1.6

368.44

373.12

nmol/l

0.28

1103

1345

Neurological diseases

6790

15849

2.30

307.65

2.1

2.3

362.95

387.32

nmol/l

16.25

6251

14736

Sleep apnoea

7378

24005

2.14

307.65

2.2

2.3

340.62

380.53

nmol/l

49.85

6775

22217

Chronic kidney disease

2237

8936

2.71

307.65

2.3

355.72

376.37

nmol/l

4.76

2107

8113

Other anxiety disorders

4088

15440

2.52

307.65

2.0

2.1

378.37

375.69

nmol/l

0.34

3715

14342

Other reaction to severe stress, and adjustment disorders

2993

13578

2.41

307.65

2.4

2.1

369.44

374.56

nmol/l

0.64

2744

12611

Cardiovascular diseases (excluding rheumatic etc)

5307

13585

2.42

307.65

2.3

2.1

358.97

380.30

nmol/l

11.26

4932

12625

Type 1 diabetes, wide definition

1920

7530

2.86

307.65

2.0

2.3

407.41

369.62

nmol/l

10.59

1777

6957

Asthma-related pneumonia

2703

12501

2.35

307.65

2.5

2.2

321.58

386.79

nmol/l

50.78

2503

11381

Use of hypnotics and sedatives

7523

25841

1.76

307.65

2.3

2.2

365.90

373.70

nmol/l

2.51

6924

23897

Substance abuse, excluding more controls

3649

15585

2.12

307.65

2.2

2.4

376.59

372.03

nmol/l

0.51

3322

14546

Systemic connective tissue disorders

3111

12735

2.76

307.65

2.1

2.2

346.90

381.81

nmol/l

15.02

2894

11581

Autoimmune diseases

8998

21799

2.25

307.65

2.3

2.2

365.85

383.04

nmol/l

10.31

8275

20153

Mood [affective] disorders

8911

27075

2.31

307.65

2.1

2.3

371.89

376.34

nmol/l

1.12

8092

25102

Influenza and pneumonia

8278

28067

2.00

307.65

2.5

2.1

363.22

377.68

nmol/l

6.89

7670

25889

Obesity, other/unspecified

2840

12702

2.47

307.65

2.1

2.2

337.53

378.96

nmol/l

22.94

2546

11769

Other systemic involvement of connective tissue (FG)

2255

8478

2.97

307.65

2.0

2.2

351.38

390.30

nmol/l

12.23

2104

7737

Hypo-osmolality and hyponatraemia

3091

4576

10.23

307.65

2.3

2.2

416.66

369.21

nmol/l

18.74

2847

4148

Lung cancer and mesothelioma

1516

3758

3.92

307.65

5.0

2.1

427.46

387.39

nmol/l

7.59

1456

3418

Hypopituitarism

1797

2049

20.62

307.65

4.6

2.0

309.12

367.67

nmol/l

15.89

1695

1904

Other headache syndromes

3316

14738

2.45

307.65

2.2

362.14

386.26

nmol/l

9.63

3044

13593

Other heart diseases, wide

6696

23569

1.83

307.65

2.3

2.2

366.41

372.40

nmol/l

1.41

6195

21784

Obesity

5411

24359

2.35

307.65

2.1

2.2

340.52

379.66

nmol/l

39.28

4911

22568

Hypothyroidism (congenital or acquired)

2987

2414

8.21

307.65

2.7

1.6

371.10

381.83

nmol/l

1.36

2745

2264

Covid-19 confirmed case

2866

13075

2.41

307.65

2.4

2.2

363.46

379.37

nmol/l

3.46

2679

11943

Gastro-oesophageal reflux disease

4820

22518

1.96

307.65

2.1

2.3

362.26

375.85

nmol/l

3.86

4379

20814

Autoimmune diseases excluding thyroid diseases

8150

21613

2.20

307.65

2.3

2.2

353.49

382.87

nmol/l

26.14

7558

19985

Diarrhoea and gastroenteritis of presumed infectious origin

5350

26119

1.96

307.65

2.5

2.1

361.73

376.96

nmol/l

5.58

4925

24058

Metabolic disorders

8271

21469

2.57

307.65

2.3

2.2

374.35

366.72

nmol/l

2.16

7627

19831

Other and unspecified anaemias

3187

13481

2.47

307.65

2.3

2.2

369.61

379.08

nmol/l

1.47

2932

12267

Insulin, intermediate and long-acting

4107

19510

2.22

307.65

2.1

2.3

387.54

372.86

nmol/l

3.89

3799

17924

Dental caries

2075

7608

2.92

307.65

2.9

2.3

361.60

380.69

nmol/l

3.47

1938

7070

Other diseases of intestines

8022

25396

1.90

307.65

2.2

365.15

377.27

nmol/l

5.49

7401

23504

Hypothyreosis and Thyroxine purchase for inclusion criteria

8123

24160

2.41

307.65

2.6

2.0

366.28

380.56

nmol/l

6.95

7432

22270

Constipation

6549

24711

1.95

307.65

2.3

363.41

374.81

nmol/l

3.98

5938

22875

Disorders of other endocrine glands

6211

15595

4.97

307.65

3.5

1.9

329.21

385.49

nmol/l

58.48

5825

14231

Chronic lower respiratory diseases

8769

28060

1.75

307.65

2.3

2.2

347.27

384.31

nmol/l

48.36

8096

25878

Heart failure, not strict

5635

17986

2.31

307.65

2.4

357.23

373.93

nmol/l

6.05

5213

16582

ILD medications: azathioprine

1426

4382

3.81

307.65

2.7

2.1

311.46

389.82

nmol/l

32.56

1339

4001

Cardiovascular diseases

4959

12008

2.38

307.65

2.3

2.1

362.37

384.06

nmol/l

10.60

4618

11142

Infections, IBD-co-morbidities

1309

2065

5.11

307.65

2.7

2.8

352.55

396.00

nmol/l

7.18

1220

1927

Soft tissue disorders

7253

22399

1.74

307.65

2.1

2.2

365.43

383.12

nmol/l

10.62

6674

20681

Diabetes, insulin treatment (Kela reimbursement)

7018

25476

1.75

307.65

2.2

2.3

374.47

371.13

nmol/l

0.60

6423

23533

Anxiety disorders, excluding more controls

7183

19923

2.56

307.65

2.1

2.3

372.57

375.12

nmol/l

0.44

6534

18548

Insulin medication

4539

18728

2.20

307.65

2.1

2.3

383.89

372.48

nmol/l

2.69

4198

17258

Insulin, fast-acting

3055

12900

2.64

307.65

2.1

2.3

386.72

370.46

nmol/l

3.52

2833

11853

Hypothyroidism, levothyroxine purchases

2946

2401

8.13

307.65

2.7

1.6

370.64

382.01

nmol/l

1.49

2708

2251

Heart failure and antihypertensive medication

1839

3932

3.40

307.65

2.4

2.6

358.11

379.93

nmol/l

3.21

1704

3642

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

946

1218

6.40

307.65

2.2

3.1

334.77

400.47

nmol/l

10.33

893

1151

Other septicaemia

2894

11498

2.67

307.65

2.5

2.2

375.08

376.76

nmol/l

0.12

2702

10458

ILD medications: immunosuppressive drugs

5847

20687

2.93

307.65

2.3

2.1

333.01

392.53

nmol/l

93.24

5527

18999

Second line medication for Crohn's disease

4641

22955

2.20

307.65

2.3

2.2

335.34

377.73

nmol/l

41.14

4368

21114

ILD medications: prednisolone, methylprednisolone, prednisone

10547

22896

2.85

307.65

2.5

2.1

338.18

394.59

nmol/l

124.49

9828

20988

Caries of dentine

1849

6704

3.00

307.65

2.9

2.3

359.96

378.89

nmol/l

3.27

1726

6219

Bacterial infection, other or unspecified

4351

15783

2.64

307.65

2.8

2.2

376.64

376.02

nmol/l

0.05

4086

14403

ILD medications

10542

23349

2.68

307.65

2.5

2.1

340.57

394.59

nmol/l

115.42

9827

21406

Obesity due to excess calories

4208

18173

2.58

307.65

2.0

2.2

338.63

378.96

nmol/l

33.64

3846

16871

Asthma (only as main-diagnosis), excluding more controls

5620

12977

2.68

307.65

2.3

2.1

337.52

385.25

nmol/l

52.03

5197

12004

Inflammatory bowel disease treatment related agents

10754

24782

2.66

307.65

2.4

2.1

338.72

392.55

nmol/l

119.50

9996

22748

Personality disorders, excluding more controls

2151

7848

3.06

307.65

2.0

2.2

365.21

376.16

nmol/l

1.77

1952

7314

Insulin, fast-acting or short human

3064

13343

2.54

307.65

2.1

2.3

386.90

370.64

nmol/l

3.53

2842

12252

Insulin, combination of fast acting with intermediate-acting or long-acting

4543

21003

2.12

307.65

2.1

2.3

383.94

372.06

nmol/l

2.92

4201

19270

Asthma, including avohilmo

8502

29068

1.72

307.65

2.2

344.60

384.16

nmol/l

57.40

7834

26800

Diseases of the skin and subcutaneous tissue

6925

21127

1.71

307.51

2.3

2.1

366.06

380.41

nmol/l

6.60

6355

19511

Dermatitis and eczema

7669

30110

1.65

305.23

2.3

2.2

362.08

378.21

nmol/l

9.19

7007

27835

Acute upper respiratory infections

7181

27581

1.68

304.34

2.3

2.2

357.42

381.29

nmol/l

18.25

6608

25382

Diseases of the respiratory system

4352

11587

1.98

303.08

2.2

2.1

368.46

390.92

nmol/l

8.71

3986

10692

Nonorganic sleeping disorders, excluding more controls

1543

5725

3.01

302.76

2.0

2.2

373.10

376.59

nmol/l

0.28

1414

5303

Dysphagia

1818

7363

2.72

298.13

2.3

2.2

375.00

382.48

nmol/l

0.72

1640

6736

Cough

2810

12855

2.22

296.75

2.3

355.54

384.49

nmol/l

10.32

2603

11869

Atrial fibrillation and flutter

2008

5256

2.66

295.24

2.1

2.5

366.13

375.22

nmol/l

0.93

1867

4878

Hernia of abdominal wall, postoperative

1278

4327

3.26

294.08

2.6

2.0

351.59

381.69

nmol/l

4.57

1184

3964

Persons encountering health services for examination and investigation

4209

11187

1.97

293.95

2.2

371.72

382.37

nmol/l

2.25

3849

10404

Dermatitis

4302

24134

1.89

292.14

2.4

2.2

356.78

378.96

nmol/l

10.43

3966

22267

Acute tubulo-interstitial nephritis

4306

20787

1.89

290.88

2.3

2.2

373.94

378.68

nmol/l

0.67

3973

19034

Asthma/COPD (KELA code 203)

6580

27987

1.68

290.59

2.3

2.2

337.92

384.28

nmol/l

62.69

6092

25808

Acute upper respiratory infections of multiple and unspecified sites

5319

23242

1.78

290.55

2.3

2.2

357.29

380.10

nmol/l

12.56

4941

21404

Heart failure,strict

3309

11846

2.11

289.98

2.2

2.4

374.16

378.66

nmol/l

0.45

3046

10886

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2020

8630

2.53

289.71

2.0

2.2

370.82

377.04

nmol/l

0.70

1829

8016

Other intervertebral disc disorders

5515

19581

1.78

287.31

2.2

2.3

359.97

383.01

nmol/l

13.44

5018

18121

L04AD Calcineurin inhibitors

1101

3557

3.76

286.67

2.9

2.3

313.00

365.76

nmol/l

15.49

1062

3299

Irritable bowel syndrome

2190

9827

2.45

286.40

2.1

364.71

380.24

nmol/l

3.22

1983

9020

Vocal cord dysfunction

969

2475

3.89

286.02

2.4

2.7

354.16

390.68

nmol/l

5.25

885

2320

Spondylosis

3540

15208

2.02

285.29

2.2

2.4

349.49

382.45

nmol/l

16.87

3233

14072

Other diseases of urinary system

6788

23722

1.68

285.15

2.1

2.3

368.70

377.86

nmol/l

2.98

6231

21945

Diseases of arteries, arterioles and capillaries (FINNGEN)

1574

3993

2.97

285.00

2.3

2.6

362.30

378.34

nmol/l

1.86

1437

3712

Other and unspecified iron deficiency

2515

11975

2.29

282.89

2.3

2.2

361.56

380.37

nmol/l

3.46

2299

10930

Thyrotropin deficiency

297

329

30.51

281.65

4.7

1.9

353.21

376.77

nmol/l

0.96

282

309

Noninfective enteritis and colitis

3436

18294

2.01

279.75

2.4

2.2

349.12

375.07

nmol/l

10.74

3186

16834

Epilepsy

2191

9862

2.40

278.88

2.4

2.3

376.87

380.96

nmol/l

0.38

2007

9079

Hard cardiovascular diseases

5459

19441

1.76

272.60

2.2

2.4

361.69

369.95

nmol/l

2.06

5034

17950

Other/unspecified dorsalgia

2651

12923

2.18

270.69

2.1

2.2

352.03

387.12

nmol/l

15.48

2443

11886

Other and unspecified dermatitis

3646

20024

1.94

269.72

2.4

2.2

353.57

377.80

nmol/l

10.95

3358

18452

Other diseases of pleura

2936

13059

2.11

269.31

2.6

2.3

375.55

375.84

nmol/l

0.02

2731

11922

Undetermined asthma, excluding more controls

1024

3237

3.57

266.90

2.4

2.1

315.97

383.13

nmol/l

23.50

952

2967

Pure hypercholesterolaemia

4350

16049

1.86

266.50

2.3

378.22

365.67

nmol/l

3.39

3974

14789

Other disorders of skin and subcutaneous tissue

4623

24144

1.80

264.56

2.3

2.2

367.85

376.15

nmol/l

1.86

4246

22185

Sleep disorders

6104

27588

1.67

264.45

2.0

2.2

373.98

375.88

nmol/l

0.31

5588

25492

Transplanted organ and tissue status

944

2907

3.91

264.08

3.0

2.4

322.48

363.75

nmol/l

8.44

919

2679

COPD (mode)

1848

6082

2.57

263.94

2.7

2.2

362.76

387.60

nmol/l

4.11

1681

5564

Certain disorders involving the immune mechanism

1605

6556

2.78

263.82

2.6

2.2

339.94

369.77

nmol/l

8.42

1520

6044

Continuous positive airway pressure

1242

3631

3.15

261.49

2.1

2.8

340.20

365.56

nmol/l

4.16

1116

3417

Sub-endpoint used in defining T1D endpoints

2240

10326

2.32

261.08

2.0

2.2

401.21

369.61

nmol/l

9.26

2076

9460

Reimbursement for rheumatic diseases

3991

22670

1.86

259.93

2.1

2.2

342.79

379.04

nmol/l

23.70

3717

20793

Diseases of the musculoskeletal system and connective tissue

3743

9981

1.97

259.54

2.2

2.3

367.49

394.31

nmol/l

11.78

3451

9213

Diseases of the digestive system

3132

16499

2.02

259.41

2.3

376.81

375.12

nmol/l

0.14

2906

15063

Hypotension

1311

4871

3.04

258.51

2.2

377.42

382.13

nmol/l

0.32

1180

4405

Atrial fibrillation and flutter with reimbursement

1569

3795

2.84

258.23

2.1

2.6

362.94

379.21

nmol/l

2.00

1460

3531

Cystitis

5776

21096

1.70

258.15

2.1

2.2

369.14

380.87

nmol/l

4.00

5301

19479

Use of cabergoline

304

376

17.92

257.58

4.6

1.9

365.37

373.80

nmol/l

0.29

296

349

Undetermined asthma

1024

3313

3.49

256.90

2.4

2.1

315.97

384.56

nmol/l

24.45

952

3042

Symptoms and signs involving the skin and subcutaneous tissue

4812

28418

1.75

253.45

2.5

2.2

366.87

375.88

nmol/l

2.58

4457

26154

Visual disturbances and blindness

3621

20227

1.91

253.45

2.4

2.2

366.63

376.95

nmol/l

1.85

3314

18563

Hyperkinetic disorders, excluding more controls

986

3005

3.55

251.69

2.0

368.48

382.67

nmol/l

1.42

913

2810

Weight loss

969

3135

3.73

250.98

2.1

2.2

400.28

369.20

nmol/l

4.46

902

2863

Sciatica+with lumbago

3413

17166

1.94

250.94

2.2

2.3

356.91

383.35

nmol/l

11.04

3107

15885

Diseases of the eye and adnexa

5561

16875

1.72

250.50

2.2

365.79

378.65

nmol/l

4.61

5108

15695

Malignant neoplasm of bronchus and lung, including Hilmo

1472

4814

2.82

250.18

5.0

1.7

427.70

367.62

nmol/l

16.14

1410

4289

Non-small cell lung cancer

823

2357

4.00

249.03

5.8

1.8

423.51

362.23

nmol/l

11.35

798

2081

Somatoform disorder

1380

5377

2.91

248.92

2.3

2.2

357.40

373.01

nmol/l

2.21

1258

4978

Erysipelas

4499

20189

1.78

248.80

2.3

2.2

353.07

374.31

nmol/l

8.61

4148

18479

Ischemic heart diseases

5303

19356

1.73

248.27

2.2

2.4

359.74

371.98

nmol/l

3.84

4888

17859

Malignant neoplasm of respiratory system and intrathoracic organs

1436

4626

2.85

248.24

5.0

1.7

430.73

367.31

nmol/l

18.60

1378

4132

STROKE

3521

13028

1.94

247.56

2.2

2.4

367.30

372.64

nmol/l

0.81

3237

12017

Generalized anxiety disorder

1368

5308

2.89

247.50

2.1

383.18

380.76

nmol/l

0.17

1237

4927

Other arrhythmias

4241

18543

1.82

247.12

2.2

2.3

369.34

373.27

nmol/l

0.61

3902

17098

Abnormal findings on examination of blood, without diagnosis

3062

14953

2.01

246.82

2.3

2.4

365.93

373.56

nmol/l

1.03

2851

13754

Myalgia

1817

8032

2.48

245.89

2.3

2.2

362.78

386.04

nmol/l

5.12

1645

7404

Other CVD

1451

5805

2.79

245.85

2.2

374.33

381.36

nmol/l

0.59

1311

5261

Other symptoms and signs involving cognitive functions and awareness

2952

14128

2.03

245.23

2.0

2.3

382.71

377.10

nmol/l

0.58

2665

12971

Migraine without aura

1595

6664

2.64

245.17

2.2

2.0

372.10

386.03

nmol/l

1.99

1466

6174

Disorders of adult personality and behaviour

2266

10974

2.26

245.01

2.0

2.1

364.50

376.68

nmol/l

2.31

2059

10152

Volume depletion

781

2221

4.07

242.27

2.5

2.2

385.87

367.15

nmol/l

1.21

717

2000

Type 2 diabetes, definitions combined

6127

22771

1.65

241.23

2.2

2.3

359.54

373.88

nmol/l

5.44

5577

21035

Personality disorders

2151

10279

2.29

241.13

2.0

2.1

365.21

374.59

nmol/l

1.45

1952

9505

Corticotropin deficiency

241

252

42.85

241.12

8.4

1.8

195.14

377.51

nmol/l

21.57

229

232

Any death

3919

16016

1.86

241.01

2.9

2.2

417.65

362.25

nmol/l

31.96

3661

14725

Acute sinusitis

3645

19075

1.87

240.91

2.2

2.1

350.09

379.63

nmol/l

15.47

3362

17610

Hyperkalaemia

546

1215

5.53

239.17

2.4

2.2

377.02

367.22

nmol/l

0.40

516

1098

Osteoporosis with pathological fracture (FG)

704

1911

4.55

239.17

2.4

2.1

306.94

401.53

nmol/l

16.24

650

1695

Other joint disorders

5984

19780

1.66

239.11

2.1

2.2

364.53

385.24

nmol/l

12.55

5510

18238

Type 2 diabetes, strict (exclude DM1)

6143

22925

1.64

237.78

2.2

2.3

359.35

373.93

nmol/l

5.62

5591

21180

Disorders of parathyroid gland

1534

6321

2.66

237.43

2.2

1.9

345.26

390.65

nmol/l

10.42

1412

5693

Percutaneous Coronary Intervention

4975

18475

1.73

236.80

2.2

2.4

357.74

371.94

nmol/l

4.60

4589

17037

Haemorrhage from respiratory passages

2141

9131

2.26

236.42

2.5

2.3

357.77

385.69

nmol/l

7.91

1980

8396

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4071

23639

1.80

236.40

2.4

2.2

368.48

375.72

nmol/l

1.28

3779

21706

Budesonide

1144

4160

3.11

235.17

2.3

2.1

328.61

390.60

nmol/l

23.38

1065

3803

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2803

9014

2.07

234.49

2.2

2.3

354.06

377.15

nmol/l

6.99

2623

8369

Disorders of calcium metabolism

634

1618

4.85

234.24

2.4

2.3

378.87

363.99

nmol/l

0.91

597

1480

Diseases of liver

2420

12202

2.15

233.39

2.2

2.3

360.91

372.23

nmol/l

1.53

2245

11234

Abnormal weight loss

883

2826

3.78

233.10

2.0

2.2

402.74

369.76

nmol/l

4.45

820

2574

Coronary revascularization (ANGIO or CABG)

4960

18479

1.72

232.02

2.2

2.4

357.30

371.95

nmol/l

4.85

4577

17041

Visual disturbances

3349

18790

1.90

231.66

2.4

2.2

367.35

376.41

nmol/l

1.40

3080

17253

Erysipelas

3426

16965

1.88

230.88

2.4

2.2

352.57

374.24

nmol/l

7.03

3154

15506

Early onset COPD, excluding more controls

1251

4758

2.86

230.50

2.6

2.2

348.91

378.33

nmol/l

4.09

1131

4397

Diagnoses used for exclusion with ILD

1835

8372

2.40

230.27

2.4

2.2

351.21

373.40

nmol/l

3.99

1713

7666

Heart failure, strict

3524

13899

1.89

229.84

2.2

2.4

375.41

376.73

nmol/l

0.11

3234

12757

Type 2 diabetes, definitions combined, including avohilmo

6127

22859

1.62

228.80

2.2

2.3

359.08

373.85

nmol/l

5.80

5569

21130

Migraine with aura

1816

8256

2.39

228.50

2.1

378.67

389.34

nmol/l

1.31

1659

7630

Exposure to unspecified factor

6649

31556

1.58

227.63

2.2

362.47

377.19

nmol/l

6.12

6130

29109

Presence of other functional implants

3645

14332

1.86

225.80

2.2

2.4

354.96

380.33

nmol/l

9.44

3335

13138

Hyperlipidaemia, other/unspecified

2263

10280

2.16

224.62

2.1

2.3

364.40

367.46

nmol/l

0.26

2078

9439

Malignant neoplasm of bronchus and lung

1259

3986

2.89

223.97

5.2

1.8

432.73

366.86

nmol/l

16.91

1207

3549

Other disorders of glucose regulation and pancreatic internal secretion

835

2643

3.79

223.55

2.1

2.2

401.20

369.92

nmol/l

3.64

772

2421

Disorders of eyelid, lacrimal system and orbit

5589

27106

1.64

223.54

2.3

2.2

364.92

376.16

nmol/l

3.68

5119

24962

Insomnia

5865

27554

1.62

223.54

2.0

2.2

374.63

376.14

nmol/l

0.23

5365

25444

All-cause Heart Failure

3458

13705

1.88

222.61

2.1

2.4

374.26

376.93

nmol/l

0.24

3170

12567

Other disorders of lacrimal gland

2494

12932

2.09

222.36

2.4

2.2

360.29

377.67

nmol/l

3.77

2277

11830

Emergency coronary revascularization (for ACS)

5283

20104

1.67

220.08

2.2

2.4

357.71

372.60

nmol/l

5.32

4868

18484

Factors influencing health status and contact with health services

1798

3822

2.48

218.44

2.1

2.2

370.33

382.94

nmol/l

1.55

1653

3543

Other general symptoms and signs

541

1282

5.16

216.45

2.4

2.0

370.37

384.23

nmol/l

0.86

513

1187

Other noninfective gastroenteritis and colitis

1870

8841

2.31

214.90

2.7

2.2

357.52

376.92

nmol/l

3.33

1743

8102

Genitourinary diseases

3760

10677

1.84

214.21

2.3

363.92

376.05

nmol/l

2.71

3461

9967

Major coronary heart disease event

5202

19729

1.66

213.19

2.2

2.4

358.49

371.77

nmol/l

4.45

4789

18169

Polycystic ovarian syndrome, consortium definition

5039

18667

1.68

212.15

2.1

2.0

371.87

384.46

nmol/l

3.71

4585

17134

Primary adrenocortical insufficiency

252

320

18.64

210.75

5.2

2.1

290.95

374.01

nmol/l

2.34

228

295

Enlarged lymph nodes

1111

4187

2.93

210.47

2.7

2.2

362.82

379.28

nmol/l

1.93

1051

3825

Disorders of lacrimal system

2922

16159

1.93

210.45

2.4

2.2

362.63

378.74

nmol/l

3.71

2667

14820

KRA_PSY_EATING, excluding more controls

750

2279

3.77

208.32

2.0

396.13

395.47

nmol/l

0.03

674

2132

Arthropathies

6053

19864

1.60

208.22

2.1

2.3

363.42

384.78

nmol/l

12.87

5601

18318

Other acute lower respiratory infections

3542

19746

1.80

208.22

2.5

2.2

345.31

378.90

nmol/l

16.21

3275

18099

Disorders of gallbladder, biliary tract and pancreas

6342

26474

1.57

208.18

2.3

2.2

357.30

376.23

nmol/l

9.60

5852

24372

Bipolar affective disorders

1432

6152

2.56

207.15

1.9

2.2

373.29

373.45

nmol/l

0.01

1319

5708

All influenza

1743

8109

2.33

206.96

2.4

2.2

346.74

376.47

nmol/l

7.50

1602

7436

Other (not insulin) diabetes medications

6174

24069

1.58

206.89

2.1

2.3

362.80

373.36

nmol/l

3.37

5609

22235

Hypoglycaemia, other or unspecified

703

2108

4.08

206.21

2.1

396.77

366.67

nmol/l

2.90

653

1936

Chronic sinusitis

2906

16142

1.91

206.14

2.3

2.2

345.31

378.79

nmol/l

16.11

2690

14892

Specific personality disorders

1851

8878

2.28

205.77

1.9

2.1

366.97

376.94

nmol/l

1.43

1675

8213

Other diseases of blood and blood-forming organs, wide

1654

7605

2.41

205.67

2.6

2.2

364.25

374.13

nmol/l

1.04

1570

6981

Dialysis, with operation codes

1006

3692

3.12

204.80

2.6

2.4

351.92

365.83

nmol/l

1.34

969

3382

Malignant neoplasm, wide definition for exclusion

5644

21420

1.61

202.41

3.2

1.8

381.27

363.80

nmol/l

7.43

5339

19589

ILD, hospital admission 2, with pulmonary infections

741

2294

3.70

201.44

2.2

342.83

381.99

nmol/l

3.72

696

2087

Malignant neoplasm

5432

20666

1.62

200.76

3.3

1.8

382.50

363.09

nmol/l

8.81

5142

18882

Other neurological diseases

4507

22088

1.68

200.61

2.3

371.32

375.31

nmol/l

0.52

4138

20281

Thyroiditis, ILD-related definition

1032

3915

3.04

198.35

2.5

2.1

374.64

380.87

nmol/l

0.41

950

3590

Spinal stenosis

2980

12645

1.88

196.50

2.2

2.4

355.64

384.92

nmol/l

10.73

2698

11645

Cushing syndrome

244

322

16.30

196.18

8.6

1.7

361.62

368.93

nmol/l

0.11

237

300

Other metabolic disorders

1078

4186

2.91

195.63

2.8

2.1

363.51

369.42

nmol/l

0.25

1016

3850

Diverticular disease of intestine

4212

16441

1.71

193.93

2.2

2.3

357.59

375.53

nmol/l

6.13

3832

15188

Lumbar disc prolapse

3965

18506

1.72

192.95

2.2

2.3

359.51

382.22

nmol/l

10.70

3625

17158

Mental and behavioural disorders due to psychoactive substance use

3780

21245

1.73

192.70

2.2

2.3

376.79

371.39

nmol/l

0.67

3440

19691

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3343

19142

1.79

191.78

2.3

353.73

377.61

nmol/l

10.29

3065

17737

Glomerular diseases

1344

5838

2.56

191.31

2.3

348.61

370.43

nmol/l

3.68

1267

5362

Infections of the skin and subcutaneous tissue

3841

23314

1.71

190.65

2.4

2.2

358.22

374.21

nmol/l

5.07

3593

21500

Follow-up examination after treatment for conditions other than malignant neoplasms

2663

9493

1.95

190.47

2.0

2.2

378.31

385.62

nmol/l

1.02

2465

8803

Shoulder lesions

4668

17792

1.65

189.64

2.3

358.47

380.86

nmol/l

11.48

4280

16426

Rheumatism, unspecified

1090

4324

2.84

189.54

2.1

2.2

330.80

389.51

nmol/l

18.36

1007

3973

Nephropathy related operations

978

3693

3.04

189.18

2.6

2.3

347.43

365.76

nmol/l

2.05

946

3384

Irregular menses

3391

15808

1.80

189.06

2.2

2.1

372.84

381.31

nmol/l

1.44

3121

14573

Allergic asthma (mode), excluding more controls

1551

6947

2.33

188.85

2.2

2.0

344.97

386.15

nmol/l

13.81

1441

6433

Panic disorder

1184

4875

2.69

188.78

2.1

384.32

380.14

nmol/l

0.30

1056

4528

Fall on same level

7450

28239

1.49

186.98

2.2

365.72

375.37

nmol/l

3.51

6877

26134

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3699

22564

1.72

186.86

2.3

2.2

369.76

375.05

nmol/l

0.75

3431

20711

Substance abuse

3649

20843

1.72

184.90

2.2

2.3

376.59

371.11

nmol/l

0.67

3322

19318

Acute bronchitis

2687

14797

1.89

183.29

2.4

2.2

342.06

377.81

nmol/l

14.40

2469

13512

Allergic asthma (mode)

1551

7066

2.29

181.18

2.2

2.0

344.97

387.53

nmol/l

14.58

1441

6541

Postprocedural endocrine and metabolic disorders, not elsewhere classified

996

3865

2.91

181.15

2.9

2.1

367.07

369.83

nmol/l

0.10

938

3558

Any event in cancer register

5866

23130

1.55

179.95

3.2

1.8

380.67

366.66

nmol/l

5.31

5531

21189

Functional dyspepsia

1843

9284

2.14

177.88

2.3

2.2

362.92

379.47

nmol/l

3.25

1692

8523

Non-allergic asthma (mode), excluding more controls

1198

5002

2.56

177.67

2.2

2.1

335.95

385.66

nmol/l

13.54

1113

4596

Other endocrine disorders

566

1554

4.35

176.99

2.9

2.1

313.98

366.55

nmol/l

6.47

542

1438

Polyneuropathies and other disorders of the peripheral nervous system

1459

6838

2.33

171.80

2.4

2.3

356.08

374.10

nmol/l

2.67

1348

6272

Intracranial injury

3705

21789

1.68

171.59

2.1

2.2

377.17

376.36

nmol/l

0.08

3382

20046

Other and unspecified polyneuropathies, also in other diseases

1295

5805

2.46

170.46

2.4

2.3

354.52

374.16

nmol/l

2.74

1189

5313

Other diseases of upper respiratory tract

6925

25115

1.48

169.76

2.2

361.47

381.12

nmol/l

12.22

6352

23174

Other necrotizing vasculopathies (FG)

546

1569

4.19

169.75

2.2

2.3

332.56

391.43

nmol/l

7.18

506

1421

Other respiratory diseases principally affecting the interstitium

1211

5288

2.52

169.22

2.1

2.3

338.55

378.91

nmol/l

7.60

1144

4808

Injuries to the head

7097

30722

1.47

169.03

2.1

2.2

373.91

374.42

nmol/l

0.07

6515

28372

1056

4350

2.70

168.80

2.5

2.2

370.00

379.04

nmol/l

0.63

981

3964

Other arthritis (FG)

2027

10722

2.02

168.59

2.3

347.54

383.72

nmol/l

13.15

1906

9858

Candidiasis

2043

10879

2.03

168.56

2.4

2.1

353.26

380.53

nmol/l

6.67

1867

9981

Disturbances of skin sensation

1987

10491

2.04

168.03

2.2

2.1

368.90

375.44

nmol/l

0.79

1825

9637

Paroxysmal tachycardia

1374

5192

2.37

167.95

2.2

2.4

364.99

381.44

nmol/l

1.99

1247

4816

Insulin, fast-acting (human)

1110

4687

2.63

167.83

1.8

2.1

397.80

370.67

nmol/l

4.79

1018

4290

Non-allergic asthma (mode)

1198

5134

2.49

167.61

2.2

2.0

335.95

385.58

nmol/l

13.45

1113

4709

Venous thromboembolism

3272

19229

1.73

166.36

2.5

2.2

363.87

376.84

nmol/l

2.79

3055

17561

Schizophrenia or delusion, excluding more controls

1822

9219

2.07

165.85

1.8

2.3

390.95

373.44

nmol/l

2.87

1672

8552

Other diseases of the digestive system

1995

10556

2.02

165.58

2.2

2.3

376.12

376.53

nmol/l

0.02

1850

9604

Nonorganic sleeping disorders

1543

7507

2.25

165.53

2.0

2.2

373.10

373.24

nmol/l

0.01

1414

6906

Paralytic ileus and intestinal obstruction

1601

7852

2.18

164.59

2.4

2.3

381.03

381.36

nmol/l

0.02

1474

7183

GI-bleeding

1987

10519

2.01

164.47

2.2

2.3

376.18

376.46

nmol/l

0.01

1847

9571

Other symptoms and signs involving the digestive system and abdomen

1173

5105

2.51

164.32

2.4

2.1

372.22

383.53

nmol/l

0.92

1061

4664

ILD, hospital admissions 3, with pneumonia sepsis

642

2068

3.57

164.16

2.1

2.2

343.70

379.43

nmol/l

2.93

603

1880

Care involving dialysis

649

2117

3.58

163.72

2.4

2.2

346.10

361.07

nmol/l

1.12

627

1927

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1589

6939

2.21

162.06

2.1

2.0

370.78

385.15

nmol/l

2.14

1459

6449

Falls/tendency to fall

7002

24634

1.47

161.69

2.1

2.3

368.96

375.65

nmol/l

1.82

6458

22792

Disorders of lens

3901

15282

1.66

161.59

2.4

354.14

373.70

nmol/l

6.43

3602

14161

COPD

2532

11768

1.85

160.28

2.6

2.3

354.80

389.02

nmol/l

10.81

2307

10765

Post-traumatic stress disorder

728

2562

3.24

159.70

2.0

389.82

384.28

nmol/l

0.21

652

2382

Acromegaly and pituitary gigantism

165

176

25.83

158.38

6.0

1.7

358.29

402.61

nmol/l

1.51

156

163

Other necrotizing vasculopathies

626

2050

3.63

158.37

2.2

2.1

342.26

377.79

nmol/l

3.13

582

1856

Sarcoidosis

1031

4355

2.67

157.56

2.4

2.2

343.24

369.92

nmol/l

4.92

983

3997

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1178

5242

2.46

157.04

5.1

1.8

424.33

365.52

nmol/l

16.38

1137

4719

Solid cancers, helper endpoint

5135

20334

1.55

156.31

3.4

1.8

383.45

363.02

nmol/l

9.13

4851

18565

Polymyalgia rheumatica

937

3790

2.77

156.11

1.9

2.1

337.54

384.67

nmol/l

7.72

868

3386

External causes of morbidity and mortality

4286

13729

1.62

155.38

2.1

2.3

368.96

380.80

nmol/l

3.02

3939

12680

Migraine without aura and triptan purchases

1290

6012

2.36

154.86

2.2

2.0

371.14

378.73

nmol/l

0.70

1183

5546

Hyperparathyroidism

1219

5472

2.41

154.56

2.2

1.9

356.24

392.30

nmol/l

6.70

1119

4927

Retention of urine

1961

8552

1.99

154.32

2.3

2.4

376.92

376.66

nmol/l

0.02

1792

7863

Thyrotoxicosis, other and/or unspecified

1371

6534

2.28

154.14

2.2

2.0

378.26

378.67

nmol/l

0.03

1258

6002

Pulmonary heart disease, diseases of pulmonary circulation

1966

10644

1.97

152.28

2.8

2.2

362.43

377.75

nmol/l

2.16

1839

9686

Chronic rhinitis, nasopharyngitis and pharyngitis

2115

11722

1.92

152.15

2.2

354.76

376.83

nmol/l

5.99

1923

10814

Other specified/unspecified arthritis

1753

9163

2.04

151.20

2.4

347.70

385.14

nmol/l

11.83

1648

8406

Glomerular disorders in diseases classified elsewhere

873

3480

2.83

150.71

2.0

2.3

364.30

371.64

nmol/l

0.50

819

3184

Disorders of choroid and retina

4745

22587

1.55

150.64

2.2

2.3

378.36

372.80

nmol/l

1.04

4329

20782

Rheumatoid arthritis

1998

9715

1.96

150.59

1.9

2.3

341.24

387.74

nmol/l

19.12

1861

8889

Bacterial pneumoniae

2401

12109

1.84

150.36

2.5

2.2

369.54

378.76

nmol/l

1.02

2229

11077

Non-small cell lung cancer, adenocarcinoma

500

1466

4.04

149.96

5.4

1.8

418.63

360.65

nmol/l

6.23

486

1306

Phobic anxiety disorders

1010

4299

2.58

148.82

2.1

378.10

376.34

nmol/l

0.09

907

4010

Psychotic depression

491

1419

3.98

148.63

2.1

2.3

395.12

383.56

nmol/l

0.43

441

1315

Other retinal disorders

3727

18583

1.63

148.40

2.1

2.3

381.04

375.81

nmol/l

0.78

3389

17047

Persistent mood disorders

1310

6229

2.28

147.77

2.0

2.2

362.02

376.01

nmol/l

1.67

1174

5736

ILD, hospital admissions

1023

4413

2.57

147.72

2.2

341.40

376.84

nmol/l

4.99

964

4019

Other interstitial pulmonary diseases

1031

4463

2.56

147.54

2.2

2.3

341.48

377.36

nmol/l

5.17

972

4062

Fungal Sepsis

397

1016

4.88

146.87

2.8

2.2

346.08

367.37

nmol/l

0.81

371

926

Interstitial lung disease

1031

4478

2.55

146.43

2.2

341.48

376.88

nmol/l

5.05

972

4077

Interstitial lung disease endpoints

1031

4478

2.55

146.43

2.2

341.48

376.88

nmol/l

5.05

972

4077

Other chronic obstructive pulmonary disease

2395

11343

1.83

146.26

2.6

2.3

354.16

389.24

nmol/l

10.55

2176

10375

Ischaemic heart disease, wide definition

4418

18083

1.57

146.14

2.2

2.4

363.78

372.72

nmol/l

1.98

4058

16646

Focal epilepsy

1469

7333

2.17

146.05

2.4

2.2

369.43

371.43

nmol/l

0.14

1350

6742

Polyuria

1405

6891

2.20

145.95

2.1

2.3

354.82

376.90

nmol/l

4.15

1266

6360

Other sleep disorders

791

3046

2.89

144.79

2.2

360.31

383.15

nmol/l

2.50

731

2790

Heart failure and coronary heart disease

2354

9502

1.85

144.24

2.1

2.4

373.56

382.72

nmol/l

0.92

2158

8637

Later onset COPD, excluding more controls

1101

3702

2.46

144.18

2.6

2.1

360.85

395.12

nmol/l

4.82

1007

3334

Implicit fungal Sepsis

378

948

5.04

144.17

2.8

2.2

344.97

369.50

nmol/l

0.95

353

866

DVT of lower extremities and pulmonary embolism

2498

14679

1.79

143.76

2.7

2.2

363.02

377.42

nmol/l

2.54

2334

13361

Alcohol use disorder, Swedish definition

3232

18588

1.66

143.57

2.2

2.3

378.13

369.13

nmol/l

1.23

2960

17235

Other external causes of accidental injury

5211

17726

1.52

143.28

2.1

2.3

367.57

378.22

nmol/l

3.15

4800

16396

Biguanides

5783

24647

1.48

143.06

2.1

2.3

365.82

374.85

nmol/l

2.39

5246

22763

Postviral fatigue syndrome

179

238

15.46

142.44

2.5

1.9

379.04

372.92

nmol/l

0.16

169

225

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

984

4233

2.56

142.18

4.6

1.8

385.20

366.60

nmol/l

2.22

945

3811

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3136

15630

1.68

141.37

2.0

2.4

370.55

374.89

nmol/l

0.50

2855

14396

Mycoses

1765

9483

2.00

141.33

2.7

2.2

344.37

375.92

nmol/l

7.73

1620

8706

Other bacterial intestinal infections

1218

5739

2.31

141.00

2.6

2.2

349.89

377.12

nmol/l

4.16

1131

5237

Testicular dysfunction

356

865

5.15

140.98

2.2

2.0

349.51

370.56

nmol/l

1.45

333

804

5-aminosalicylic acid

1370

6740

2.18

140.29

2.3

2.1

330.69

387.34

nmol/l

23.72

1269

6181

Pain and other conditions associated with female genital organs and menstrual cycle

1457

6742

2.14

138.89

1.9

2.1

368.10

388.75

nmol/l

3.83

1308

6197

3409

19711

1.63

138.79

2.1

2.3

378.72

370.46

nmol/l

1.13

3126

18261

Bacterial pneumonia, not elsewhere classified

2245

11354

1.83

138.66

2.4

2.2

371.00

379.17

nmol/l

0.85

2087

10379

Focal epilepsy, strict definition

1352

6679

2.20

138.49

2.4

2.2

369.34

371.79

nmol/l

0.16

1238

6148

Rotator cuff syndrome

3502

16046

1.63

138.12

2.3

352.54

380.74

nmol/l

13.95

3224

14824

Pleural effusion

982

4277

2.51

137.60

2.8

2.2

401.46

375.61

nmol/l

2.28

917

3891

Noninfectious colitis NAS

1036

4641

2.48

137.50

2.8

2.2

356.76

375.93

nmol/l

1.89

967

4251

Hypertensive heart and/or renal disease

1392

5065

2.17

136.61

2.2

2.4

367.97

381.95

nmol/l

1.25

1272

4638

Migraine with aura and triptan purchases

1201

5728

2.30

135.89

2.1

2.0

369.18

378.71

nmol/l

0.80

1094

5280

3565

20381

1.60

135.58

2.2

2.3

377.95

370.45

nmol/l

1.03

3266

18871

Unspecified haematuria

2356

11415

1.80

135.54

2.5

2.4

370.11

375.22

nmol/l

0.48

2144

10527

Bacterial pneumonia (organism specified)

2619

14351

1.73

135.14

2.5

2.2

369.21

379.78

nmol/l

1.33

2435

13076

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2020

11470

1.88

134.63

2.0

2.1

370.82

376.53

nmol/l

0.64

1829

10593

Poisoning by drugs, medicaments and biological substances

1682

9049

2.00

134.18

2.1

2.2

369.32

373.23

nmol/l

0.32

1527

8350

Pulmonary embolism

1782

9741

1.95

133.98

2.8

2.2

362.77

377.53

nmol/l

1.90

1671

8859

Emotionally unstable personality disorder

987

4382

2.50

133.93

1.9

2.1

369.85

381.16

nmol/l

1.07

888

4062

Non-ischemic cardiomyopathy

1769

7669

1.97

133.92

2.2

2.4

370.57

382.15

nmol/l

1.28

1624

6979

Inflammatory bowel disease

2088

11984

1.85

133.80

2.2

338.64

373.24

nmol/l

13.31

1936

11043

Disturbance of activity and attention

963

4138

2.53

133.80

2.0

366.66

381.03

nmol/l

1.53

892

3843

Viral pneumonia

888

3757

2.60

133.20

2.5

2.2

336.81

376.57

nmol/l

6.45

815

3439

Unspecified mental disorder

2596

15802

1.73

133.03

1.9

2.2

388.20

371.53

nmol/l

2.86

2378

14561

Accidents

5147

17726

1.50

132.95

2.1

2.3

368.06

378.22

nmol/l

2.86

4737

16396

Diseases of the ear and mastoid process

7304

26845

1.40

132.92

2.2

360.92

378.58

nmol/l

11.14

6703

24857

Pulmonary heart disease

1782

9778

1.94

132.38

2.8

2.2

362.77

377.56

nmol/l

1.91

1671

8891

Cervical disc disorders

2084

11952

1.84

132.36

2.3

2.4

359.95

381.64

nmol/l

6.02

1893

11058

Chronic apical periodontitis

6948

28890

1.41

132.27

2.3

2.2

361.87

379.53

nmol/l

10.56

6367

26684

Disorders of skin appendages

3071

19493

1.65

131.98

2.3

2.2

370.47

375.04

nmol/l

0.60

2816

17969

Other gastritis (incl. Duodenitis)

1386

7008

2.12

131.90

2.5

2.3

359.26

380.92

nmol/l

3.67

1281

6422

Cervicalgia

1332

6653

2.15

131.29

2.1

2.2

358.48

386.64

nmol/l

5.54

1219

6105

Ulcer of lower limb, not elsewhere classified

952

4187

2.50

131.12

2.1

2.2

366.56

376.53

nmol/l

0.71

874

3804

Mental and behavioural disorders due to alcohol

2993

18140

1.65

131.05

2.2

2.3

379.13

370.26

nmol/l

1.14

2739

16834

Other bacterial intestinal infections

1476

7663

2.06

130.43

2.5

2.2

356.15

376.26

nmol/l

2.67

1356

7012

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2603

15837

1.71

130.35

2.2

2.4

379.74

368.06

nmol/l

1.52

2383

14676

Disorders of synovium and tendon

3163

17663

1.63

130.08

2.1

2.3

360.19

383.44

nmol/l

9.42

2903

16333

Triptan medication for migraine, min. 3 purchases

3731

18797

1.58

129.83

2.1

368.29

376.21

nmol/l

1.58

3454

17358

Poisoning by medicine

1539

8140

2.04

129.59

2.1

2.2

371.92

373.27

nmol/l

0.09

1397

7516

Polyarthrosis

1268

5787

2.19

128.98

2.2

2.3

354.33

393.10

nmol/l

8.03

1144

5277

Other diseases of liver

1247

6152

2.21

128.92

2.1

2.2

355.09

370.13

nmol/l

1.40

1151

5654

Urticaria and erythema

2409

14533

1.75

128.67

2.3

2.1

350.07

375.01

nmol/l

8.12

2234

13373

Cerebral cysts

525

1753

3.54

128.48

2.3

2.0

390.56

373.90

nmol/l

0.52

494

1611

Elevated blood glucose level

669

2541

3.02

128.14

2.5

2.2

377.87

370.16

nmol/l

0.36

615

2335

Mouth breathing

2430

14682

1.74

128.05

2.4

344.73

368.14

nmol/l

7.50

2245

13605

Hypoparathyroidism

376

1030

4.66

128.01

2.5

1.9

311.04

385.98

nmol/l

4.72

348

929

Endocrine disorders, other/unspecified

254

518

6.91

127.70

2.9

1.8

313.95

371.57

nmol/l

2.88

239

476

Migraine, single triptan purchase ok & required. ICD-code if available is included

4875

22960

1.49

127.47

2.1

2.2

370.62

374.92

nmol/l

0.78

4507

21193

Triptan medication for migraine, single purchase ok

4875

22960

1.49

127.47

2.1

2.2

370.62

374.92

nmol/l

0.78

4507

21193

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

724

2867

2.87

127.34

2.7

2.1

358.16

373.25

nmol/l

1.11

676

2625

Fentanyl

658

2448

2.94

127.27

4.0

2.0

377.79

396.81

nmol/l

1.10

618

2190

Diabetes insipidus

176

261

12.91

126.98

5.2

1.7

299.90

381.24

nmol/l

4.38

165

241

Substance use, excluding alcohol

1348

6872

2.11

126.15

2.3

2.2

364.03

370.99

nmol/l

0.55

1205

6346

Testicular hypofunction

316

765

5.18

125.86

2.2

2.0

355.15

370.70

nmol/l

0.85

299

709

Intestinal stricture

1854

10462

1.88

125.66

2.4

2.2

380.29

374.73

nmol/l

0.40

1710

9564

Amenorrhoea

601

2177

3.15

125.49

2.8

2.1

384.17

391.61

nmol/l

0.33

558

2002

Other chronic obstructive pulmonary disease, including avohilmo

2943

15364

1.65

125.29

2.5

2.3

351.94

377.03

nmol/l

7.23

2681

14099

Primary_lymphoid and hematopoietic malignant neoplasms

1473

7756

2.04

125.15

2.4

2.3

377.82

377.13

nmol/l

0.04

1406

7087

Viral infections characterized by skin and mucous membrane lesions

2628

16300

1.69

124.80

2.4

2.2

353.02

373.63

nmol/l

5.86

2458

14979

Methotrexate

938

4177

2.45

124.68

1.9

2.1

322.94

395.17

nmol/l

24.75

885

3813

Focal epilepsy, mode (most common among epilepsy diagnosis)

1264

6332

2.16

124.57

2.4

2.2

371.14

371.44

nmol/l

0.02

1164

5828

Non-small cell lung cancer, adenocarcinoma, helper endpoint

500

1654

3.55

123.84

5.4

2.1

418.63

368.71

nmol/l

5.25

486

1485

Other cataract

2471

11298

1.73

123.84

2.4

360.03

378.85

nmol/l

4.35

2292

10437

Myocarditis

359

948

4.33

123.49

2.4

2.1

362.21

378.07

nmol/l

0.66

340

878

ILD, hospital admissions 1, main diag only

900

3975

2.50

123.26

2.1

2.2

344.89

374.09

nmol/l

3.10

848

3628

Hyperkinetic disorders

1001

4520

2.39

123.25

2.0

2.1

367.00

378.48

nmol/l

1.13

928

4195

Senile cataract

3364

13307

1.61

122.96

2.3

2.4

358.09

375.33

nmol/l

3.91

3084

12316

Diaphragmatic hernia

2153

12778

1.78

122.03

2.2

362.75

380.23

nmol/l

3.39

1948

11688

Malignant melanoma, including Hilmo

1048

4927

2.30

121.71

6.0

1.8

377.21

364.77

nmol/l

1.15

997

4427

Hyperhidrosis

304

731

5.09

121.19

2.0

1.8

350.12

391.57

nmol/l

2.51

278

668

Viral and other specified intestinal infections

1847

10124

1.86

121.00

2.4

2.0

367.35

381.66

nmol/l

2.14

1725

9298

Viral infections characterized by skin and mucous membrane lesions

5261

32202

1.44

120.78

2.3

2.2

359.06

377.04

nmol/l

9.21

4878

29684

Bacterial intestinal infections, IBD co-morbidities

1206

6006

2.17

120.71

2.6

2.2

350.19

377.06

nmol/l

4.10

1120

5490

Dentofacial anomalies [including malocclusion]

4409

24570

1.49

120.15

2.2

367.61

374.14

nmol/l

1.35

4051

22728

Sulfasalazine

1662

9183

1.91

119.79

2.0

2.1

344.89

392.66

nmol/l

21.44

1546

8409

Other arthrosis

2962

13009

1.64

119.75

2.2

2.4

359.00

382.03

nmol/l

7.63

2718

11995

Postmenopausal osteoporosis with pathological fracture

532

1868

3.38

119.72

2.1

324.34

385.28

nmol/l

5.88

483

1666

Coronary atherosclerosis

3489

14487

1.58

119.43

2.1

2.4

365.52

375.83

nmol/l

1.99

3194

13306

Gout

1467

6808

2.00

119.42

2.1

2.5

349.94

388.61

nmol/l

9.53

1361

6238

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

604

2257

3.06

119.13

2.4

2.1

343.81

374.62

nmol/l

3.45

554

2043

Asthma and allergy, excluding more controls

879

3813

2.45

119.06

2.3

1.9

342.45

384.66

nmol/l

8.63

819

3539

Glucagon-like peptide-1 (GLP-1) analogues

1761

9955

1.88

119.04

2.1

2.4

336.78

370.31

nmol/l

11.08

1611

9274

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1761

9955

1.88

119.04

2.1

2.4

336.78

370.31

nmol/l

11.08

1611

9274

Symptoms and signs involving speech and voice

2059

12169

1.79

118.96

2.2

365.01

376.61

nmol/l

1.90

1889

11164

Statin medication

4307

16535

1.51

118.90

2.1

2.3

362.69

373.96

nmol/l

3.15

3939

15353

Malignant melanoma

898

4010

2.45

118.84

6.2

1.8

376.50

366.48

nmol/l

0.73

855

3605

Benign neoplasm of colon, rectum, anus and anal canal

3525

20402

1.56

118.77

2.3

364.26

375.69

nmol/l

2.76

3239

18744

Carpal tunnel syndrome

3613

21352

1.55

118.71

2.1

2.2

357.69

376.77

nmol/l

7.29

3300

19671

Asthma and allergy

879

3820

2.45

118.54

2.3

1.9

342.45

384.97

nmol/l

8.71

819

3548

Gastroduodenal ulcer

1448

7660

1.99

118.52

2.2

2.3

366.56

381.79

nmol/l

1.86

1331

6997

Cerebrovascular diseases

4105

19700

1.52

118.33

2.2

2.3

376.91

372.40

nmol/l

0.64

3741

18142

Other respiratory disorders and diseases

1220

6131

2.14

118.24

2.3

351.33

375.49

nmol/l

2.60

1126

5569

Other diseases of the respiratory system

1220

6131

2.14

118.24

2.3

351.33

375.49

nmol/l

2.60

1126

5569

Missing teeth due to accident, extraction or parodontitis

3387

21192

1.57

117.99

2.4

2.3

359.10

376.15

nmol/l

5.34

3021

19542

Mycoses

5166

32224

1.44

117.70

2.3

2.2

355.08

378.23

nmol/l

13.13

4724

29775

Hypertensive Heart Disease

1223

4729

2.14

117.24

2.3

2.4

367.59

382.77

nmol/l

1.26

1110

4311

Chronic gastritis

1574

8624

1.94

117.11

2.2

2.3

364.49

381.82

nmol/l

2.63

1410

7880

Malignant melanoma of skin, including Hilmo

895

4018

2.43

116.81

6.6

1.8

374.36

367.55

nmol/l

0.49

857

3616

Heart failure and bmi 25plus

1948

7540

1.84

116.52

2.1

2.5

360.22

361.00

nmol/l

0.05

1774

6865

Any operation in hilmo

246

186

7.16

115.95

1.9

1.2

388.42

415.70

nmol/l

0.95

224

176

Deforming dorsopathies

1695

9530

1.88

115.84

2.2

350.79

386.23

nmol/l

9.72

1539

8785

Other complications of surgical and medical care, not elsewhere classified

741

3096

2.68

115.75

2.9

2.1

359.97

372.03

nmol/l

0.78

704

2831

Other or unspecified ileus, impaction or obstruction

1095

5325

2.20

115.50

2.4

2.3

390.41

381.93

nmol/l

0.42

1003

4873

Coagulation defects, purpura and other haemorrhagic conditions

1307

6810

2.07

115.43

2.3

2.2

358.17

372.78

nmol/l

1.57

1230

6250

Hyperaldosteronism

297

740

5.22

115.40

2.4

2.0

321.54

376.00

nmol/l

3.78

281

684

Alcohol use disorder, ICD-based

2381

14691

1.70

115.17

2.1

2.4

376.36

367.99

nmol/l

1.07

2176

13615

Excessive, frequent and irregular menstruation

2543

8513

1.72

115.13

2.0

2.1

373.25

390.77

nmol/l

3.61

2300

7781

Thyrotoxicosis

1667

9388

1.90

114.87

2.3

2.1

375.62

375.51

nmol/l

0.01

1530

8569

Injury, poisoning and certain other consequences of external causes

3392

11058

1.59

114.11

2.1

2.3

371.98

382.20

nmol/l

2.01

3115

10199

Diabetic maculopathy, excluding more controls

743

3117

2.63

113.86

1.9

2.2

395.48

374.58

nmol/l

2.10

687

2866

Chronic pancreatitis

817

3582

2.51

113.59

2.5

2.3

384.12

369.04

nmol/l

1.13

764

3300

Arthrosis

4072

15207

1.51

113.09

2.1

2.3

353.61

381.38

nmol/l

14.90

3752

14006

Malignant melanoma of skin

721

2996

2.66

112.99

7.1

1.8

372.01

366.57

nmol/l

0.32

692

2693

Diseases of arteries, arterioles and capillaries

3661

18254

1.54

112.87

2.3

379.49

374.09

nmol/l

0.71

3353

16735

Diseases of pulp and periapical tissues, including avohilmo

6462

24699

1.39

112.75

2.2

365.18

381.93

nmol/l

8.28

5905

22816

Cholelithiasis, broad definition with cholecystitis

5088

24518

1.44

112.38

2.2

352.58

377.50

nmol/l

14.10

4676

22537

Cholelithiasis

4905

24107

1.45

111.52

2.2

351.75

377.70

nmol/l

14.82

4512

22156

Vasomotor and allergic rhinitis

2380

14533

1.68

111.20

2.2

2.1

357.95

378.66

nmol/l

6.32

2191

13460

COPD related to multimorbidity

2085

10526

1.75

111.11

2.5

2.3

353.06

378.62

nmol/l

5.20

1888

9628

Valvular heart disease excluding rheumatic fever

2523

11341

1.67

111.06

2.2

2.4

377.11

372.21

nmol/l

0.45

2321

10420

Non-rheumatic valve diseases

2501

11231

1.67

110.19

2.2

2.4

377.13

372.70

nmol/l

0.40

2302

10314

Pain in thoracic spine

1010

4872

2.24

109.90

2.4

2.2

352.97

385.49

nmol/l

5.43

930

4475

Eating disorder

751

3236

2.60

109.56

2.0

396.09

387.61

nmol/l

0.50

675

2982

Coxibs

1654

4729

1.92

109.52

2.0

2.2

363.94

401.18

nmol/l

10.36

1512

4370

Sequelae of external causes of morbidity and mortality

1592

8974

1.89

108.98

2.4

2.2

366.19

375.44

nmol/l

0.96

1502

8217

COPD, early/later onset

2408

12645

1.68

108.94

2.6

2.3

354.25

378.31

nmol/l

5.46

2187

11584

Temporomandibular joint disorders, including avohilmo

2843

18292

1.60

108.77

2.1

372.33

378.01

nmol/l

0.83

2608

16879

Kidney transplant status

453

1540

3.49

107.91

3.0

2.3

322.55

361.23

nmol/l

3.96

444

1434

COPD, hospital admission 2, with asthma infections

1725

8468

1.84

107.69

2.6

2.3

350.11

378.64

nmol/l

5.18

1561

7731

Kela-code for severe mental illness

2253

13972

1.69

107.39

1.9

2.2

387.04

370.26

nmol/l

2.47

2054

12874

Diseases of oral cavity, salivary glands and jaws

3421

11637

1.56

107.26

2.2

367.90

384.98

nmol/l

4.72

3112

10741

Candidiasis

969

4676

2.28

106.90

2.7

2.1

348.08

376.01

nmol/l

3.70

887

4283

COPD, hospital admissions

2380

12576

1.67

106.35

2.6

2.3

354.34

378.21

nmol/l

5.32

2159

11520

Extrapyramidal and movement disorders

2176

13433

1.70

105.76

2.1

2.2

377.09

376.41

nmol/l

0.05

1983

12276

Enterocolitis due to Clostridium difficile

733

3172

2.55

105.08

2.6

2.1

342.47

377.94

nmol/l

4.03

678

2874

Unknown and unspecified causes of morbidity

479

1677

3.17

104.78

2.5

2.0

341.70

382.86

nmol/l

5.15

454

1521

Subjective visual disturbances

1605

9180

1.86

104.73

2.2

368.96

376.52

nmol/l

0.72

1472

8421

Other and unspecified drugs and medicaments

664

2773

2.71

104.71

2.8

2.1

357.40

372.54

nmol/l

1.04

622

2526

Other disorders of skin and subcutaneous tissue, not elsewhere classified

948

4563

2.26

104.50

2.6

2.2

347.64

375.07

nmol/l

4.07

861

4176

Agranulocytosis

801

3637

2.45

103.62

2.8

2.2

375.79

370.39

nmol/l

0.25

762

3337

Injuries to the abdomen, lower back, lumbar spine and pelvis

2341

14605

1.66

103.57

2.2

2.1

355.76

380.24

nmol/l

6.46

2127

13344

Collagenous colitis

688

2933

2.64

103.48

2.8

2.1

355.45

373.82

nmol/l

1.49

649

2683

Respiratory insufficiency

465

1605

3.16

102.91

2.2

2.1

335.39

378.92

nmol/l

2.91

427

1451

Extracorporeal dialysis

476

1703

3.25

102.79

2.5

2.3

340.35

366.76

nmol/l

2.27

461

1566

Type 1 diabetes, definitions combined

740

3240

2.51

102.67

2.1

2.2

432.61

363.89

nmol/l

11.90

696

3011

Cervicobrachial syndrome

1336

7254

1.96

102.59

2.0

2.2

366.16

382.77

nmol/l

2.47

1228

6694

Hernia

5488

27080

1.40

102.17

2.2

362.53

374.71

nmol/l

3.75

5046

24962

Suicide or other Intentional self-harm

1595

9169

1.85

102.03

2.1

2.2

371.66

372.47

nmol/l

0.05

1433

8463

Ulcerative colitis

1561

8916

1.86

101.87

2.3

2.2

333.96

373.35

nmol/l

13.05

1452

8207

Eating disorders

840

3904

2.37

101.87

1.9

2.0

395.97

384.46

nmol/l

0.85

760

3592

Dental operations

3506

12115

1.53

101.46

2.2

365.87

383.59

nmol/l

5.40

3187

11163

Type 1 diabetes, strict (exclude DM2)

736

3241

2.50

100.84

2.1

2.2

432.79

363.87

nmol/l

11.87

692

3013

Biological medication for rheuma

1192

6318

2.04

100.33

2.1

2.2

318.38

372.63

nmol/l

20.61

1141

5819

Other diseases of anus and rectum

1678

9770

1.80

100.29

2.2

354.64

380.88

nmol/l

6.17

1545

8942

Disorders of conjunctiva

5048

29701

1.40

99.90

2.3

2.2

357.46

378.45

nmol/l

11.90

4657

27382

Injuries to the thorax

2544

16478

1.61

99.85

2.1

2.3

364.56

375.31

nmol/l

1.72

2330

15124

Unspecified kidney failure

635

2631

2.65

99.72

2.4

2.2

364.39

377.95

nmol/l

0.86

596

2375

Hypercalcemia

388

1270

3.71

99.44

2.4

2.2

384.68

370.54

nmol/l

0.61

365

1158

IBD patients in KELA-register

1484

8426

1.87

99.00

2.2

331.33

372.64

nmol/l

14.73

1381

7763

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1151

6064

2.05

98.49

2.0

2.2

373.13

374.20

nmol/l

0.06

1033

5592

Purpura and other haemorrhagic conditions

918

4476

2.24

98.32

2.3

2.2

359.38

371.59

nmol/l

0.85

866

4097

Benign neoplasm: Colon

2918

18633

1.55

98.31

2.3

363.31

376.52

nmol/l

2.97

2679

17103

Inflammatory diseases of female pelvic organs

3829

19734

1.48

98.03

2.1

2.0

374.74

382.12

nmol/l

1.45

3484

18130

Syndrome of inappropriate secretion of antidiuretic hormone

113

136

18.76

98.03

3.3

1.7

413.60

390.56

nmol/l

0.43

101

120

Other eating disorders

453

1618

3.23

97.62

1.9

2.1

389.53

387.56

nmol/l

0.07

408

1494

Other enthesopathies

1711

10121

1.78

97.55

2.2

2.3

353.89

380.55

nmol/l

6.82

1565

9352

Other problems related to primary support group, including family circumstances

878

4108

2.29

97.50

2.9

2.1

336.10

374.37

nmol/l

6.87

822

3808

Urticaria

1924

11783

1.72

97.16

2.3

2.1

354.61

375.03

nmol/l

4.61

1782

10829

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1863

11180

1.74

97.15

2.5

2.0

355.03

377.52

nmol/l

5.53

1724

10321

Drug-induced osteoporosis with pathological fracture

208

456

6.57

97.12

3.1

2.0

270.40

375.54

nmol/l

6.40

198

416

Diseases of the myoneural junction and muscle

800

3717

2.36

96.87

2.3

2.2

359.42

370.87

nmol/l

0.82

728

3398

Crohn disease

910

4447

2.23

96.68

2.1

2.2

335.68

373.60

nmol/l

7.45

844

4087

Emotional disorders starting during childhood or adolecense, excluding more controls

353

1059

3.68

96.25

2.3

2.0

381.92

394.34

nmol/l

0.44

322

990

Delirium, not induced by alcohol and other psychoactive substances

723

3215

2.44

96.02

2.0

2.1

392.94

379.41

nmol/l

0.81

663

2913

Soft tissue disorders related to use, overuse and pressure

1546

8937

1.82

96.01

2.3

355.64

382.97

nmol/l

5.61

1423

8241

Dental caries, including avohilmo

4316

15636

1.45

95.81

2.2

363.95

384.51

nmol/l

7.95

3944

14461

Caries of dentine, including avohilmo

4642

17018

1.43

95.66

2.2

364.08

382.79

nmol/l

7.23

4229

15763

Biological medicines for asthma

232

558

5.62

95.42

3.1

2.1

265.54

369.67

nmol/l

14.18

226

523

Ulcerative colitis, NAS

955

4774

2.17

95.19

2.4

2.2

324.66

372.97

nmol/l

12.22

892

4381

Viral and other specified intestinal infections

1373

7503

1.89

94.98

2.5

2.0

363.86

382.13

nmol/l

2.66

1280

6891

Sequelae with surgical and medical care as external cause

1254

6868

1.96

94.84

2.3

2.2

366.32

376.79

nmol/l

0.95

1181

6279

Disorders of ocular muscles, binocular movement, accommodation and refraction

2860

19110

1.54

93.62

2.4

2.2

363.78

375.45

nmol/l

2.50

2647

17609

Gastric ulcer

995

5047

2.10

93.54

2.2

2.3

367.63

383.14

nmol/l

1.48

910

4593

Giant cell arteritis

354

1136

3.74

93.27

2.2

2.1

343.50

380.81

nmol/l

2.89

322

1024

Dialysis

344

1087

3.79

92.77

3.0

2.2

332.33

357.43

nmol/l

1.55

337

1012

Seropositive rheumatoid arthritis

1428

8122

1.85

92.60

1.9

2.3

334.64

388.80

nmol/l

19.59

1332

7435

Malignant neoplasm of urinary organs

586

2426

2.65

92.30

5.1

1.8

396.32

364.44

nmol/l

3.29

565

2172

COPD, hospital admissions 3, with asthma pneumonia sepsis

1415

6833

1.86

92.28

2.6

2.2

349.50

379.63

nmol/l

4.50

1280

6229

Gout, FINNGEN

1467

8438

1.82

91.38

2.1

2.4

349.94

381.55

nmol/l

6.93

1361

7702

Cutaneous abscess, furuncle and carbuncle

1588

9396

1.79

91.29

2.4

2.2

355.73

372.74

nmol/l

2.74

1493

8651

Other extrapyramidal and movement disorders in other diseases

1416

8128

1.85

91.24

2.1

2.2

363.02

375.92

nmol/l

1.66

1301

7445

Problems related to lifestyle

698

3136

2.43

91.14

2.2

363.00

378.02

nmol/l

1.11

642

2858

Abnormal results of function studies

623

2681

2.59

91.12

2.3

2.1

374.83

370.47

nmol/l

0.18

574

2459

Gonarthrosis [arthrosis of knee](FG)

4018

16571

1.45

90.65

2.1

2.4

355.45

381.57

nmol/l

13.79

3670

15260

Inflammatory bowel disease, strict (require KELA)

1484

8651

1.82

90.40

2.2

331.33

371.50

nmol/l

14.03

1381

7976

Obsessive-compulsive disorder

500

1945

2.86

90.19

1.9

2.0

397.45

380.82

nmol/l

0.94

452

1805

Mixed and other personality disorders

609

2614

2.61

89.91

2.0

2.1

363.79

371.33

nmol/l

0.45

547

2441

Nonalcoholic fatty liver disease

700

3194

2.44

89.55

2.0

2.2

341.11

370.96

nmol/l

3.92

643

2943

Injuries to the knee and lower leg

7083

30462

1.32

89.27

2.2

357.95

379.42

nmol/l

15.66

6542

28073

Rheumatoid arthritis, including avohilmo

2209

14261

1.62

89.00

1.9

2.2

342.31

378.74

nmol/l

14.21

2061

13005

Other pleural conditions

623

2695

2.53

88.94

2.7

2.2

395.37

374.26

nmol/l

1.14

582

2444

Early onset COPD

1251

6975

1.91

88.57

2.6

2.3

348.91

371.14

nmol/l

2.61

1131

6444

Acetic acid derivatives and related substances

1570

4648

1.82

88.42

2.0

2.2

369.62

400.98

nmol/l

5.60

1428

4289

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

603

2579

2.56

88.27

5.0

1.8

393.86

363.75

nmol/l

3.04

576

2309

Other and unspecified effects of external causes

1751

10729

1.72

88.26

2.3

2.2

362.53

374.30

nmol/l

1.13

1624

9881

Exposure to other specified factors

4437

29922

1.40

88.15

2.1

2.2

362.42

375.10

nmol/l

4.06

4048

27670

Disorders of pituitary gland, other and/or unspecified

112

151

14.33

87.59

5.7

1.9

294.65

390.77

nmol/l

4.17

105

139

Other diseases of hard tissues of teeth

3260

11560

1.50

86.27

2.2

362.51

384.89

nmol/l

7.23

2957

10685

All influenza (not pneumonia)

899

4536

2.12

86.19

2.3

2.1

348.17

372.36

nmol/l

2.88

837

4172

Diseases of pulp and periapical tissues and dental caries

3819

13819

1.45

86.01

2.2

365.35

386.73

nmol/l

7.77

3478

12789

Immunodeficiencies

408

1488

3.22

85.74

3.3

2.2

330.28

368.94

nmol/l

3.44

383

1375

Cellulitis

1324

7591

1.85

85.38

2.4

2.2

362.13

373.59

nmol/l

1.07

1238

6971

Dental pulpitis, including avohilmo

5447

26707

1.36

85.35

2.1

2.2

359.27

375.96

nmol/l

8.31

5005

24753

Pain associated with micturition

767

3694

2.26

84.68

2.0

2.2

373.30

375.64

nmol/l

0.11

694

3400

Angina pectoris

2883

13053

1.52

84.59

2.1

2.4

367.03

377.62

nmol/l

1.77

2653

11981

Monoamine oxidase A inhibitors

691

3182

2.35

84.57

2.2

2.4

351.78

379.82

nmol/l

3.48

637

2954

Abnormal involuntary movements

857

4303

2.16

84.39

2.2

2.3

365.49

375.66

nmol/l

0.77

788

3941

Disorders of sclera, cornea, iris and ciliary body

3144

22019

1.48

84.22

2.3

2.2

359.56

375.11

nmol/l

4.77

2909

20222

Eosinophilic disease (BM)

162

316

6.67

84.03

3.1

2.2

314.55

373.29

nmol/l

3.40

157

296

Conjunctivitis

4545

28154

1.39

83.99

2.2

358.40

377.89

nmol/l

9.57

4193

25959

Zoster [herpes zoster]

1102

6018

1.96

83.98

2.4

2.2

361.05

379.46

nmol/l

1.99

1019

5503

Internal derangement of knee

2046

13075

1.62

83.20

2.2

2.4

357.93

383.87

nmol/l

8.05

1876

12037

Other viral diseases

2314

15208

1.57

82.69

2.4

2.1

353.34

374.33

nmol/l

6.08

2157

14058

Menorrhagia

2102

7392

1.65

82.61

2.0

2.1

369.86

384.69

nmol/l

2.60

1890

6758

Gonarthrosis

3418

13634

1.47

82.55

2.1

2.4

355.65

382.17

nmol/l

11.99

3129

12560

Vasculitis limited to skin, not elsewhere classified

257

732

4.38

82.41

2.8

2.0

320.28

375.74

nmol/l

4.34

242

672

Conduction disorders

1532

7407

1.75

81.56

2.2

2.4

362.08

377.50

nmol/l

1.63

1394

6774

Disorders of vestibular function (Vertigo)

2614

17520

1.53

81.05

2.1

2.2

359.51

378.45

nmol/l

5.49

2362

16061

Fracture of lumbar spine and pelvis

1250

7141

1.85

80.95

2.2

2.1

359.17

383.72

nmol/l

3.16

1130

6457

Other disorders of white blood cells

419

1590

3.03

80.87

2.7

2.2

338.37

368.37

nmol/l

2.49

400

1457

Arthropathies in other diseases classified elsewhere

303

961

3.72

80.80

2.3

387.63

380.23

nmol/l

0.19

287

876

Malignant neoplasm of kidney, except renal pelvis

531

2237

2.61

80.63

5.1

1.8

393.91

363.08

nmol/l

2.88

510

2013

Temporal arteritis

307

988

3.73

80.60

2.2

2.1

339.88

383.18

nmol/l

3.31

277

886

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5435

26486

1.35

80.41

2.3

362.00

373.98

nmol/l

4.17

5044

24387

Gingivitis and periodontal diseases

6011

23805

1.33

80.27

2.2

364.30

377.53

nmol/l

5.09

5481

22020

Sicca syndrome [Sjögren]

605

2733

2.47

79.50

2.1

354.64

379.24

nmol/l

1.48

565

2484

Chronic ulcer of skin, not elsewhere classified

475

1924

2.77

79.39

2.6

2.1

340.97

377.70

nmol/l

3.18

436

1744

Social phobias

584

2585

2.46

79.09

1.9

2.1

379.29

374.52

nmol/l

0.21

523

2411

Cholecystectomy

3982

25217

1.40

78.91

2.2

354.69

377.92

nmol/l

10.05

3678

23133

Voice disturbances

1573

9658

1.72

78.85

2.3

2.2

358.13

374.21

nmol/l

2.68

1444

8871

Immunodeficiency with predominantly antibody defects

264

791

4.18

78.75

3.3

2.1

323.58

369.13

nmol/l

2.88

247

734

Ovarian dysfunction

568

2503

2.52

78.75

2.4

1.7

365.19

392.57

nmol/l

2.10

532

2291

Oxicams

1277

4057

1.86

78.69

2.2

358.73

398.22

nmol/l

7.99

1175

3743

Other diseases of lip and oral mucosa

2304

15421

1.56

78.59

2.4

2.2

364.25

373.80

nmol/l

1.54

2137

14162

Tumor necrosis factor alpha inhibitors

1036

5682

1.96

78.43

2.0

2.2

319.82

372.63

nmol/l

16.98

994

5241

Iron deficiency anaemia secondary to blood loss (chronic)

953

5075

2.01

78.38

2.2

2.1

366.10

379.80

nmol/l

1.03

865

4618

Hirsutism in women

224

606

4.82

78.37

2.1

1.9

367.76

380.47

nmol/l

0.38

204

567

Other and unspecified vasculitis limited to skin

238

671

4.46

77.69

2.9

2.0

321.04

373.74

nmol/l

3.77

227

617

Ovarian cyst

2169

8116

1.61

77.60

2.0

2.1

369.25

389.49

nmol/l

4.52

1989

7425

Pneumonia due to other infectious organisms, not elsewhere classified

275

843

3.86

77.48

2.6

2.2

360.86

365.19

nmol/l

0.09

264

780

Viral hepatitis, IBD co-morbidity

287

882

3.52

77.30

2.4

2.5

354.00

393.69

nmol/l

2.63

261

816

Disorders of adrenal gland, other and/or unspecified

125

14.81

77.17

5.6

1.6

281.64

378.97

nmol/l

1.47

112

Hypertrichosis

241

694

4.41

76.64

2.1

1.9

362.72

384.42

nmol/l

0.82

220

645

Paracetamol or NSAID medication

957

2441

2.05

76.11

1.9

2.2

380.31

395.08

nmol/l

1.19

885

2272

Fracture of rib(s), sternum and thoracic spine

1619

10074

1.68

76.11

2.2

2.3

363.19

375.10

nmol/l

1.33

1461

9225

Unspecified fall

2823

19448

1.48

76.05

2.0

2.2

367.58

376.45

nmol/l

1.35

2597

17817

Giant cell arteritis with polymyalgia rheumatica

307

1024

3.59

75.99

2.2

2.0

339.88

379.99

nmol/l

2.95

277

920

Injuries to the ankle and foot

4158

27495

1.38

75.97

2.1

2.2

368.37

373.91

nmol/l

0.96

3831

25437

Other degenerative diseases of the nervous system

1318

5708

1.79

75.95

1.8

2.4

389.57

388.28

nmol/l

0.07

1160

5279

Type 1 diabetes, strict definition

593

2690

2.42

75.91

1.8

2.2

442.37

363.51

nmol/l

11.66

555

2515

Hypermobility syndrome

442

1780

2.84

75.84

2.3

2.0

359.35

383.31

nmol/l

1.63

417

1639

Stroke, including SAH

3239

16709

1.45

75.62

2.1

2.3

379.82

373.55

nmol/l

0.89

2944

15367

Type 1 diabetes, strict definition, subgroup 1

568

2541

2.46

75.30

1.7

2.2

446.54

363.28

nmol/l

12.13

530

2373

Glomerulonephritis

649

3080

2.31

74.81

2.6

2.2

326.68

370.01

nmol/l

6.70

618

2829

Persons with potential health hazards related to communicable diseases

2330

15641

1.54

74.76

2.3

2.1

358.76

375.69

nmol/l

3.48

2231

14429

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1827

11759

1.63

74.70

2.3

2.2

354.02

375.15

nmol/l

4.70

1674

10795

Type of accident

1706

10812

1.65

74.66

2.3

2.2

354.33

376.16

nmol/l

4.67

1564

9923

Hernia of abdominal wall

2470

16917

1.51

74.65

2.3

359.21

374.59

nmol/l

2.82

2290

15577

Speech and linguistic disorders, excluding more controls

501

1984

2.57

74.56

2.6

2.1

342.04

377.14

nmol/l

3.34

463

1840

Other disorders starting during childhood or adolecense, excluding more controls

343

1152

3.18

74.45

2.3

2.1

351.09

372.17

nmol/l

1.11

317

1076

Peripheral artery disease

2160

11385

1.57

74.11

2.2

2.3

377.64

379.34

nmol/l

0.13

1966

10375

Primary hyperparathyroidism

710

3506

2.22

73.99

2.3

2.2

353.18

377.10

nmol/l

2.14

659

3193

Transport accidents

2608

15458

1.50

73.97

2.0

2.3

376.37

378.51

nmol/l

0.17

2422

14279

Endometriosis

2072

7897

1.60

73.84

2.0

2.1

376.19

387.12

nmol/l

1.59

1907

7223

Stroke, excluding SAH

3049

15732

1.46

73.79

2.2

2.3

381.03

373.73

nmol/l

1.05

2773

14443

Traumatic subdural haemorrhage

626

2785

2.28

73.61

2.1

2.4

419.92

385.53

nmol/l

2.72

572

2568

Malignant neoplasm of brain, including Hilmo

366

1358

3.06

73.22

2.7

1.8

333.14

358.99

nmol/l

0.63

347

1238

Thyrotoxicosis with diffuse goitre

850

4471

2.04

72.70

2.1

2.0

374.53

375.97

nmol/l

0.08

779

4107

Intestinal malabsorption

370

1394

3.07

72.66

2.4

2.1

382.12

371.89

nmol/l

0.41

347

1276

Major coronary heart disease event excluding revascularizations

2992

14038

1.46

72.65

2.1

2.4

367.20

376.05

nmol/l

1.23

2740

12865

Pacemaker

1633

9850

1.66

72.51

2.1

2.2

371.58

382.88

nmol/l

1.21

1492

8927

Visual field defects

557

2528

2.43

71.87

3.4

2.1

357.33

372.70

nmol/l

0.49

512

2305

Non-small cell lung cancer, squamous

278

885

3.48

71.63

6.5

1.7

427.00

371.60

nmol/l

3.56

269

779

Special screening examination for infectious and parasitic diseases

1289

5558

1.77

71.45

1.9

2.0

385.04

380.78

nmol/l

0.32

1121

5184

Heartburn

646

3101

2.24

71.15

2.1

2.2

357.44

386.94

nmol/l

3.05

581

2850

Open wound of head

2878

19666

1.45

71.11

2.2

2.3

378.72

372.68

nmol/l

0.80

2629

18117

Mixed connective tissue disease

481

2076

2.62

70.93

2.1

367.76

371.87

nmol/l

0.12

457

1891

Other diseases of intestine

792

4097

2.06

70.83

2.6

2.4

369.94

379.93

nmol/l

0.51

741

3772

Presence of cardiac and vascular implants and grafts

2140

10590

1.55

70.50

2.0

2.4

378.89

381.54

nmol/l

0.20

1944

9696

Organic, including symptomatic, mental disorders

2518

12325

1.50

70.46

1.9

2.3

388.15

378.96

nmol/l

1.29

2250

11284

Postprocedural disorders of nervous system

537

2427

2.46

70.40

2.2

2.0

365.22

374.60

nmol/l

0.57

505

2241

Adjustment and management of implanted device

931

5077

1.94

70.36

2.0

2.1

379.63

377.95

nmol/l

0.08

868

4540

Thrombocytopenia, unspecified

489

2124

2.57

70.33

2.2

354.55

369.95

nmol/l

0.88

465

1943

Lung diseases due to external agents

765

3919

2.08

70.27

2.4

2.2

364.35

375.12

nmol/l

0.59

694

3575

Secondary uncertain malignant neoplasm

700

3477

2.15

70.17

3.3

1.8

373.99

369.21

nmol/l

0.25

665

3118

Neuromuscular dysfunction of bladder

563

2585

2.38

70.12

2.2

362.66

376.29

nmol/l

0.85

515

2366

Diseases of inner ear

2934

20267

1.45

70.10

2.1

2.2

361.74

377.67

nmol/l

4.09

2658

18612

Enthesopathies of lower limb, excluding foot

1228

7281

1.77

69.71

2.1

2.3

357.62

382.15

nmol/l

4.00

1119

6723

Benign neoplasm of meninges

669

3305

2.22

69.64

2.7

2.1

369.42

375.96

nmol/l

0.32

619

3011

Special screening examination for other diseases and disorders

614

2902

2.25

69.63

2.2

374.17

385.57

nmol/l

0.74

577

2682

Pneumocystosis

194

517

4.91

69.41

3.1

2.2

359.76

376.62

nmol/l

0.33

187

479

Disorder of lipoprotein metabolism, unspecified

675

3318

2.17

69.37

2.6

2.3

357.48

369.77

nmol/l

0.78

611

3022

Other disorders of bladder

652

3174

2.21

69.25

2.3

341.76

373.61

nmol/l

3.39

589

2915

Allergic rhinitis

1897

12385

1.58

68.94

2.2

2.1

357.58

373.94

nmol/l

3.39

1743

11439

Diabetic retinopathy, excluding more controls

1662

5871

1.69

68.89

1.9

2.3

381.50

370.54

nmol/l

1.20

1524

5342

Spondylolisthesis/Spondylolysis

1013

5717

1.87

68.80

2.1

2.3

352.19

384.37

nmol/l

5.51

915

5273

Other disorders of ear

5112

25825

1.33

68.75

2.2

2.3

362.29

374.31

nmol/l

4.03

4665

23837

Dissociative [conversion] disorders

312

1102

3.25

68.72

2.2

1.9

366.73

389.73

nmol/l

1.05

287

1018

Use of pramipexole

1248

7485

1.76

68.65

2.1

2.2

357.23

377.18

nmol/l

3.20

1145

6832

Adverse effects, not elsewhere classified

1237

7412

1.77

68.51

2.4

2.2

355.73

372.43

nmol/l

2.03

1147

6820

Total colectomy

332

1220

3.16

68.47

2.9

2.1

354.03

371.80

nmol/l

0.78

315

1130

Total colectomy operation

332

1220

3.16

68.47

2.9

2.1

354.03

371.80

nmol/l

0.78

315

1130

Clear cell adenocarcinoma of kidney

311

1098

3.25

68.47

5.7

1.8

387.38

364.59

nmol/l

1.21

302

986

Brachial plexus disorders

631

3065

2.25

68.36

2.2

368.66

373.55

nmol/l

0.27

589

2842

Schizophrenia, schizotypal and delusional disorders

1830

12012

1.59

68.34

1.8

2.2

390.64

371.22

nmol/l

3.54

1678

11075

Cluster headache, strict

273

897

3.49

67.99

2.4

2.1

341.63

382.60

nmol/l

3.26

252

835

Hypocalcemia

223

660

4.25

67.96

2.5

2.1

375.82

368.12

nmol/l

0.19

207

608

Cluster headache, wide

286

965

3.38

67.91

2.4

2.1

338.66

381.91

nmol/l

3.65

264

898

Schizophrenia or delusion

1822

11969

1.59

67.80

1.8

2.2

390.95

371.39

nmol/l

3.57

1672

11036

L01XE Protein kinase inhibitors

393

1581

2.85

67.70

5.6

2.2

402.90

370.48

nmol/l

2.75

384

1444

Non-Hodgkin lymphoma, all, including Hilmo

703

3549

2.12

67.50

2.3

1.8

371.19

366.50

nmol/l

0.25

670

3174

Disease of hard tissues of teeth, NOS

3022

11201

1.45

67.50

2.2

356.86

385.35

nmol/l

11.09

2761

10373

Isolated growth hormone deficiency

129

267

8.79

67.49

4.4

3.1

312.17

321.95

nmol/l

0.22

124

259

Extreme obesity with alveolar hypoventilation

314

1130

3.23

67.30

2.2

2.1

310.55

373.27

nmol/l

5.76

289

1046

Other and unspecified myopathies

539

2480

2.38

67.02

2.3

2.1

358.22

372.96

nmol/l

0.84

483

2261

Benign intracranial hypertension

133

272

6.83

66.77

2.4

1.9

373.20

388.87

nmol/l

0.32

126

248

Chronic laryngitis and laryngotracheitis

824

4415

2.00

66.73

2.3

2.2

335.28

381.74

nmol/l

8.48

745

4049

SLE (Finngen)

266

874

3.53

66.58

2.0

349.26

381.10

nmol/l

1.65

242

800

Diabetic nephropathy, excluding more controls

947

4343

1.94

66.54

1.9

2.3

380.75

369.94

nmol/l

0.86

884

3935

Other symptoms and signs involving the circulatory and respiratory systems

412

1691

2.67

66.14

2.3

2.1

358.41

384.60

nmol/l

1.88

384

1543

Other and unspecified mood [affective] disorders

483

2132

2.48

66.07

2.0

2.1

403.17

381.51

nmol/l

1.46

446

1976

Pruritus

699

3565

2.12

65.99

2.4

2.1

344.96

376.67

nmol/l

4.29

639

3256

Acute pancreatitis

1056

6111

1.82

65.69

2.3

356.23

372.95

nmol/l

1.60

973

5633

Adalimumab

658

3301

2.18

65.56

2.1

315.84

372.24

nmol/l

13.51

631

3045

Abnormal findings on diagnostic imaging of central nervous system

370

1469

2.87

65.27

2.7

2.1

363.13

375.41

nmol/l

0.56

349

1349

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

326

1220

3.11

65.20

2.0

2.2

383.12

359.61

nmol/l

1.58

314

1153

Other viral diseases

1751

11481

1.59

65.01

2.5

2.2

349.72

373.43

nmol/l

5.62

1632

10595

Other shoulder lesions

593

2867

2.24

64.58

2.4

2.3

364.47

382.99

nmol/l

1.39

539

2645

Injuries to the hip and thigh

2495

15878

1.47

64.51

2.1

2.2

370.43

377.94

nmol/l

0.79

2271

14487

Crohn's disease NAS

466

2063

2.51

64.20

2.1

321.29

375.41

nmol/l

8.37

435

1900

Carbimazole or st.post thyroidectomy, condition for graves disease

1269

7788

1.72

64.13

2.3

2.2

373.71

375.01

nmol/l

0.07

1175

7131

AV-block

881

4225

1.92

64.08

2.2

2.4

362.68

379.80

nmol/l

1.49

795

3833

Trochanteric bursitis

823

4464

1.97

64.06

2.2

349.60

389.39

nmol/l

6.99

752

4091

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

815

4411

1.97

64.02

2.1

2.3

368.42

369.26

nmol/l

0.03

756

4054

Zoster [herpes zoster]

2642

18543

1.45

63.98

2.2

362.37

379.78

nmol/l

4.40

2433

16957

Other specified and unspecified personality disorders

606

2975

2.22

63.88

2.1

355.55

373.84

nmol/l

1.64

545

2755

Malignant neoplasm of skin

2416

11496

1.48

63.68

3.6

1.8

375.51

366.22

nmol/l

1.35

2230

10386

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

321

1197

3.03

63.59

2.2

1.8

349.42

360.34

nmol/l

0.39

296

1068

Other specified/unspecified systemic involvement of connective tissue

424

1816

2.63

63.46

2.0

2.1

370.89

374.40

nmol/l

0.09

402

1653

Coxarthrosis [arthrosis of hip](FG)

2652

13190

1.45

63.41

2.2

2.5

359.48

385.14

nmol/l

7.79

2410

12121

Short stature, not elsewhere classified

234

683

3.93

63.40

2.8

2.5

313.27

352.18

nmol/l

2.33

228

648

Transient ischemic attack

2613

14995

1.45

63.29

2.2

2.3

374.75

376.49

nmol/l

0.14

2376

13747

Childhood asthma (age<16), excluding more controls

771

3175

2.01

63.23

2.0

1.8

379.16

393.82

nmol/l

1.10

713

2961

Chronic diseases of tonsils and adenoids

4444

21504

1.34

62.97

2.2

369.96

378.55

nmol/l

2.14

4110

19934

FESS (DNB20)

777

4178

2.00

62.74

2.6

2.2

327.33

370.78

nmol/l

6.34

727

3855

Benign neoplasm: Cerebral meninges

607

3011

2.21

62.61

2.7

2.1

372.97

374.20

nmol/l

0.04

563

2738

Other symptoms and signs involving the urinary system

599

2942

2.19

62.46

2.6

2.3

350.03

373.33

nmol/l

2.23

559

2713

Alcohol dependence

1382

8682

1.66

62.38

2.2

2.4

376.20

367.55

nmol/l

0.74

1258

8070

Radiculopathy

865

4794

1.91

62.26

2.2

358.95

389.39

nmol/l

4.35

788

4398

Papulosquamous disorders

2143

14807

1.50

62.19

2.2

354.81

372.32

nmol/l

3.60

1953

13616

Gout, idiopatic and unspecified

1213

7400

1.72

61.85

2.1

2.4

348.56

375.10

nmol/l

4.19

1118

6774

Ethmoidectomy

800

4362

1.97

61.81

2.6

2.2

325.06

372.50

nmol/l

7.62

749

4028

Fenamates

852

3122

1.95

61.73

2.3

2.2

363.72

403.94

nmol/l

6.51

785

2875

Childhood asthma (age<16)

771

3203

1.99

61.72

2.0

1.8

379.16

393.59

nmol/l

1.08

713

2988

Explicit bacterial Sepsis

577

2802

2.20

61.54

2.6

2.2

367.58

372.77

nmol/l

0.18

543

2567

Wide developmental disorders, excluding more controls

237

745

3.55

61.30

2.1

2.3

335.07

361.61

nmol/l

1.37

227

700

Other dialysis

258

884

3.49

61.19

2.6

2.3

343.54

358.45

nmol/l

0.57

252

825

Other (seronegative) rheumatoid arthritis, wide

1091

6522

1.77

60.94

2.0

2.2

338.55

377.13

nmol/l

7.70

1008

5946

Malignant neoplasm of eye, brain and central nervous system

311

1170

3.01

60.72

2.7

1.8

321.70

360.28

nmol/l

3.28

297

1069

Ascites

435

1904

2.49

60.64

2.6

2.3

420.81

381.48

nmol/l

1.89

419

1737

Other viral diseases, not elsewhere classified

1584

10303

1.60

60.44

2.5

2.2

350.14

372.61

nmol/l

5.16

1487

9497

Malignant neoplasm of brain

264

915

3.33

60.37

2.4

1.9

317.02

363.61

nmol/l

3.79

251

831

Abnormal findings on diagnostic imaging of other body structures

801

4397

1.95

60.36

2.6

2.1

377.29

375.53

nmol/l

0.08

750

4023

Noninflammatory disorders of female genital tract

2469

8641

1.48

60.29

2.0

2.1

381.25

391.12

nmol/l

1.42

2256

7903

Meniscus derangement

2827

13720

1.42

60.24

2.2

2.4

356.86

382.29

nmol/l

9.92

2619

12653

Diplopia

769

4171

1.97

60.19

2.4

2.2

360.11

374.86

nmol/l

1.21

713

3818

Crohn's disease of small intestine

483

2230

2.39

60.07

2.2

2.1

339.87

376.57

nmol/l

3.88

450

2053

Coxarthrosis

2443

11327

1.46

59.96

2.2

2.5

359.13

384.26

nmol/l

6.77

2233

10423

Mental and behavioural disorders due to sedatives or hypnotics

472

2160

2.41

59.95

2.4

2.1

355.15

370.43

nmol/l

0.90

409

2011

Pemphigoid

217

678

3.81

59.67

2.6

2.0

349.96

379.13

nmol/l

1.21

199

609

Ventral hernia

1298

8133

1.67

59.66

2.4

2.2

363.75

378.27

nmol/l

1.33

1200

7464

Other and unspecified urticaria

1200

7397

1.71

59.54

2.3

2.2

353.14

373.78

nmol/l

3.19

1102

6812

Suggestive for eosinophilic asthma

550

2670

2.24

59.52

2.6

2.1

295.12

379.14

nmol/l

23.01

514

2444

Drug-induced neutropenia

480

2224

2.40

59.50

3.0

2.2

371.67

367.43

nmol/l

0.16

462

2035

Anorexia (incl.atypical)

431

1908

2.49

58.99

1.9

2.1

423.45

383.32

nmol/l

3.39

390

1761

Vitamin deficiency

339

1351

2.82

58.93

2.2

2.1

374.69

379.82

nmol/l

0.16

308

1238

Vitamin deficiency, wide

339

1351

2.82

58.93

2.2

2.1

374.69

379.82

nmol/l

0.16

308

1238

Iron deficiency

251

865

3.45

58.78

2.0

389.56

388.83

nmol/l

0.02

237

809

Hyperosmolality and hypernatraemia

128

277

5.78

58.66

2.4

2.1

383.04

373.58

nmol/l

0.15

119

250

Seronegative rheumatoid arthritis

674

3527

2.04

58.65

1.9

2.3

334.72

390.84

nmol/l

9.56

625

3211

Other Crohn's disease

482

2245

2.37

58.60

2.1

326.24

377.14

nmol/l

7.13

451

2070

Persons encountering health services for specific procedures, not carried out

530

2553

2.25

58.47

2.2

2.0

367.57

375.61

nmol/l

0.40

481

2320

Restless leg syndrome

812

4530

1.92

58.39

2.2

361.90

373.72

nmol/l

0.91

756

4153

Neuralgia and neuritis, unspecified

346

1399

2.76

58.08

2.3

2.1

354.01

381.57

nmol/l

1.80

324

1287

Disorders of psychological development

777

3948

1.95

58.04

2.4

2.0

342.31

379.46

nmol/l

5.97

723

3644

Nephrotic syndrome

260

920

3.34

58.01

3.4

2.3

313.90

363.57

nmol/l

3.46

252

855

Faecal incontinence

531

2565

2.24

57.96

2.1

358.11

392.30

nmol/l

3.09

480

2332

Other and unspecified nerve root and plexus disorders, also in other diseases

1103

6699

1.73

57.63

2.2

362.16

372.21

nmol/l

0.94

996

6184

Benign paroxysmal vertigo

1594

10556

1.58

57.57

2.1

2.2

354.74

379.70

nmol/l

6.04

1438

9649

Myocardial infarction

2313

11432

1.47

57.46

2.2

2.5

370.07

378.35

nmol/l

0.85

2119

10473

Mucosal proctocolitis

779

4306

1.93

57.34

2.3

2.2

331.71

374.36

nmol/l

8.63

728

3959

Malnutrition

201

622

3.99

57.00

2.2

387.85

370.71

nmol/l

0.44

190

567

Injuries to the shoulder and upper arm

4551

28677

1.31

56.94

2.2

2.3

361.69

375.55

nmol/l

4.82

4192

26422

Ischaemic Stroke, excluding all haemorrhages

2748

14859

1.41

56.89

2.1

2.3

380.85

376.04

nmol/l

0.54

2491

13634

COPD-related respiratory insufficiency

611

3121

2.09

56.86

2.2

2.3

317.84

375.84

nmol/l

8.90

553

2843

Respiratory conditions due to other external agents

183

532

4.22

56.80

3.1

2.0

357.29

375.35

nmol/l

0.46

176

480

Unspecified acute lower respiratory infection

862

4937

1.85

56.01

2.5

2.2

347.70

368.06

nmol/l

2.11

812

4536

Other abnormal uterine and vaginal bleeding

1292

5806

1.67

55.96

1.9

2.2

373.35

385.23

nmol/l

1.21

1162

5282

Gout, unspecified

1002

5975

1.76

55.96

2.1

2.4

352.48

377.14

nmol/l

3.07

931

5486

Misadventures to patients during surgical and medical care

818

4626

1.88

55.75

2.7

2.2

376.70

373.27

nmol/l

0.17

757

4235

Other disorders of eye and adnexa

868

5004

1.85

55.65

2.2

371.89

373.29

nmol/l

0.07

795

4597

Status epilepticus

247

859

3.24

55.52

2.3

2.1

356.11

384.20

nmol/l

1.42

228

784

Eosinophilia

163

449

4.62

55.38

3.1

2.0

314.47

372.50

nmol/l

3.34

158

414

Haemorrhoids and perianal venous thrombosis

1576

10435

1.56

55.36

2.4

2.3

363.66

381.61

nmol/l

2.69

1450

9556

Fissure and fistula of anal and rectal regions

1262

7984

1.65

55.35

2.0

2.3

367.49

376.50

nmol/l

0.89

1140

7345

Bullous pemphigoid

181

532

4.14

55.12

2.7

1.9

338.20

381.12

nmol/l

2.05

163

477

Abnormalities of gait and mobility

667

3556

2.01

55.10

1.9

2.3

373.07

372.59

nmol/l

0.02

613

3248

Diseases of salivary glands

1797

12307

1.52

54.90

2.3

2.2

358.06

374.57

nmol/l

3.16

1631

11332

Autism spe, excluding more controls

178

511

3.97

54.69

2.1

2.0

341.63

373.63

nmol/l

1.40

171

479

Localized swelling, mass and lump of skin and subcutaneous tissue

1700

11516

1.53

54.68

2.6

2.2

371.25

374.85

nmol/l

0.33

1579

10568

Acidosis

167

465

4.30

54.65

2.3

398.07

353.70

nmol/l

1.40

150

431

Disorders of magnesium metabolism

184

7.78

54.44

3.1

2.1

387.63

353.54

nmol/l

0.66

169

Diabetic retinopathy, strict definition

1110

6082

1.73

54.11

1.8

2.2

388.76

369.64

nmol/l

2.54

1011

5564

Cervicocranial syndrome

620

3242

2.04

54.07

2.2

369.39

384.72

nmol/l

1.21

570

2983

Cytomegalovirus infection, IBD co-morbidity

203

652

3.79

54.05

3.0

2.2

343.54

371.25

nmol/l

0.83

192

611

Acute pancreatitis (for exclusion)

1056

6446

1.72

54.03

2.3

356.23

371.56

nmol/l

1.41

973

5921

Fibrosis and cirrhosis of liver

474

2265

2.29

53.93

2.1

2.2

358.06

372.26

nmol/l

0.52

447

2069

Other diseases of pericardium

285

1086

2.93

53.89

2.9

2.3

330.14

366.90

nmol/l

2.52

272

994

Polycystic ovarian syndrome

401

1794

2.47

53.80

2.2

1.6

359.03

393.32

nmol/l

3.08

374

1633

Gout, strict definition

890

5198

1.80

53.78

2.0

2.4

349.43

375.86

nmol/l

3.00

821

4771

Non-small cell lung cancer, squamous, helper endpoint

278

1042

2.93

53.73

6.5

2.0

427.00

376.64

nmol/l

3.18

269

933

Bullous disorders

381

1671

2.54

53.73

2.6

2.1

348.62

373.83

nmol/l

1.70

352

1521

Complications of internal orthopaedic prosthetic devices, implants and grafts

1135

7061

1.68

53.68

2.2

363.42

381.51

nmol/l

1.31

1027

6400

Intestinal adhesions without obstruction

477

2282

2.25

53.37

2.6

2.3

372.33

375.96

nmol/l

0.14

443

2074

Other inflammatory liver diseases

434

2014

2.38

53.35

2.8

2.1

348.60

371.47

nmol/l

1.66

409

1843

6-mercaptopurine

257

937

3.12

53.34

2.4

1.9

339.45

385.62

nmol/l

3.96

244

871

Psoriatic and enteropathic arthropathies

669

3609

1.97

53.04

2.1

2.4

335.74

381.83

nmol/l

6.78

621

3328

Anankastic personality disorder

301

1197

2.86

53.03

2.0

369.88

370.97

nmol/l

0.04

277

1118

Disorders of muscles

584

3013

2.07

52.95

2.1

2.2

357.03

381.26

nmol/l

1.58

549

2769

Autoimmune hyperthyroidism

390

1731

2.46

52.88

2.1

376.22

379.35

nmol/l

0.12

362

1589

Spondyloarthritis

966

5787

1.75

52.86

2.2

346.74

378.53

nmol/l

5.25

896

5317

Diseases of male genital organs

2450

8801

1.44

52.76

2.4

2.5

357.16

364.97

nmol/l

0.97

2253

8277

Amputation

535

2679

2.14

52.68

2.1

2.2

367.71

378.54

nmol/l

0.55

495

2448

Parkinson's disease, excluding more controls

557

2644

2.08

52.30

1.7

2.7

390.66

387.65

nmol/l

0.13

494

2457

Agoraphobia

246

885

3.15

52.27

1.8

2.0

369.91

374.65

nmol/l

0.12

211

824

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

957

5756

1.76

52.26

2.3

2.2

328.57

372.30

nmol/l

11.25

887

5293

Benign neoplasm of other and ill-defined parts of digestive system

983

5962

1.74

52.07

2.5

2.2

363.28

375.65

nmol/l

1.13

889

5445

Cytomegaloviral disease

206

683

3.64

51.91

3.0

2.2

342.91

370.00

nmol/l

0.81

195

636

Atherosclerosis, excluding cerebral and coronary sclerosis

1902

10441

1.49

51.91

2.2

2.3

377.24

380.56

nmol/l

0.24

1717

9486

Cardiomyopathy

838

4850

1.81

51.87

2.4

381.29

372.58

nmol/l

0.54

795

4468

Other/unspecified cytomegaloviral diseases

179

547

4.05

51.84

3.0

2.0

334.34

364.34

nmol/l

0.84

170

514

Stomatitis and related lesions

1133

7127

1.67

51.74

2.5

2.2

369.79

373.65

nmol/l

0.28

1039

6544

Other disorders of kidney and ureter

724

4045

1.91

51.59

2.4

2.3

352.53

370.61

nmol/l

1.62

685

3708

Streptococcal septicaemia

475

2298

2.22

51.48

2.7

2.2

371.95

373.79

nmol/l

0.05

446

2087

Alcohol abuse, main dg, excluding more controls

727

4049

1.88

51.29

2.1

2.4

373.76

370.19

nmol/l

0.18

671

3756

Ulcerative colitis (strict definition, require KELA)

979

5960

1.73

50.99

2.3

2.2

327.62

372.78

nmol/l

12.16

908

5483

Other and unspecified nonorganic psychotic disorders

1119

7037

1.67

50.87

1.8

2.2

399.61

371.43

nmol/l

4.77

1030

6493

Oter anti-inflammatory and antirheumatic agents, non-steroids

1081

3603

1.71

50.71

2.1

2.3

355.80

399.76

nmol/l

9.39

970

3326

Unspecified/other endometriosis

579

3030

2.05

50.54

2.0

2.1

390.18

382.98

nmol/l

0.35

534

2788

Other skin changes

984

6012

1.72

50.42

2.8

2.2

354.23

378.61

nmol/l

3.78

917

5493

Drug-induced osteoporosis

138

364

5.01

50.37

3.0

1.7

320.53

368.51

nmol/l

0.76

127

334

Malignant neoplasm of endocrine gland

448

2151

2.28

50.36

3.4

1.8

384.08

363.22

nmol/l

0.49

424

1952

Emotional disorders and disorders of social functioning with onset specific to childhood

378

1665

2.46

50.36

2.2

2.1

379.84

389.69

nmol/l

0.37

342

1551

Seropositive rheumatoid arthritis, wide

1426

9500

1.57

50.07

1.9

2.2

334.76

378.09

nmol/l

13.30

1331

8669

Leisure time condition

1026

6350

1.70

50.01

2.2

356.32

375.78

nmol/l

2.29

924

5822

Chronic periodontitis, complicated

2769

20524

1.37

49.90

2.4

2.3

368.89

371.49

nmol/l

0.27

2518

18960

L04AC Interleukin inhibitors

404

1876

2.38

49.77

2.2

2.1

301.70

371.38

nmol/l

12.76

386

1749

Periodontitis

5237

28224

1.26

49.59

2.3

2.2

363.83

374.52

nmol/l

3.31

4773

26095

Disorders resulting from impaired renal tubular function

268

1044

2.95

49.53

2.6

2.2

347.81

362.57

nmol/l

0.64

262

963

Other local infections of skin and subcutaneous tissue

606

3247

2.00

49.48

2.5

2.2

357.68

370.75

nmol/l

0.83

567

2981

1926

12441

1.47

49.48

2.5

2.2

371.14

382.47

nmol/l

1.41

1744

11311

Endometriosis of pelvic peritoneum

931

5358

1.74

49.46

2.1

2.2

379.92

380.69

nmol/l

0.04

858

4936

Chronic periodontitis, including avohilmo

5216

28183

1.26

49.24

2.3

2.2

363.91

374.42

nmol/l

3.21

4754

26055

Haemorrhage, not elsewhere classified

217

747

3.21

49.19

2.3

2.0

383.56

384.02

nmol/l

0.01

209

675

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1387

9223

1.57

49.18

1.9

2.2

333.60

378.06

nmol/l

13.57

1294

8425

Other and unspecified local infections of skin and subcutaneous tissue

578

3059

2.03

49.09

2.5

2.2

357.91

370.14

nmol/l

0.73

542

2803

Fitting and adjustment of other devices

1653

10220

1.50

48.93

2.1

358.15

375.63

nmol/l

2.63

1498

9205

Congenital malformations, deformations and chromosomal abnormalities

3620

25913

1.32

48.93

2.2

370.30

374.19

nmol/l

0.57

3348

23950

Hypoplasia of dental enamel

134

364

5.63

48.79

5.9

2.6

253.29

332.29

nmol/l

5.36

129

351

Disorders of refraction and accommodation

1528

10337

1.53

48.77

2.3

2.2

363.39

373.93

nmol/l

1.27

1409

9546

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1032

6437

1.69

48.72

2.3

2.2

328.61

372.02

nmol/l

11.63

958

5916

Strabismus

1491

10061

1.54

48.58

2.5

2.2

359.71

373.24

nmol/l

1.93

1387

9284

Protozoal diseases

233

857

3.19

48.47

3.3

2.2

357.81

371.69

nmol/l

0.32

223

800

Injuries to the neck

1285

8436

1.59

48.38

2.1

2.2

371.22

375.34

nmol/l

0.27

1175

7757

Other diseases of stomach and duodenum

380

1733

2.39

48.31

2.5

2.2

359.21

378.83

nmol/l

1.08

348

1588

Viral pneumonia (unknown virus, not influenza)

434

2090

2.26

48.29

2.4

2.1

334.41

377.18

nmol/l

3.86

407

1923

Asthma mixed form (mode), excluding more controls

289

1162

2.68

48.14

2.3

2.0

317.76

380.07

nmol/l

6.95

271

1066

Abnormal blood-pressure reading, without diagnosis

284

1141

2.74

48.08

2.2

350.24

378.76

nmol/l

1.50

253

1049

COPD, hospital admissions 1, only main diagnosis

1593

9305

1.51

47.96

2.4

2.3

344.07

378.24

nmol/l

7.15

1443

8496

Invasive ventilation

437

2118

2.25

47.83

2.4

2.2

351.44

367.25

nmol/l

0.82

406

1936

Other disorders of optic [2nd] nerve and visual pathways

419

2009

2.30

47.55

2.9

2.1

380.60

372.82

nmol/l

0.16

394

1848

Atopic dermatitis, strict definition with reimbursement

1735

11690

1.48

47.55

2.3

2.1

360.91

379.13

nmol/l

3.27

1593

10806

Diabetic nephropathy

953

5819

1.73

47.53

1.9

2.2

381.00

373.14

nmol/l

0.57

889

5294

Other/unspecified seropositive rheumatoid arthritis

1398

9377

1.55

47.52

1.9

2.2

334.14

377.95

nmol/l

13.33

1305

8558

Atypical facial pain

345

1532

2.50

47.34

2.4

2.1

373.20

372.32

nmol/l

0.02

308

1391

Spondylopathies (FG)

767

4461

1.81

47.16

2.3

340.07

382.10

nmol/l

7.38

713

4112

Sequelae of injuries, of poisoning and of other consequences of external causes

1269

8357

1.58

47.03

2.1

2.2

368.23

368.27

nmol/l

0.00

1171

7705

Speech disturbances, not elsewhere classified

511

2632

2.09

46.99

2.0

2.1

383.88

376.96

nmol/l

0.32

467

2388

Keratitis

1902

13536

1.45

46.96

2.3

2.2

359.34

374.42

nmol/l

2.92

1745

12442

Congenital malformations, deformations and chromosomal abnormalities

3295

24235

1.33

46.84

2.2

369.03

374.99

nmol/l

0.97

3051

22408

Deviated nasal septum

1606

11063

1.50

46.83

2.3

2.4

353.68

376.22

nmol/l

5.08

1471

10256

Multiple myeloma, including Hilmo

277

1119

2.76

46.71

2.2

1.7

383.52

366.88

nmol/l

0.62

264

995

Conjunctivitis (acute, non atopic)

1565

10730

1.51

46.66

2.3

2.2

358.49

375.98

nmol/l

3.03

1450

9897

Skin changes due to chronic exposure to nonionizing radiation

1798

11667

1.47

46.64

2.5

2.2

370.80

383.12

nmol/l

1.52

1625

10587

Other viral diseases, not elsewhere classified

1070

6784

1.65

46.62

2.7

2.2

343.53

369.89

nmol/l

4.71

1009

6262

Excessive attrition of teeth

3084

23662

1.34

46.61

2.2

360.87

374.28

nmol/l

3.63

2816

21914

Cholangitis (primary sclerosing, PSC)

375

1728

2.37

46.59

2.7

2.1

348.14

369.35

nmol/l

1.05

355

1577

Atopic dermatitis

3253

20512

1.33

46.58

2.1

365.42

376.41

nmol/l

2.54

2960

19002

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

580

3131

1.99

46.49

2.6

2.2

368.23

370.89

nmol/l

0.09

543

2863

Bulimia nervosa (incl. atypical)

267

1067

2.83

46.44

2.0

2.1

378.81

389.85

nmol/l

0.35

239

982

Crohn disease (strict definition, require KELA)

432

2113

2.24

46.43

2.0

2.1

337.78

376.02

nmol/l

4.26

403

1951

Decubitus ulcer and pressure area

356

1607

2.41

46.41

1.9

2.1

377.24

377.42

nmol/l

0.00

330

1451

Other obstetric conditions, not elsewhere classified

1962

8857

1.46

46.31

2.0

1.9

374.89

385.29

nmol/l

1.53

1828

8181

Nontoxic multinodular goitre

993

6211

1.67

46.14

2.2

2.0

368.39

382.33

nmol/l

1.47

912

5647

Sequelae of cerebrovascular disease

1671

10005

1.49

46.04

2.0

2.3

380.19

377.59

nmol/l

0.18

1498

9137

Chronic hepatitis, not elsewhere classified

253

992

2.92

46.04

2.2

2.1

356.29

375.42

nmol/l

0.42

237

914

Pollen allergy

1139

7273

1.62

45.99

2.1

354.91

374.01

nmol/l

2.85

1035

6747

Artrosis, including avohilmo

4552

19848

1.28

45.99

2.1

2.3

356.45

377.44

nmol/l

9.33

4184

18364

Morphin

140

387

4.17

45.73

4.6

1.8

324.84

389.10

nmol/l

2.83

133

347

Other diseases of pancreas

463

2330

2.15

45.59

2.2

2.3

368.12

364.19

nmol/l

0.15

434

2132

Superficial injury of head

1262

8357

1.57

45.33

2.0

2.2

370.65

375.31

nmol/l

0.36

1147

7639

Disorders of continuity of bone

575

3120

1.97

45.20

2.2

2.1

348.89

380.99

nmol/l

3.04

525

2872

Other ulcerative colitis

388

1841

2.32

45.19

2.6

2.2

323.27

376.91

nmol/l

6.26

367

1704

Seborrhoeic dermatitis

536

2841

2.02

45.16

2.4

2.1

363.26

371.93

nmol/l

0.46

489

2600

Crohn disease (strict definition, require KELA, min 2 HDR)

425

2088

2.23

45.15

2.0

2.1

336.87

375.60

nmol/l

4.32

396

1928

Fracture of femur

1281

7690

1.56

45.12

2.2

2.1

377.53

382.47

nmol/l

0.24

1156

6950

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1915

8634

1.46

45.10

2.0

1.9

374.45

386.02

nmol/l

1.75

1783

7972

Psoriasis

1501

10314

1.51

45.10

2.2

352.91

371.80

nmol/l

2.92

1376

9493

Disorders of oesophagus in diseases classified elsewhere

166

524

3.75

44.97

3.0

2.2

347.55

379.33

nmol/l

0.84

159

479

Mental and behavioural disorders due to tobacco

522

2755

2.05

44.92

2.3

2.2

361.79

370.47

nmol/l

0.35

470

2555

Osteonecrosis

374

1752

2.34

44.89

2.8

2.1

354.32

377.91

nmol/l

1.39

351

1591

Diseases of peritoneum

580

3165

1.96

44.76

2.4

2.1

355.57

368.63

nmol/l

0.64

540

2890

Familial hypercholesterolemia

674

3823

1.85

44.76

2.3

381.48

366.99

nmol/l

1.09

613

3476

Asthma mixed form (mode)

289

1206

2.58

44.53

2.3

1.9

317.76

381.61

nmol/l

7.26

271

1106

Smoking dependency

522

2764

2.04

44.49

2.3

2.2

361.79

371.56

nmol/l

0.41

470

2560

Other disorders of eyelid

2165

15098

1.40

44.43

2.2

366.56

380.17

nmol/l

2.46

1989

13808

Dislocation, sprain and strain of joints and ligaments at neck level

884

5437

1.71

44.38

2.1

364.40

375.38

nmol/l

0.88

805

5009

Dermatitis due to substances taken internally

358

1656

2.37

44.34

3.1

2.0

336.24

377.02

nmol/l

3.48

335

1505

Malignant neoplasm of bladder, including Hilmo

512

2655

2.01

44.17

3.7

1.8

392.23

363.59

nmol/l

2.12

478

2358

Other/unspecified rheumatoid arthritis

680

3907

1.85

44.08

2.0

2.1

329.35

379.84

nmol/l

8.18

625

3553

Other disorders of nervous system

400

1937

2.25

43.97

2.2

2.1

341.80

373.89

nmol/l

2.92

362

1768

Degeneration of macula and posterior pole

2189

12749

1.40

43.92

2.2

2.3

374.64

380.93

nmol/l

0.65

1953

11636

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

996

6326

1.66

43.85

2.0

2.1

381.88

383.92

nmol/l

0.12

907

5808

Other infectious diseases

522

2777

2.02

43.60

2.4

2.1

366.09

372.33

nmol/l

0.21

492

2525

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

449

2279

2.15

43.54

2.0

2.1

338.24

374.06

nmol/l

3.83

419

2105

Systemic lupus erythematosus

266

1099

2.76

43.50

2.0

349.26

375.49

nmol/l

1.30

242

1009

Actinic keratosis

1727

11321

1.46

43.31

2.5

2.2

370.47

383.16

nmol/l

1.53

1559

10263

Conductive and sensorineural hearing loss

4019

21542

1.28

43.24

2.2

2.3

360.81

375.78

nmol/l

4.68

3646

19847

Other diseases of oesophagus

499

2617

2.03

43.09

2.4

2.2

369.76

379.19

nmol/l

0.36

458

2397

Cluster headache, strict, including avohilmo

345

1596

2.40

43.06

2.3

2.1

346.81

371.94

nmol/l

1.83

322

1484

Superficial injury of lower leg

1360

9252

1.53

43.00

2.1

351.22

381.92

nmol/l

7.38

1251

8469

Parkinson's disease, strict definition, excluding more controls

502

2491

2.00

42.95

1.8

2.7

389.91

387.76

nmol/l

0.08

443

2309

Artificial opening status

335

1533

2.40

42.66

2.9

2.3

360.23

369.90

nmol/l

0.34

315

1409

Osteomyelitis

367

1738

2.29

42.55

2.1

2.2

367.27

371.12

nmol/l

0.11

341

1590

Cluster headache, wide,, including avohilmo

358

1688

2.34

42.53

2.3

2.1

344.28

374.13

nmol/l

2.46

334

1568

Iridocyclitis

1208

8051

1.56

42.42

2.3

2.2

358.16

373.33

nmol/l

2.03

1132

7404

Propionic acid derivatives

1505

5119

1.52

42.39

2.0

2.2

374.51

394.95

nmol/l

3.26

1367

4744

Anosmia

204

4.99

42.27

2.7

1.5

363.51

360.69

nmol/l

0.04

189

Sensorineural hearing loss

3779

20304

1.29

42.01

2.2

2.3

362.71

375.99

nmol/l

3.56

3422

18699

Disorders of optic nerve and visual pathways

581

3242

1.92

42.00

2.9

2.1

377.59

369.62

nmol/l

0.21

546

2986

Lateral epicondylitis

704

4131

1.79

41.96

2.2

2.3

361.34

376.39

nmol/l

1.34

645

3838

Ocular pain

525

2844

1.99

41.88

2.4

2.1

366.77

371.43

nmol/l

0.21

488

2602

Recurrent aphthous stomatitis , including avohilmo

813

4975

1.73

41.81

2.4

2.1

367.85

375.10

nmol/l

0.50

739

4557

Fracture of lower leg, including ankle

2866

21862

1.33

41.66

2.2

359.46

379.31

nmol/l

5.90

2651

20112

Vitamin B12 deficiency anaemia

542

2954

1.94

41.54

2.0

2.1

378.01

379.36

nmol/l

0.05

488

2673

Bronchiectasis

425

2146

2.13

41.37

2.5

2.1

321.93

387.58

nmol/l

9.85

394

1939

Other postsurgical states

393

1934

2.21

41.35

2.3

2.2

366.82

371.08

nmol/l

0.17

361

1770

Other disorders involving the immune mechanism, not elsewhere classified

229

903

2.90

41.29

2.5

2.2

340.28

362.13

nmol/l

1.04

212

846

Vitamin D deficiency

154

490

3.72

41.27

2.6

2.1

362.99

379.75

nmol/l

0.48

144

456

Myocardial infarction, without ST-elevation

1797

11759

1.43

41.25

2.0

2.3

375.39

378.90

nmol/l

0.19

1633

10698

Oligomenorrhoea

255

1056

2.69

41.00

2.4

2.1

372.62

383.54

nmol/l

0.39

234

967

Type1 diabetes, definitions combined, early onset

463

2417

2.07

40.94

1.9

2.2

439.71

361.82

nmol/l

12.26

432

2254

Anaemia in chronic diseases classified elsewhere

177

613

3.36

40.88

2.5

2.0

350.77

374.38

nmol/l

0.85

164

560

Small fibre neuropathy

211

804

3.03

40.86

2.9

2.2

325.52

371.65

nmol/l

2.42

195

740

Crohn's disease of large intestine

345

1633

2.32

40.53

2.4

2.1

316.51

374.52

nmol/l

6.51

317

1521

Charcot foot

140

424

3.90

40.47

2.2

2.5

389.08

372.00

nmol/l

0.49

132

400

Other specified/unspecified soft tissue disorders

296

1312

2.46

40.39

2.0

2.1

349.34

389.66

nmol/l

2.93

271

1187

Other follicular disorders

453

2369

2.07

40.17

2.4

2.1

356.26

376.08

nmol/l

1.39

426

2197

Fibroblastic disorders

1084

7123

1.58

40.17

2.1

2.4

373.13

382.80

nmol/l

0.87

988

6543

Peripheral artery operations in Hilmo

599

3391

1.85

40.17

2.1

2.3

383.27

378.35

nmol/l

0.21

550

3088

Secondary and unspecified malignant neoplasm of lymph nodes

427

2182

2.09

40.00

2.7

1.8

366.54

362.57

nmol/l

0.16

403

1976

Inflammatory disease of uterus

834

5201

1.69

39.79

2.1

361.47

378.86

nmol/l

1.70

765

4776

Dermatopolymyositis (FG)

122

343

4.32

39.75

1.9

2.2

345.73

390.66

nmol/l

0.63

115

322

Cerebral palsy and other paralytic syndromes

631

3658

1.83

39.65

2.3

2.2

359.65

369.16

nmol/l

0.56

581

3353

Other mental disorders due to brain damage and dysfunction and to physical disease

585

3316

1.87

39.59

2.1

2.2

377.80

376.98

nmol/l

0.03

524

3015

Acute peritonitis

370

1809

2.22

39.57

2.6

2.1

350.45

370.48

nmol/l

0.75

354

1650

Trigeminal neuralgia

358

1731

2.25

39.51

2.2

2.1

367.59

375.76

nmol/l

0.34

322

1578

Visual impairment including blindness (binocular or monocular)

394

1970

2.16

39.50

2.5

2.1

376.61

376.33

nmol/l

0.00

342

1790

Other and unspecified tonsillitis

1790

10867

1.42

39.37

2.3

2.1

362.06

379.41

nmol/l

3.28

1676

10071

Necrosis of pulp, including avohilmo

3082

24099

1.30

39.35

2.1

2.2

356.49

373.59

nmol/l

5.17

2816

22329

Hepatic failure, not elsewhere classified

248

1038

2.68

39.15

2.1

2.2

346.54

369.73

nmol/l

1.08

232

949

Other and unspecified immunodeficiencies with predominantly antibody defects

127

376

4.30

39.10

3.4

2.0

313.07

363.55

nmol/l

1.84

118

354

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2073

15343

1.38

39.10

2.1

367.89

375.99

nmol/l

1.01

1890

14179

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3046

23204

1.31

38.94

2.2

2.1

358.37

377.79

nmol/l

6.72

2798

21356

Emotional disorders starting during childhood or adolescence

356

1717

2.26

38.91

2.3

2.1

381.85

386.12

nmol/l

0.13

325

1591

Lichen simplex chronicus and prurigo

370

1823

2.20

38.82

2.3

2.0

351.79

374.44

nmol/l

1.28

341

1658

Thyroiditis

445

2349

2.05

38.56

2.2

2.1

388.26

373.83

nmol/l

0.85

406

2149

Contact with and exposure to communicable diseases

1762

12754

1.42

38.50

2.2

2.1

358.53

377.79

nmol/l

3.45

1697

11743

Mental and behavioural disorders due to opioids

262

1131

2.57

38.46

2.5

2.0

331.98

365.30

nmol/l

1.99

230

1069

Open wound of lower leg

808

5034

1.68

38.39

2.5

2.1

336.01

378.74

nmol/l

6.95

738

4600

Ulcerative ileocolitis

279

1241

2.50

38.35

2.4

2.1

317.16

371.61

nmol/l

5.23

253

1159

Coeliac disease

694

4172

1.76

38.29

2.2

374.55

374.06

nmol/l

0.02

642

3838

Acute and subacute iridocyclitis

1010

6630

1.59

38.20

2.3

2.2

356.94

373.49

nmol/l

1.99

948

6114

Drug-induced cataract

185

686

3.16

38.03

3.6

2.2

272.47

367.55

nmol/l

7.58

176

640

Other strabismus

1210

8222

1.53

38.03

2.4

2.2

359.42

373.14

nmol/l

1.67

1128

7581

Colectomy operation

846

5342

1.66

38.03

2.7

2.2

377.11

372.46

nmol/l

0.25

795

4885

Pneumonitis due to solids and liquids

415

2136

2.07

37.91

2.1

378.01

373.49

nmol/l

0.12

367

1937

Dermatographic urticaria

426

2229

2.07

37.89

2.3

2.0

349.72

376.25

nmol/l

2.26

399

2050

Unspecified urinary incontinence

496

2720

1.95

37.81

2.0

2.1

365.61

377.27

nmol/l

0.61

416

2481

Alcoholic liver disease

509

2808

1.93

37.79

2.0

2.3

379.82

366.54

nmol/l

0.49

466

2579

Allergic conjunctivitis

3190

24597

1.29

37.72

2.2

2.1

358.49

376.93

nmol/l

6.41

2932

22650

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

211

836

2.88

37.71

2.5

2.2

341.71

362.04

nmol/l

0.87

194

781

Injuries to the wrist and hand

5502

31764

1.22

37.71

2.1

2.2

365.04

375.65

nmol/l

3.10

5096

29304

Other and unspecified visual disturbances

576

3308

1.86

37.65

2.5

2.1

379.12

375.58

nmol/l

0.17

537

3040

Peripheral arterial reconstruction

763

4703

1.69

37.51

2.2

374.46

378.58

nmol/l

0.19

682

4261

Autoimmune thyroiditis

146

477

3.56

37.26

2.5

1.8

409.03

383.65

nmol/l

0.82

134

437

Erosion of teeth , including avohilmo

1355

9477

1.48

37.26

2.3

2.2

360.02

373.67

nmol/l

1.85

1245

8745

Anterior Iridocyclitis

1064

7106

1.56

37.12

2.3

2.2

357.53

372.77

nmol/l

1.83

996

6538

Multiple myeloma and malignant plasma cell neoplasms

283

1282

2.43

37.07

2.2

388.56

370.47

nmol/l

0.72

270

1153

severe traumatic brain injury, does not include concussion

1037

6875

1.56

37.05

2.1

2.2

409.35

374.43

nmol/l

3.97

951

6268

Diabetic retinopathy

1924

8836

1.41

37.05

1.9

2.2

382.65

370.41

nmol/l

1.66

1765

8080

Hypertrophy of breast in women and men

1099

7403

1.55

36.95

2.0

2.2

352.80

373.50

nmol/l

3.15

1019

6811

Trigger finger

734

4504

1.71

36.94

1.9

2.3

360.51

384.30

nmol/l

2.58

662

4159

Flat foot [pes planus] (acquired)

521

2917

1.90

36.87

2.1

2.3

362.38

388.02

nmol/l

2.17

475

2672

Emphysema

355

1747

2.17

36.79

2.4

2.2

347.27

385.37

nmol/l

2.97

329

1578

Disorders of vitreous body and globe

2482

18337

1.33

36.72

2.2

2.3

367.52

375.98

nmol/l

1.31

2273

16855

Brain meningioma, including Hilmo

307

1445

2.33

36.52

3.0

1.8

364.88

364.40

nmol/l

0.01

289

1294

Phlebitis and thrombophlebitis (not including DVT)

1153

7849

1.53

36.49

2.3

2.2

355.91

378.48

nmol/l

3.54

1078

7177

Cirrhosis of liver, NAS

312

1479

2.31

36.47

2.1

2.2

350.26

369.70

nmol/l

0.53

299

1358

Dermatopolymyositis

127

389

3.94

36.46

1.8

2.0

351.54

382.63

nmol/l

0.39

120

360

Asthma and opportunity respiratory infection

278

1260

2.43

36.41

2.6

2.1

292.59

387.90

nmol/l

12.85

261

1138

Sleep disorders, other/unspecified

245

1055

2.59

36.26

2.1

372.64

379.78

nmol/l

0.22

220

981

Gonarthrosis,primary

4428

22310

1.24

36.13

2.1

2.3

358.54

374.28

nmol/l

5.87

4040

20566

Disorders of vitreous body

2415

17929

1.33

36.00

2.2

2.3

367.90

375.61

nmol/l

1.11

2210

16470

DVT of lower extremities

937

6126

1.59

35.97

2.4

2.2

361.16

380.52

nmol/l

2.03

869

5581

Postprocedural disorders of digestive system, not elsewhere classified

225

939

2.70

35.88

2.8

2.1

365.47

370.06

nmol/l

0.11

215

859

Hydronephrosis

565

3259

1.82

35.88

3.0

2.2

378.08

374.60

nmol/l

0.15

536

2971

Vascular disorders of the intestines

340

1664

2.18

35.78

2.4

2.2

386.74

381.93

nmol/l

0.13

316

1501

Anti-inflammatory and antirheumatic products, non-steroids

1463

5120

1.47

35.71

2.1

2.2

375.26

394.93

nmol/l

2.95

1335

4745

Adhesive capsulitis of shoulder

812

5147

1.64

35.67

2.3

353.06

383.91

nmol/l

4.52

752

4742

Suppurative and necrotic conditions of lower respiratory tract

311

1482

2.28

35.63

2.5

2.2

385.83

367.94

nmol/l

0.61

294

1361

Wegener granulomatosis

130

410

3.81

35.62

2.2

1.9

313.75

380.08

nmol/l

3.74

125

378

Hypothyroidism due to medicaments and other exogenous substances

104

284

4.54

35.61

5.6

1.8

398.72

362.49

nmol/l

0.97

257

Focal brain injury

290

1331

2.30

35.59

2.2

2.4

384.07

393.14

nmol/l

0.20

270

1234

Oesophagitis

305

1445

2.29

35.36

2.4

2.2

351.87

378.82

nmol/l

1.12

290

1326

Mixed hyperlipidaemia

219

902

2.65

35.21

1.8

2.2

365.66

361.29

nmol/l

0.11

186

832

Respiratory disorders in diseases classified elsewhere

124

385

3.95

35.12

2.0

335.89

375.06

nmol/l

0.53

114

350

Somnolence, stupor and coma

253

1114

2.48

35.11

2.1

380.61

371.30

nmol/l

0.27

237

1010

Brain meningioma

298

1409

2.32

35.09

3.0

1.8

365.14

364.92

nmol/l

0.01

280

1261

Other infectious diseases

422

2251

2.01

35.05

2.4

2.1

365.76

374.19

nmol/l

0.25

395

2045

Female infertility, associated with anovulation

465

2553

1.93

35.02

2.2

2.0

362.10

387.00

nmol/l

1.63

441

2354

SLE, strict definition

247

1090

2.56

34.99

2.0

2.1

348.96

372.33

nmol/l

1.04

226

1001

SLE, ICD10

247

1090

2.56

34.99

2.0

2.1

348.96

372.33

nmol/l

1.04

226

1001

Other inflammation of eyelid

722

4483

1.69

34.99

2.4

2.2

362.44

379.22

nmol/l

1.32

659

4116

Alzheimer disease, excluding more controls

685

2698

1.73

34.83

1.8

2.6

403.89

390.08

nmol/l

0.89

587

2489

Other/unspecified synovitis and tenosynovitis

598

3535

1.78

34.82

2.1

2.2

356.74

383.37

nmol/l

2.99

555

3242

Other disorders of bone

1034

6954

1.55

34.82

2.4

2.2

354.20

377.50

nmol/l

3.40

958

6387

Other disorders of electrolyte and fluid balance, not elsewhere classified

199

5.27

34.70

2.3

1.8

407.85

374.44

nmol/l

0.62

181

Benign neoplasm: Colon, unspecified

1176

8115

1.50

34.66

2.3

354.95

377.18

nmol/l

3.37

1072

7427

Glaucoma

2661

17865

1.31

34.60

2.1

2.3

381.62

376.57

nmol/l

0.45

2405

16367

Herpesviral [herpes simplex] infections

1350

9569

1.46

34.54

2.2

2.1

360.07

375.73

nmol/l

2.34

1252

8795

Disorders of tooth development and eruption

864

4494

1.61

34.49

2.4

2.1

376.28

383.39

nmol/l

0.40

801

4181

Papilloedema, unspecified

177

674

3.03

34.44

2.5

2.1

382.42

376.68

nmol/l

0.12

171

620

Vitreous haemorrhage

532

3062

1.84

34.41

2.1

2.2

389.63

372.94

nmol/l

1.13

502

2794

Inflammatory diseases of the central nervous system

481

2693

1.91

34.40

2.6

2.1

353.42

372.63

nmol/l

1.26

451

2465

Kela reimbursement Agammaglobulinemia (D80-84)

239

5.04

34.32

3.2

1.9

335.22

365.78

nmol/l

0.77

223

Selective deficiency of immunoglobulin G [IgG] subclasses

210

5.55

34.28

3.4

2.0

310.57

364.58

nmol/l

1.40

194

Hallux valgus (acquired)

1627

8492

1.41

34.02

2.0

2.3

373.46

387.41

nmol/l

1.90

1466

7789

Rash and other nonspecific skin eruption

538

3122

1.83

33.91

2.5

2.1

358.14

373.09

nmol/l

0.98

505

2851

Sequelae of injuries of head

314

1533

2.23

33.89

2.0

2.2

391.59

368.30

nmol/l

1.04

286

1425

Other abnormal findings of blood chemistry

286

1351

2.33

33.86

2.3

2.1

345.18

371.54

nmol/l

1.32

269

1238

Psoriatic arthropathies

524

3011

1.84

33.84

2.0

2.4

343.62

382.15

nmol/l

3.85

484

2771

Cholangitis (primary sclerosing, PSC), with reimbursement 202

149

525

3.33

33.69

2.9

2.0

338.05

366.04

nmol/l

1.00

143

487

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

373

1906

2.08

33.60

2.3

2.2

352.69

368.94

nmol/l

0.87

344

1779

Any dementia, excluding more controls

1449

7098

1.44

33.55

1.8

2.3

396.70

383.33

nmol/l

1.52

1257

6459

Preparatory care for dialysis

263

1211

2.40

33.28

1.8

2.3

352.81

366.77

nmol/l

0.51

255

1122

Fracture of shoulder and upper arm

1795

13370

1.38

33.26

2.1

2.2

366.62

377.17

nmol/l

1.32

1630

12216

ILD-related respiratory insufficiency

203

836

2.72

33.22

2.0

2.2

333.49

371.33

nmol/l

1.44

193

756

Rare circulating lymphoid malignancy, including Hilmo

195

788

2.78

33.22

2.3

2.0

363.73

358.17

nmol/l

0.15

187

709

Non-Hodgkin lymphoma, all

226

971

2.53

33.10

2.1

1.7

375.85

370.51

nmol/l

0.13

213

867

Amputation of toe

365

1891

2.07

33.08

2.3

2.2

366.99

371.84

nmol/l

0.17

340

1715

Other disorders of the musculoskeletal system and connective tissue

757

4819

1.65

33.07

2.2

367.20

373.05

nmol/l

0.31

687

4408

Myocardial infarction, strict

2008

10762

1.36

33.01

2.2

2.5

368.67

378.48

nmol/l

0.97

1835

9867

Primary biliary cholangitis (PBC)

144

499

3.28

32.98

2.1

2.0

361.82

388.97

nmol/l

0.74

130

449

Non-follicular lymphoma

490

2792

1.87

32.90

2.1

2.3

372.28

371.06

nmol/l

0.05

470

2542

Other and unspecified disorders of white blood cells

258

1186

2.41

32.84

2.5

2.2

354.89

369.13

nmol/l

0.56

244

1087

Nontoxic goitre/thyroid nodule

1508

10989

1.42

32.81

2.2

2.1

368.58

378.66

nmol/l

1.26

1377

9994

Need for other prophylactic measures

355

1837

2.10

32.76

2.8

2.2

385.04

369.39

nmol/l

0.41

339

1677

Infections with a predominantly sexual mode of transmission

2171

15519

1.34

32.68

2.0

2.1

387.22

377.06

nmol/l

1.53

1979

14361

Fracture of foot, except ankle

1282

9090

1.46

32.65

2.3

2.2

371.33

373.48

nmol/l

0.12

1191

8351

Idiopathic pulmonary fibrosis

378

1990

2.03

32.57

1.9

2.1

360.25

373.75

nmol/l

0.40

356

1781

Other disorders of patella

879

5792

1.58

32.52

2.2

2.3

358.58

381.60

nmol/l

3.27

802

5327

Polyarteritis nodosa and related conditions

119

376

3.79

32.51

2.9

1.8

305.05

377.78

nmol/l

3.55

113

345

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

518

2983

1.81

32.51

2.8

1.7

382.26

370.50

nmol/l

0.60

469

2635

Enteropathic arthropathies

164

616

3.02

32.45

2.4

2.1

316.52

378.13

nmol/l

3.56

155

575

Appendectomy

3462

26881

1.25

32.39

2.3

2.2

369.95

374.24

nmol/l

0.50

3214

24799

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

410

2229

1.98

32.36

1.9

2.1

379.53

377.83

nmol/l

0.05

377

2055

Viral warts

562

3345

1.78

32.36

2.5

2.1

347.04

374.64

nmol/l

2.64

533

3069

Lesion of ulnar nerve

690

4313

1.67

32.35

2.2

2.3

356.04

371.65

nmol/l

1.34

633

3989

Other diseases of biliary tract

448

2501

1.90

32.11

2.5

2.2

379.79

371.81

nmol/l

0.31

424

2274

Injuries to the elbow and forearm

3730

26832

1.24

32.06

2.2

368.77

377.91

nmol/l

1.61

3438

24674

Diseases of middle ear and mastoid

3108

20387

1.27

32.03

2.1

367.09

376.94

nmol/l

1.99

2864

18807

Colonic or urogenital fistula

1348

9674

1.44

32.02

2.1

2.2

369.56

372.06

nmol/l

0.18

1215

8913

Other specified/unspecified inflammatory spondylopathies

284

1362

2.26

31.98

2.3

2.0

340.93

375.66

nmol/l

2.28

267

1268

Diabetic neuropathy

644

3978

1.72

31.92

2.0

2.2

384.05

371.55

nmol/l

0.75

584

3621

Acute gastritis

388

2073

1.99

31.91

2.2

377.80

376.06

nmol/l

0.06

357

1894

Lack of expected normal physiological development

161

519

3.04

31.88

3.1

1.9

309.33

377.50

nmol/l

4.69

155

488

Alzheimer’s disease (Atypical or mixed), excluding more controls

324

1268

2.12

31.74

1.7

2.3

382.59

394.59

nmol/l

0.46

268

1163

Myositis

169

651

2.92

31.70

2.3

2.1

348.90

387.07

nmol/l

0.77

163

590

Abnormal serum enzyme levels

1302

9054

1.44

31.59

2.3

2.5

378.46

370.14

nmol/l

0.57

1232

8382

Other symptoms and signs involving general sensations and perceptions

240

1086

2.42

31.42

2.0

392.76

382.63

nmol/l

0.27

221

978

Acute alcohol intoxication

1205

8503

1.46

31.27

2.3

370.48

371.01

nmol/l

0.03

1104

7870

Mental disorders, not otherwise specified

488

2822

1.84

31.25

1.9

2.1

391.54

374.07

nmol/l

1.14

458

2612

Diseases of external ear

1688

12607

1.38

31.14

2.3

2.2

365.29

374.81

nmol/l

1.17

1503

11610

Impingement syndrome of shoulder

1103

7667

1.48

31.13

2.4

361.23

379.49

nmol/l

2.49

1020

7107

Infective dermatitis

581

3517

1.74

31.12

2.4

2.1

364.98

375.92

nmol/l

0.57

537

3220

Abnormal findings on examination of urine, without diagnosis

264

1249

2.31

31.10

2.4

2.2

353.40

367.52

nmol/l

0.56

247

1145

Cardiomyopathy, other and unspecified

382

2049

1.98

31.00

2.4

359.84

367.51

nmol/l

0.30

361

1881

Fracture of skull and facial bones

1070

7407

1.49

30.99

2.1

2.3

369.28

370.29

nmol/l

0.06

1001

6825

Alcohol-induced chronic pancreatitis

344

1790

2.07

30.97

2.2

2.4

379.27

363.10

nmol/l

0.74

319

1663

Generalized skin eruption due to drugs and medicaments

254

1189

2.36

30.95

3.1

2.1

330.34

376.49

nmol/l

3.03

238

1097

Diffuse large B-cell lymphoma, helper endpoint

249

1151

2.36

30.95

2.0

1.8

368.77

363.29

nmol/l

0.17

238

1027

Diffuse large B-cell lymphoma, including Hilmo

249

1151

2.36

30.95

2.0

1.8

368.77

363.29

nmol/l

0.17

238

1027

Diffuse large B-cell lymphoma

249

1151

2.36

30.95

2.0

1.8

368.77

363.29

nmol/l

0.17

238

1027

Speech and linguistic disorders

530

3011

1.79

30.91

2.7

2.1

338.29

372.61

nmol/l

3.73

492

2790

Unstable angina pectoris

1588

9217

1.39

30.90

2.1

2.4

370.97

383.09

nmol/l

1.23

1456

8387

Traumatic subarachnoid haemorrhage

177

700

2.73

30.76

2.0

2.3

408.09

401.65

nmol/l

0.15

162

641

Herpesviral [herpes simplex] infections

635

3951

1.69

30.68

2.5

2.1

350.25

377.10

nmol/l

2.84

595

3626

Acute generalized exanthematous pustulosis

279

1359

2.25

30.58

3.0

2.1

335.98

377.45

nmol/l

2.79

263

1250

Systemic lupus erythematosus, unspecified

214

943

2.56

30.53

1.9

2.1

350.89

373.67

nmol/l

0.89

197

870

Crohn disease (strict definition, all UC cases excluded)

318

1624

2.13

30.49

1.8

2.1

360.03

374.77

nmol/l

0.69

295

1503

Nonhereditary hypogammaglobulinemia

101

302

4.15

30.48

4.2

1.9

286.26

369.40

nmol/l

4.27

271

Ulcerative colitis (strict definition, all Crohn cases excluded)

763

4957

1.61

30.44

2.3

2.2

330.31

372.28

nmol/l

8.26

706

4554

Other overlap syndromes

139

499

3.25

30.36

2.0

1.9

348.46

386.21

nmol/l

0.92

132

462

Umbilical hernia

1304

9391

1.43

30.27

2.3

2.4

354.39

375.19

nmol/l

2.49

1201

8690

Pure hyperglyceridaemia

139

496

3.14

30.06

2.0

2.3

343.39

356.65

nmol/l

0.27

125

459

Other or ill-defined heart diseases

281

1369

2.19

30.03

2.6

2.2

383.14

372.76

nmol/l

0.35

255

1261

Acute laryngitis and tracheitis

648

3992

1.67

29.99

2.3

1.9

364.21

382.51

nmol/l

1.71

599

3679

Cardiomyopathies, Primary/intrinsic

534

3185

1.75

29.91

2.4

2.5

392.32

372.10

nmol/l

1.17

505

2943

Tonsillectomy and adenotomy

3188

17946

1.26

29.86

2.2

2.1

370.77

371.26

nmol/l

0.05

2941

16671

Secondary parkinsonism, excluding more controls

124

413

3.28

29.80

1.9

2.3

407.00

394.22

nmol/l

0.27

109

380

Polycystic ovarian syndrome, broad definition

625

3901

1.68

29.74

1.6

1.7

367.45

390.87

nmol/l

2.47

588

3584

Idiopathic thrombocytopenic purpura

201

869

2.59

29.72

2.6

2.1

354.28

373.06

nmol/l

0.37

189

805

Disorders of orbit

272

1327

2.24

29.64

2.5

2.0

354.69

372.05

nmol/l

0.81

250

1225

Scoliosis

468

2710

1.82

29.61

2.2

2.1

346.03

388.61

nmol/l

3.41

424

2481

Later onset COPD

1165

6537

1.46

29.55

2.6

2.2

359.75

383.39

nmol/l

3.03

1061

5898

Other and unspecified follicular disorders

247

1164

2.33

29.46

2.6

2.1

341.05

373.90

nmol/l

2.02

238

1082

Other disorders starting during childhood or adolescence

347

1830

2.03

29.40

2.3

2.2

351.94

369.42

nmol/l

0.94

321

1707

Infections with a predominantly sexual mode of transmission

1652

12393

1.37

29.40

2.1

387.74

375.54

nmol/l

1.65

1518

11422

Other peripheral vascular diseases

448

2574

1.85

29.35

2.3

2.2

388.70

372.20

nmol/l

0.78

424

2352

1258

7855

1.43

29.20

2.0

2.2

374.07

383.77

nmol/l

0.82

1104

7072

Primary gonarthrosis, bilateral

2383

16062

1.30

29.09

2.0

2.3

357.87

379.39

nmol/l

5.81

2151

14745

Dermatophytosis

643

4061

1.66

29.07

2.8

2.2

332.13

370.92

nmol/l

5.76

591

3719

Female genital prolapse

1483

6118

1.41

29.02

1.9

2.2

369.67

380.29

nmol/l

1.14

1374

5584

Other embolism and thrombosis

643

4061

1.66

29.00

2.6

2.2

363.57

378.79

nmol/l

1.06

593

3702

Glaucoma suspect

1701

12858

1.36

28.94

2.1

2.2

380.66

377.61

nmol/l

0.20

1545

11740

Adenomyosis (Endometriosis of uterus)

689

4429

1.63

28.84

2.1

2.2

365.33

381.81

nmol/l

1.51

642

4034

Pericarditis

198

857

2.51

28.64

3.1

2.3

345.30

369.73

nmol/l

1.12

184

791

Other/unspecified enthesopathies of lower limb, excluding foot

376

2066

1.93

28.41

2.2

369.58

381.10

nmol/l

0.54

345

1914

Ulcerative rectosigmoiditis

453

2635

1.82

28.37

2.3

2.1

327.95

372.28

nmol/l

5.59

420

2428

Atopic dermatitis, strict definition

1623

11972

1.37

28.33

2.2

2.1

364.22

376.63

nmol/l

1.66

1492

11062

Fall on same level involving ice and snow

2890

23383

1.26

28.33

2.1

2.2

372.96

375.99

nmol/l

0.33

2673

21468

Magnesium deficiency

8.82

28.31

4.5

2.4

413.36

396.71

nmol/l

0.21

Hypertensive Renal Disease

172

699

2.64

28.25

2.1

2.2

348.19

375.21

nmol/l

0.90

161

628

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1477

10983

1.38

28.13

2.2

364.79

373.71

nmol/l

0.97

1364

10129

Diffuse brain injury

173

706

2.62

28.08

1.7

2.3

395.81

388.25

nmol/l

0.14

162

649

Etanercept

388

2173

1.92

27.99

1.9

2.1

322.48

370.20

nmol/l

5.92

374

2011

Other enthesopathy of foot (+metatarsalgia)

523

3168

1.73

27.96

2.0

2.3

350.56

384.78

nmol/l

4.03

479

2924

Nasal polyp

884

6023

1.52

27.85

2.5

2.3

337.33

376.72

nmol/l

5.53

809

5555

Other immunodeficiencies

104

336

3.80

27.81

3.2

2.1

337.04

374.65

nmol/l

0.98

312

Chronic nephritic syndrome

230

1079

2.33

27.74

2.2

324.91

369.52

nmol/l

3.16

220

995

176

741

2.66

27.65

2.4

2.0

348.35

367.27

nmol/l

0.59

163

697

Paralytic ileus

203

902

2.44

27.61

2.2

2.3

375.44

372.04

nmol/l

0.07

193

813

Cardiomyopathy (excluding other)

552

3395

1.69

27.52

2.4

2.5

393.24

369.68

nmol/l

1.55

523

3132

Disorders of iron metabolism

114

386

3.42

27.51

2.0

2.1

351.04

355.07

nmol/l

0.09

107

365

Cardiodefibrillation

1543

11557

1.37

27.45

2.1

2.4

366.64

378.79

nmol/l

1.32

1446

10562

Other bursopathies

613

3874

1.65

27.44

2.1

2.3

357.23

384.68

nmol/l

2.33

577

3564

Duodenal ulcer

474

2803

1.76

27.43

2.4

2.3

362.42

379.50

nmol/l

1.05

439

2565

Graves disease, strict definition

577

3614

1.69

27.36

2.0

2.1

377.85

372.05

nmol/l

0.32

532

3325

Other blood glucose lowering drugs, excl. Insulins

736

4854

1.58

27.27

2.0

2.3

360.10

376.83

nmol/l

1.48

663

4440

Acute suppurative otitis media

1427

9883

1.39

27.27

2.3

2.1

360.33

378.24

nmol/l

2.72

1322

9128

Rosacea

619

3943

1.65

27.22

2.3

2.2

353.90

373.39

nmol/l

1.25

560

3642

Acute pharyngitis

767

5061

1.56

27.15

2.5

2.1

363.82

381.04

nmol/l

1.67

702

4689

Congenital malformations of the musculoskeletal system, not elsewhere classified

128

470

3.22

27.12

2.2

2.1

341.74

376.25

nmol/l

1.27

112

445

Other encephalitis

183

792

2.58

27.02

2.5

2.1

355.08

370.69

nmol/l

0.55

172

734

Malignant neoplasm of head and neck

362

1994

1.91

26.95

3.4

1.8

424.50

367.87

nmol/l

5.56

343

1799

Wide developmental disorders

237

1141

2.28

26.79

2.1

2.3

335.07

370.65

nmol/l

2.34

227

1072

Disorders of breast

2623

19175

1.27

26.78

2.0

2.1

373.76

379.31

nmol/l

0.77

2423

17571

Astigmatism

361

2002

1.93

26.72

2.3

2.2

347.70

368.07

nmol/l

1.19

334

1853

Other hammer toe(s) (acquired)

789

4878

1.55

26.71

2.0

2.3

360.01

394.58

nmol/l

4.80

702

4438

Tinnitus

1143

8235

1.43

26.68

2.3

365.35

375.47

nmol/l

1.02

1027

7580

Ehlers-Danlos syndrome

314

3.86

26.66

2.1

1.9

349.46

383.60

nmol/l

0.98

295

Car occupant injured in other and unspecified transport accidents

980

6880

1.47

26.57

2.0

2.2

369.63

375.89

nmol/l

0.46

899

6320

Bell's palsy

582

3669

1.66

26.51

2.4

2.2

349.22

378.18

nmol/l

3.06

537

3368

Encephalitis

195

875

2.48

26.49

2.4

2.0

350.35

373.44

nmol/l

0.99

181

811

Postmenopausal bleeding

1312

5085

1.42

26.27

2.0

2.3

372.15

381.47

nmol/l

0.87

1181

4633

Hypertrophy of breast

938

6558

1.49

26.26

2.0

2.1

353.37

374.52

nmol/l

2.84

878

6031

Autism

183

801

2.54

26.25

2.0

343.50

382.04

nmol/l

2.09

175

746

Other diseases of blood and blood-forming organs

363

2028

1.91

26.25

2.6

2.1

357.84

369.96

nmol/l

0.60

342

1849

Postprocedural musculoskeletal disorders, not elsewhere classified

380

2155

1.88

26.25

2.2

350.11

370.85

nmol/l

1.09

344

1967

Oesophageal varices

232

1116

2.26

26.22

2.2

358.73

370.51

nmol/l

0.20

220

1021

Bruxism

147

587

2.88

26.20

2.3

2.1

349.40

371.80

nmol/l

0.64

128

546

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

394

2254

1.85

26.20

2.3

2.0

367.53

371.60

nmol/l

0.15

358

2092

Cramp and spasm

276

1418

2.11

26.09

2.2

2.1

341.36

371.54

nmol/l

1.82

258

1315

Other abnormalities of plasma proteins

121

439

3.23

26.07

2.5

1.8

355.21

383.69

nmol/l

0.85

114

408

Early lumbar disc prolapse, operated

503

3068

1.71

26.07

2.1

2.2

356.60

369.54

nmol/l

0.81

465

2856

Covid-19 suspected case

1146

8295

1.43

26.02

2.3

2.1

368.43

376.16

nmol/l

0.79

1073

7614

Anorexia

123

451

3.19

26.00

2.3

2.0

389.52

377.65

nmol/l

0.27

117

415

Benign neoplasm: Stomach

493

3011

1.73

25.83

2.6

2.2

356.82

372.60

nmol/l

1.06

440

2744

Manic episode

184

810

2.49

25.81

2.2

2.1

366.07

372.60

nmol/l

0.17

167

750

Polyarthritis, unspecified

212

990

2.33

25.80

2.4

2.3

348.72

379.28

nmol/l

1.41

204

906

908

5922

1.49

25.77

2.0

2.1

373.96

385.62

nmol/l

0.83

794

5296

Diseases of appendix

3853

29135

1.21

25.70

2.2

369.33

373.20

nmol/l

0.49

3585

26904

Acne

565

3559

1.66

25.70

2.1

1.9

393.31

385.86

nmol/l

0.36

527

3287

Otalgia

449

2685

1.78

25.65

2.3

2.2

350.07

374.31

nmol/l

1.97

414

2469

Volvulus

160

664

2.65

25.63

2.2

2.4

397.09

380.41

nmol/l

0.38

146

599

Benign neoplasm: Sigmoid colon

870

6017

1.50

25.60

2.4

2.3

366.06

373.42

nmol/l

0.47

805

5526

Allergic contact dermatitis

717

4779

1.56

25.53

2.0

2.1

371.39

374.59

nmol/l

0.13

653

4394

Other specified/unspecified necrotizing vasculopathies

104

350

3.48

25.52

2.4

1.8

297.25

382.55

nmol/l

4.17

316

Melanocytic naevi

1491

11277

1.36

25.44

3.0

2.1

368.33

376.20

nmol/l

0.91

1389

10382

Ulcerative enterocolitis

201

928

2.39

25.39

2.4

2.1

311.92

371.18

nmol/l

4.73

184

857

Hypersomnia

112

395

3.32

25.38

2.2

2.1

341.91

371.16

nmol/l

1.03

104

369

Assault

688

4548

1.57

25.38

2.0

2.1

364.83

371.45

nmol/l

0.31

633

4203

Metatarsalgia

479

2911

1.73

25.35

2.0

2.3

346.78

384.65

nmol/l

4.48

437

2684

Acute alcohol intoxication, ICD10

971

6860

1.46

25.35

2.2

2.3

375.84

369.74

nmol/l

0.37

893

6332

Acute appendicitis, no complications

2856

23250

1.24

25.27

2.2

365.89

372.57

nmol/l

1.01

2657

21519

Anxious personality disorder

141

559

2.85

25.22

1.7

2.0

354.09

379.12

nmol/l

0.80

129

520

Pyothorax

230

1118

2.23

25.20

2.4

2.1

389.23

365.72

nmol/l

0.89

219

1027

Other hearing loss

1220

8754

1.40

25.17

2.0

2.2

375.24

384.86

nmol/l

0.83

1106

7971

Endocarditis

180

792

2.45

25.05

2.4

2.3

386.85

369.57

nmol/l

0.50

171

726

Other noninflammatory disorders of uterus, except cervix

1048

5015

1.45

25.03

2.0

2.3

383.44

383.82

nmol/l

0.02

946

4563

Superficial injury of abdomen, lower back and pelvis

769

5216

1.53

25.03

2.3

2.1

352.68

375.13

nmol/l

2.52

698

4775

Allergic urticaria

463

2808

1.74

24.99

2.5

2.1

348.68

375.83

nmol/l

1.95

440

2573

Melanocytic naevi, other sites/unspecified

439

2628

1.77

24.94

3.4

2.1

366.06

371.67

nmol/l

0.26

413

2416

Plantar fascial fibromatosis

485

2971

1.71

24.88

2.0

2.3

363.70

379.84

nmol/l

1.02

442

2742

Algoneurodystrophy

207

977

2.33

24.75

2.3

2.0

347.37

373.48

nmol/l

1.12

189

898

Raynaud syndrome

487

3004

1.72

24.71

2.2

2.1

378.80

371.28

nmol/l

0.36

454

2760

Viral pneumonia (known virus, not influenza)

166

716

2.58

24.71

2.7

2.1

346.89

374.58

nmol/l

0.96

150

658

Other pulmonary heart/vessel disease

243

1214

2.16

24.69

2.2

2.1

348.38

372.68

nmol/l

0.84

225

1102

Malignant neoplasm of bladder

274

1414

2.03

24.68

4.2

1.7

415.38

369.48

nmol/l

3.01

261

1252

Personal history of other diseases and conditions

635

4140

1.60

24.66

2.3

2.1

365.43

375.58

nmol/l

0.65

573

3813

Fall on and from stairs and steps

1267

9400

1.39

24.64

2.3

2.2

365.82

375.80

nmol/l

1.05

1148

8627

Appendicitis, broad definition

3810

29007

1.21

24.52

2.2

369.21

373.22

nmol/l

0.50

3547

26794

Other and unspecified rosacea

466

2847

1.73

24.49

2.3

2.1

355.24

369.37

nmol/l

0.59

423

2621

Female infertility

1519

6954

1.36

24.43

2.1

373.44

387.26

nmol/l

1.63

1409

6392

Psoriasis vulgaris

901

6330

1.47

24.38

2.3

345.75

370.08

nmol/l

3.06

832

5835

Other disorders of veins

1971

15453

1.30

24.37

2.0

2.2

359.09

376.60

nmol/l

3.86

1803

14169

Other and unspecified pemphigoid

249

4.11

24.34

2.4

1.8

353.52

379.04

nmol/l

0.46

224

Secondary right heart disease

222

1079

2.23

24.34

2.1

2.0

349.12

377.44

nmol/l

0.93

204

972

Corns and callosities

354

2009

1.88

24.33

2.3

2.1

369.82

373.34

nmol/l

0.14

325

1840

Superficial injury of thorax

723

4872

1.54

24.30

2.0

2.2

359.02

372.36

nmol/l

0.98

667

4478

Cardiac arrest

250

1062

2.10

24.28

2.1

2.5

365.42

383.38

nmol/l

0.72

233

989

Diabetes mellitus in pregnancy

1804

8950

1.32

24.21

1.9

2.0

379.70

381.63

nmol/l

0.15

1672

8292

Other and unspecified disorders of skin and subcutaneous tissue

340

1911

1.90

24.16

2.8

2.1

347.69

371.59

nmol/l

1.54

298

1743

Prurigo nodularis

159

681

2.61

24.13

2.0

350.99

373.13

nmol/l

0.64

143

623

Attention to artificial openings

213

1022

2.25

24.09

2.5

2.1

377.09

369.85

nmol/l

0.19

193

918

Gingival hyperplasia

223

1098

2.23

24.01

4.2

2.3

314.26

367.03

nmol/l

3.06

217

1023

Speech therapy

1273

9492

1.38

24.00

2.2

370.94

374.95

nmol/l

0.30

1205

8684

Unspecified misadventure during surgical and medical care

305

1666

1.97

23.95

3.1

2.1

374.16

372.05

nmol/l

0.05

285

1530

Systemic sclerosis (FG)

151

633

2.66

23.93

1.7

2.1

351.02

393.15

nmol/l

1.18

139

579

Viral warts

1093

7964

1.42

23.93

2.3

2.2

357.08

374.80

nmol/l

2.38

1020

7329

Squamous cell neoplasms and carcinomas of the skin

341

1911

1.87

23.88

2.8

1.7

385.84

372.38

nmol/l

0.53

307

1663

Autonomic disorders

149

622

2.68

23.86

2.4

1.9

406.88

380.51

nmol/l

0.64

139

574

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2041

10909

1.29

23.79

2.2

1.8

375.17

366.57

nmol/l

0.97

1861

9850

Autism spe

178

807

2.44

23.61

2.1

341.63

380.48

nmol/l

2.09

171

751

Other condition

729

4956

1.53

23.61

2.3

2.2

348.71

372.01

nmol/l

2.94

687

4553

Drug-induced hypoglycaemia without coma

112

409

3.12

23.56

1.6

2.0

417.61

378.17

nmol/l

1.07

103

373

Tubulo-interstitial nephritis, not specified as acute or chronic

341

1928

1.86

23.47

2.4

2.0

355.70

380.28

nmol/l

1.51

309

1734

Diabetic maculopathy

725

4663

1.55

23.46

1.9

2.2

395.50

368.88

nmol/l

3.16

671

4273

Varicose veins

2927

18191

1.23

23.44

2.2

2.3

363.47

376.47

nmol/l

2.94

2697

16669

Viral infections of the central nervous system

392

2315

1.80

23.42

2.5

2.0

353.57

374.82

nmol/l

1.43

368

2124

Other juvenile arthritis

251

1295

2.09

23.42

2.5

2.1

332.11

385.85

nmol/l

4.46

235

1186

Viral infections of the central nervous system

417

2504

1.76

23.40

2.5

2.1

352.01

374.82

nmol/l

1.71

392

2296

Other menopausal disorders

1380

5813

1.37

23.38

2.1

2.2

368.72

378.16

nmol/l

1.03

1281

5337

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

147

613

2.64

23.37

1.7

1.6

376.26

368.87

nmol/l

0.14

141

540

Multiple myeloma

147

613

2.64

23.37

1.7

1.6

376.26

368.87

nmol/l

0.14

141

540

Nummular dermatitis

397

2352

1.78

23.29

2.5

2.1

386.65

372.23

nmol/l

0.71

374

2142

Gluteal tendinitis

217

1064

2.20

23.27

2.0

2.1

347.62

377.00

nmol/l

1.21

194

983

Presence of other devices

1014

7287

1.42

23.21

2.0

2.3

368.18

387.46

nmol/l

1.94

948

6608

Seropositive rheumatoid arthritis, strict definition

742

5088

1.52

23.05

1.8

2.2

347.22

374.55

nmol/l

3.09

695

4662

Suppurative and unspecified otitis media

1903

13309

1.29

23.02

2.2

2.1

369.04

378.71

nmol/l

1.23

1766

12279

Mixed disorders of conduct and emotions, excluding more controls

123

471

2.83

23.00

2.0

1.9

347.44

400.16

nmol/l

2.03

109

433

Open wound of forearm

482

3011

1.68

22.95

2.3

2.1

344.73

378.44

nmol/l

3.32

440

2754

Other female pelvic inflammatory diseases

827

5796

1.48

22.92

2.1

379.37

378.48

nmol/l

0.04

741

5305

Other coagulation defects

409

2459

1.76

22.91

2.3

2.1

354.31

374.35

nmol/l

1.32

385

2249

Defects in the complement system

215

4.34

22.89

3.4

2.1

321.07

359.35

nmol/l

0.75

201

Combinations of oral blood glucose lowering drugs

1214

9047

1.38

22.83

2.1

2.4

377.40

372.69

nmol/l

0.32

1122

8380

Other specified/unspecified bacterial intestinal infections

350

2019

1.84

22.79

2.5

2.2

359.19

372.91

nmol/l

0.59

322

1840

Osteonecrosis due to drugs

107

392

3.21

22.76

3.2

1.9

351.13

374.80

nmol/l

0.47

366

Striking against or struck by other objects

1634

12687

1.32

22.74

2.3

357.46

370.38

nmol/l

1.85

1496

11745

Artificial joint operation, meniscal resection

4457

24745

1.18

22.68

2.2

2.3

358.67

374.85

nmol/l

6.41

4080

22794

Otitis externa

1102

8112

1.40

22.66

2.4

2.2

363.17

373.21

nmol/l

0.93

990

7473

Disorder of the sleep-wake schedule

132

536

2.80

22.64

2.4

2.2

408.74

373.88

nmol/l

0.91

121

500

Cardiac murmurs and other cardiac sounds

459

2805

1.69

22.57

2.3

2.2

379.30

382.48

nmol/l

0.11

425

2578

conjunctival haemorrhage

380

2250

1.79

22.48

2.4

2.1

342.03

372.85

nmol/l

2.64

349

2050

Sequelae of injuries of neck and trunk

184

862

2.35

22.47

2.1

2.3

361.01

368.53

nmol/l

0.20

170

802

Other noninflammatory disorders of vulva and perineum

476

2984

1.67

22.31

2.2

393.15

383.63

nmol/l

0.36

434

2722

Caries of enamel

4689

29123

1.18

22.31

2.2

365.04

373.79

nmol/l

2.28

4293

26975

Hyperplasia of prostate

1411

6039

1.35

22.17

2.4

2.7

362.88

369.56

nmol/l

0.46

1284

5675

Redundant prepuce, phimosis and paraphimosis

855

5979

1.45

22.09

2.3

2.4

354.06

365.35

nmol/l

0.91

790

5609

Symptoms and signs involving appearance and behaviour

222

3.99

22.05

2.1

1.8

375.94

367.90

nmol/l

0.11

205

Malignant neoplasm of thyroid gland

345

2001

1.83

22.03

2.6

1.8

388.41

364.05

nmol/l

0.79

324

1813

Other specified/unspecified dorsopathies

189

897

2.27

22.02

2.4

2.0

352.51

384.81

nmol/l

1.29

173

825

Seborrhoeic keratosis

1002

7295

1.41

22.02

2.4

2.2

377.45

377.16

nmol/l

0.01

912

6660

Pneumothorax

324

1840

1.85

22.01

3.2

2.2

382.25

375.02

nmol/l

0.23

301

1682

Diseases of tongue

308

1725

1.89

21.99

2.4

2.1

356.22

383.60

nmol/l

1.62

271

1582

Nonsuppurative otitis media

1197

7728

1.38

21.97

2.3

2.0

369.25

385.59

nmol/l

2.01

1100

7093

Convalescence

289

1593

1.94

21.93

2.3

2.0

349.07

364.22

nmol/l

0.70

253

1435

Thiazolidinediones

501

3192

1.64

21.89

1.9

2.4

368.68

372.67

nmol/l

0.16

454

2936

Alcohol withdrawal state with delirium

331

1899

1.84

21.85

2.2

2.4

382.18

362.98

nmol/l

0.35

303

1765

Molar incisor enamel hypoplasia

240

1209

2.10

21.81

4.4

2.2

301.34

364.40

nmol/l

5.51

228

1142

Arthropathic psoriasis

563

3692

1.59

21.80

2.0

2.2

349.49

369.42

nmol/l

1.25

519

3397

Specific development disorders of scholastic skills

268

1429

1.99

21.72

2.4

2.2

336.99

372.14

nmol/l

2.24

252

1330

Retinal detachments and breaks

1561

12134

1.31

21.67

2.2

2.3

380.89

375.67

nmol/l

0.45

1433

11108

Pneumonia due to Streptococcus pneumoniae

213

1062

2.14

21.66

3.0

2.2

358.32

370.36

nmol/l

0.25

195

983

Other/unspecified enthesopathies, not elsewhere classified

399

2411

1.73

21.60

2.4

2.3

354.92

385.98

nmol/l

2.17

368

2207

Cholecystitis

617

4120

1.55

21.59

2.4

2.2

360.67

378.33

nmol/l

1.19

561

3750

Congenital iodine-deficiency syndrome/hypothyroidism

169

778

2.37

21.45

2.1

1.7

361.79

375.28

nmol/l

0.36

157

699

Acute appendicitis

3543

28041

1.20

21.44

2.2

369.65

372.73

nmol/l

0.34

3299

25909

Other neurotic disorders

245

1289

2.03

21.42

2.4

2.1

367.36

370.57

nmol/l

0.09

222

1173

Other congenital malformations

485

3095

1.65

21.34

2.3

2.2

357.19

368.65

nmol/l

0.60

452

2861

Blepharochalasis

1322

10082

1.35

21.33

2.2

371.34

380.01

nmol/l

0.86

1217

9210

Congenital malformations and deformations of the musculoskeletal system

615

4109

1.56

21.31

2.2

357.33

370.08

nmol/l

0.91

565

3800

Familial hypercholesterolemia, with ischemic heart disease

401

2436

1.72

21.28

2.2

2.4

372.55

379.06

nmol/l

0.26

359

2212

Subacute thyroiditis

200

985

2.20

21.26

1.9

1.8

373.64

370.82

nmol/l

0.08

185

895

Malignant neoplasm of thyroid gland, including Hilmo

380

2287

1.75

21.16

2.6

1.8

385.84

365.56

nmol/l

0.68

357

2073

Excessive vomiting in pregnancy

456

2876

1.67

21.12

2.1

373.26

381.47

nmol/l

0.29

426

2648

Injuries to unspecified part of trunk, limb or body region

515

3336

1.62

21.10

2.1

359.85

375.13

nmol/l

0.93

472

3054

Endometriosis ASRM stages 1,2

950

6926

1.42

21.01

2.1

379.34

373.61

nmol/l

0.39

876

6361

Acne vulgaris

444

2781

1.67

20.97

2.0

1.9

395.85

386.18

nmol/l

0.41

415

2573

Haemolytic anaemias

202

1008

2.18

20.87

2.5

2.1

343.96

368.33

nmol/l

1.03

187

922

Acquired haemolytic anaemia

149

662

2.50

20.80

2.4

2.0

349.54

374.60

nmol/l

0.84

139

604

Spinal instabilities

162

743

2.38

20.73

2.3

2.1

347.49

374.19

nmol/l

1.03

143

698

Superficial injury of hip and thigh

681

4679

1.50

20.71

2.1

374.44

380.72

nmol/l

0.35

614

4244

Disorders of lacrimal system and orbit in diseases classified elsewhere

159

728

2.42

20.69

2.4

2.0

367.24

376.09

nmol/l

0.24

147

672

Anomalies of dental arch relationship, including avohilmo

1035

6890

1.40

20.68

2.4

2.2

360.04

374.79

nmol/l

1.39

948

6372

141

612

2.54

20.62

1.9

2.0

366.00

389.83

nmol/l

0.81

129

552

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

404

2490

1.71

20.59

2.6

2.1

375.04

371.96

nmol/l

0.11

372

2268

Pyogenic arthritis

309

1765

1.84

20.55

2.3

346.90

383.20

nmol/l

1.66

291

1609

Other diseases of arteries and capillaries

424

2644

1.68

20.39

2.1

2.2

380.18

373.61

nmol/l

0.22

387

2404

Tobacco use

290

1640

1.89

20.36

2.2

2.1

377.28

371.21

nmol/l

0.19

268

1520

Corneal ulcer

899

6520

1.42

20.33

2.2

358.27

371.45

nmol/l

1.36

822

6003

Hemiplegia

266

1464

1.93

20.27

2.3

2.1

380.41

369.96

nmol/l

0.34

241

1333

Abscess of anal and rectal regions

404

2491

1.69

20.24

2.4

2.2

375.31

367.65

nmol/l

0.32

367

2303

Ankylosing spondylitis

409

2529

1.69

20.23

2.2

339.34

376.78

nmol/l

3.19

378

2335

Heterophoria

434

2734

1.67

20.21

2.6

2.1

343.48

376.36

nmol/l

2.95

403

2506

Idiopathic gout

404

2494

1.70

20.21

2.1

2.3

337.76

371.77

nmol/l

2.94

364

2289

Sacroiliitis, not elsewhere classified

255

1385

1.95

20.21

2.4

1.9

355.07

381.42

nmol/l

1.56

231

1284

Lymphoid leukaemia

283

1592

1.89

20.17

2.5

2.2

389.87

366.73

nmol/l

1.14

271

1448

Vulvovaginal ulceration/inflammation in other diseases

348

2079

1.78

20.11

2.1

2.0

375.56

378.47

nmol/l

0.11

319

1910

Maternal care for other conditions predominantly related to pregnancy

1111

8180

1.37

20.11

1.9

2.0

372.89

379.38

nmol/l

0.55

1029

7564

Benign neoplasm: Rectum, anus and anal canal

883

6397

1.42

20.07

2.4

2.3

373.30

374.82

nmol/l

0.08

807

5866

Juvenile arthritis (FINNGEN)

271

1508

1.92

20.04

2.5

2.1

329.41

385.82

nmol/l

5.36

253

1395

Hypoplasia of dental enamel , including avohilmo

225

1152

2.08

20.03

4.3

2.2

299.60

363.65

nmol/l

5.40

214

1090

Superficial injury of wrist and hand

1017

7539

1.39

20.02

2.1

2.2

353.38

375.28

nmol/l

3.41

951

6932

Dermatophytosis

2969

24914

1.21

19.97

2.3

2.2

351.97

375.54

nmol/l

9.76

2714

22992

Benign neoplasm of brain and other parts of central nervous system

337

2000

1.79

19.92

3.1

2.2

337.88

369.22

nmol/l

2.29

312

1834

Deficiency of other B group vitamins

128

542

2.62

19.87

1.7

2.1

395.83

385.22

nmol/l

0.19

114

498

Assault by bodily force

407

2532

1.69

19.85

2.0

2.1

366.23

376.55

nmol/l

0.51

371

2348

Spontaneous rupture of synovium and tendon

373

2271

1.72

19.68

2.2

2.3

333.63

383.36

nmol/l

5.65

341

2094

Ganglion

973

7177

1.39

19.62

2.3

2.2

361.88

384.54

nmol/l

3.39

892

6632

Primary ovarian failure

133

579

2.57

19.61

2.5

1.8

382.10

374.29

nmol/l

0.10

125

538

Systemic sclerosis

151

694

2.41

19.50

1.7

2.0

351.02

379.59

nmol/l

0.67

139

635

Brain glioblastoma and astrocytoma

111

445

2.80

19.48

2.1

1.7

301.76

364.76

nmol/l

2.64

101

413

Cerebral aneurysm, nonruptured

427

2705

1.66

19.37

2.5

2.2

373.99

368.64

nmol/l

0.25

397

2486

Salpingitis and oophoritis

871

6345

1.42

19.35

2.4

2.2

370.96

373.94

nmol/l

0.16

790

5836

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

436

2785

1.65

19.28

2.1

2.2

360.25

371.52

nmol/l

0.53

408

2594

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1866

10239

1.27

19.24

2.2

1.8

375.99

366.52

nmol/l

1.09

1691

9227

Calcific aortic valvular stenosis

1183

8723

1.34

19.23

2.0

2.2

387.68

382.11

nmol/l

0.28

1070

7887

Calcific aortic valvular stenosis, operated

1183

8723

1.34

19.23

2.0

2.2

387.68

382.11

nmol/l

0.28

1070

7887

Olecranon bursitis

278

1572

1.86

19.22

2.6

2.4

344.89

372.56

nmol/l

1.30

263

1457

Diseases of spleen

118

492

2.70

19.15

2.4

1.9

367.28

371.80

nmol/l

0.08

110

449

Other and unspecified injuries of head

346

2088

1.74

19.06

1.9

2.2

392.02

374.81

nmol/l

0.75

311

1911

Panniculitis affecting regions of neck and back

190

956

2.12

18.95

2.1

2.0

325.67

378.36

nmol/l

3.28

177

874

Operations 2 for CAVS

1178

8701

1.34

18.91

2.0

2.2

387.78

382.48

nmol/l

0.26

1065

7865

Calcific aortic valvular stenosis, diagnosis (helper)

1178

8701

1.34

18.91

2.0

2.2

387.78

382.48

nmol/l

0.26

1065

7865

Cutaneous lupus erythematosus

149

690

2.39

18.90

1.9

2.0

359.43

372.27

nmol/l

0.28

133

630

Procreative management

1717

11430

1.28

18.88

2.6

2.2

373.00

371.26

nmol/l

0.13

1596

10588

Optic atrophy

124

535

2.62

18.80

3.7

2.0

378.06

359.93

nmol/l

0.12

115

498

Chorioretinal inflammation

163

782

2.27

18.73

3.0

2.1

340.40

370.32

nmol/l

1.33

152

716

Periapical abscess

2164

17771

1.24

18.67

2.3

356.26

369.66

nmol/l

2.57

2006

16428

Calcific aortic valvular stenosis, including rheumatic fever

1181

8737

1.34

18.62

2.0

2.2

387.41

382.49

nmol/l

0.24

1068

7898

Other disorders of conjunctiva

647

4506

1.49

18.56

2.4

2.2

347.95

377.25

nmol/l

3.43

596

4124

Other erythematous conditions

197

1017

2.10

18.54

2.2

2.0

342.85

375.61

nmol/l

1.60

186

932

Hypermetropia

373

2313

1.70

18.53

2.6

2.2

364.27

369.53

nmol/l

0.17

342

2120

Paralytic strabismus

339

2054

1.74

18.45

2.8

2.1

357.81

373.37

nmol/l

0.80

313

1867

Hodgkin lymphoma, hilmo

170

836

2.22

18.40

3.2

2.0

371.83

374.77

nmol/l

0.07

161

774

Aneurysms, operations, SAH

729

5191

1.45

18.39

2.3

369.47

375.20

nmol/l

0.35

665

4759

Reactive arthropathies

411

2607

1.64

18.39

2.1

2.3

353.67

380.01

nmol/l

2.00

380

2397

Barrett oesophagus

231

1255

1.96

18.38

2.1

2.4

382.10

374.33

nmol/l

0.21

210

1156

Anogenital herpesviral [herpes simplex] infection

578

3954

1.52

18.34

2.1

2.0

380.87

380.41

nmol/l

0.02

526

3663

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1348

10517

1.31

18.33

2.2

2.3

354.91

372.25

nmol/l

2.93

1244

9689

Mental retardation, excluding more controls

194

967

2.08

18.27

2.6

2.3

358.10

356.75

nmol/l

0.03

184

908

Otitis externa, unspecified

562

3831

1.53

18.16

2.6

2.2

354.34

373.21

nmol/l

1.38

511

3529

Nontoxic single thyroid nodule

343

2092

1.72

18.16

2.4

2.0

365.17

370.66

nmol/l

0.21

314

1918

Sequelae of other external causes

287

1673

1.82

18.09

2.5

2.1

373.21

369.97

nmol/l

0.10

276

1528

Other disorders of breast

664

4678

1.48

18.09

2.1

381.09

377.97

nmol/l

0.17

610

4282

Amyloidosis

114

477

2.61

18.02

2.2

2.1

382.98

360.27

nmol/l

0.48

105

432

Benign neoplasm: Transverse colon

485

3217

1.57

17.93

2.3

358.91

372.08

nmol/l

0.78

443

2941

Pleural plaque

361

2229

1.68

17.92

2.2

357.54

376.83

nmol/l

1.01

329

2015

Psoriatic arthropathies, ICD10

514

3452

1.55

17.92

2.0

2.2

342.84

368.59

nmol/l

1.99

476

3179

Alcohol abuse, main dg

727

5200

1.44

17.92

2.1

2.2

373.76

371.48

nmol/l

0.11

671

4800

Reactive arthropathies, FINNGEN

345

2115

1.71

17.86

2.2

347.42

380.99

nmol/l

2.58

322

1936

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

303

1806

1.79

17.83

2.5

2.1

373.55

372.89

nmol/l

0.02

268

1643

Optic atrophy

126

560

2.53

17.83

3.8

2.0

372.38

362.19

nmol/l

0.06

117

517

Chronic tubulo-interstitial nephritis

199

1041

2.04

17.83

2.5

2.0

356.69

375.86

nmol/l

0.64

189

936

Nail disorders

417

2682

1.63

17.78

2.7

2.1

361.46

372.83

nmol/l

0.61

384

2468

Other and unspecified trigeminal disorders

103

417

2.77

17.77

2.9

2.2

348.29

363.62

nmol/l

0.29

388

Golimumab

202

1068

2.04

17.74

2.0

309.52

372.82

nmol/l

5.70

196

993

Female infertility, cervical, vaginal, other or unspecified origin

1338

6758

1.32

17.74

2.1

376.29

385.49

nmol/l

0.81

1242

6220

Alzheimer’s disease (Late onset), excluding more controls

512

2209

1.56

17.73

1.7

2.5

406.77

391.46

nmol/l

0.83

432

2024

D07AA Corticosteroids, weak (group I)

797

5795

1.42

17.72

2.6

2.2

345.87

372.64

nmol/l

3.61

739

5333

Malignant neoplasm of digestive organs

1496

9328

1.29

17.65

2.5

1.8

409.84

367.20

nmol/l

10.50

1392

8412

Open wound of ankle and foot

502

3362

1.55

17.65

2.0

2.2

365.13

373.67

nmol/l

0.44

466

3076

Other maternal disorders predominantly related to pregnancy

2958

15679

1.20

17.60

2.1

372.25

379.77

nmol/l

1.18

2742

14439

Systemic sclerosis, icd10

150

718

2.31

17.58

1.7

2.1

351.54

374.58

nmol/l

0.50

138

663

Graves ophthalmopathy

156

758

2.27

17.58

2.3

2.1

366.79

373.58

nmol/l

0.17

144

693

Dystonia

291

1721

1.80

17.52

2.4

2.1

390.68

372.57

nmol/l

0.81

268

1571

Unspecified jaundice

217

1170

1.95

17.50

2.2

2.1

374.77

378.87

nmol/l

0.10

205

1054

Fracture at wrist and hand level

1627

13029

1.27

17.45

2.0

2.3

366.75

374.02

nmol/l

0.55

1512

12025

Polyp of the female genital tract

1486

6717

1.30

17.45

2.0

2.2

381.19

380.99

nmol/l

0.01

1357

6136

Use of disulfiram, acamprosate or naltrexone

417

2694

1.62

17.38

2.2

2.3

365.85

363.93

nmol/l

0.07

379

2505

Other keratitis

554

3797

1.52

17.38

2.2

359.16

373.69

nmol/l

1.03

517

3486

Urolithiasis

1386

10925

1.29

17.34

2.4

2.3

358.73

373.69

nmol/l

1.90

1276

10079

Presbycusis

549

3708

1.51

17.32

1.9

2.1

378.71

390.08

nmol/l

0.58

494

3304

Benign neoplasm of mouth and pharynx

513

3470

1.54

17.24

2.7

2.2

374.97

371.93

nmol/l

0.13

458

3186

Dementia, including avohilmo

1868

10418

1.25

17.18

1.8

2.3

389.46

380.44

nmol/l

1.07

1632

9495

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2360

17118

1.22

17.16

2.0

2.1

358.66

378.24

nmol/l

5.48

2190

15773

Moderate visual impairment, binocular

157

766

2.21

17.16

2.3

1.9

387.72

380.62

nmol/l

0.15

131

687

Intentional self-harm by unspecified means

366

2.88

17.09

1.9

1.8

371.87

405.49

nmol/l

0.83

334

Schizoaffective disorder

391

2502

1.64

17.08

1.8

2.1

399.15

371.44

nmol/l

1.90

361

2331

Hidradenitis suppurativa

211

1146

1.98

17.04

2.1

2.0

367.31

375.71

nmol/l

0.25

194

1068

Graves ophthalmopathy, strict

143

681

2.33

17.04

2.4

2.1

360.19

374.28

nmol/l

0.43

131

628

Coxarthrosis, primary

2610

18586

1.21

17.03

2.2

2.3

369.46

376.76

nmol/l

0.78

2367

17040

Ulcer of oesophagus

295

1757

1.76

17.01

2.3

388.31

374.88

nmol/l

0.45

264

1604

Other and unspecified erythematous conditions

178

916

2.11

16.98

2.3

2.0

342.58

376.80

nmol/l

1.57

168

840

Basal cell carcinoma, including avohilmo

1852

10353

1.25

16.95

2.3

1.8

371.04

366.43

nmol/l

0.41

1681

9331

Basal cell carcinoma

1769

9886

1.26

16.92

2.3

1.8

375.46

366.77

nmol/l

0.89

1603

8904

Lactose intolerance

164

819

2.15

16.82

2.2

2.1

380.47

365.64

nmol/l

0.36

146

756

Radial styloid tenosynovitis [de Quervain]

278

1637

1.79

16.82

2.1

2.2

362.43

384.65

nmol/l

1.18

253

1510

Pregnancy hypertension

2135

15849

1.23

16.74

2.0

2.1

359.25

377.76

nmol/l

4.45

1977

14623

Other epidermal thickening

225

1252

1.92

16.73

2.2

2.1

359.41

372.54

nmol/l

0.40

205

1144

Vascular diseases of the intestine

185

966

2.04

16.62

2.4

2.2

388.35

371.88

nmol/l

0.46

171

874

Carrier of infectious disease

148

719

2.25

16.61

2.4

2.0

354.79

379.86

nmol/l

0.76

137

660

Other predominantly sexually transmitted diseases, not elsewhere classified

1052

8065

1.34

16.54

2.1

2.0

394.50

378.48

nmol/l

1.71

972

7434

Other and unspecified abdominal hernia

209

1141

1.96

16.54

2.4

2.1

366.07

370.11

nmol/l

0.10

195

1036

Discitis, unspecified

364

2.79

16.50

2.1

2.2

372.97

381.58

nmol/l

0.12

334

Other peripheral vertigo

431

2841

1.58

16.47

2.1

2.2

368.31

374.47

nmol/l

0.28

386

2603

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

260

1508

1.80

16.46

2.7

1.8

400.89

365.80

nmol/l

1.67

241

1346

Malignant cancer of tonsil and base of tongue, including Hilmo

128

588

2.37

16.45

3.8

1.6

394.62

360.38

nmol/l

1.05

120

532

Isolated proteinuria

160

803

2.16

16.39

2.1

356.16

378.03

nmol/l

0.82

152

741

Benign neoplasm: Ascending colon

608

4288

1.47

16.39

2.3

361.04

373.81

nmol/l

0.86

565

3907

Other psoriatic arthropathies

495

3362

1.53

16.37

2.0

2.2

343.06

369.05

nmol/l

1.97

460

3097

Short Achilles tendon (acquired)

146

706

2.23

16.36

2.1

2.0

401.16

383.65

nmol/l

0.44

136

645

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

113

498

2.54

16.30

2.8

2.3

316.65

367.43

nmol/l

1.99

106

466

Calculus of kidney and ureter

1289

10153

1.30

16.29

2.4

2.3

358.08

373.30

nmol/l

1.85

1183

9368

Somnolence

353

2.86

16.15

1.8

1.9

393.37

382.91

nmol/l

0.13

326

Nontraumatic intracranial haemmorrhage

820

6074

1.38

16.15

2.1

2.2

379.84

377.34

nmol/l

0.13

746

5522

Gonarthrosis, primary, with knee surgery

2512

16843

1.20

16.10

2.0

2.4

358.87

378.63

nmol/l

5.10

2275

15460

Early complications of trauma

222

1245

1.90

16.08

2.3

2.1

330.23

373.06

nmol/l

2.99

205

1137

!Aliquae complicationes praecoces traumatis

222

1245

1.90

16.08

2.3

2.1

330.23

373.06

nmol/l

2.99

205

1137

Pulmonary eosinophilia, not elsewhere classified

319

2.98

16.08

2.3

2.0

313.17

370.80

nmol/l

0.54

284

Endometriosis of rectovaginal septum and vagina

381

2458

1.62

16.04

2.1

2.2

373.11

381.90

nmol/l

0.37

354

2245

Thyrotoxicosis factitia

5.66

16.03

2.2

2.1

337.85

384.96

nmol/l

0.78

Sacrococcygeal disorders, not elsewhere classified

168

863

2.09

16.00

1.9

2.0

345.60

380.47

nmol/l

1.68

154

793

Intracerebral haemorrhage

510

3490

1.51

15.92

2.2

2.1

386.41

378.07

nmol/l

0.41

467

3169

Lichen planus

581

4090

1.47

15.86

2.4

2.2

366.03

374.49

nmol/l

0.48

520

3745

Specific development disorders of speech and language

316

1883

1.70

15.85

2.9

2.1

321.08

371.50

nmol/l

4.99

291

1734

Nonischemic cardiomyopathy

414

2719

1.58

15.84

2.7

2.4

379.42

371.62

nmol/l

0.34

390

2488

IgA nephropathy (IgA glomerulonephritis)

139

672

2.26

15.83

2.3

2.0

349.29

369.28

nmol/l

0.65

126

625

Benign neoplasm: Brain, supratentorial

107

467

2.57

15.80

3.4

1.8

303.03

373.09

nmol/l

3.17

426

Other and unspecified disorders of vitreous body

1854

15049

1.24

15.75

2.2

2.3

359.82

375.38

nmol/l

2.85

1685

13829

Endometriosis of ovary

798

5773

1.39

15.74

2.0

2.2

376.81

382.08

nmol/l

0.32

736

5294

Dementia

1726

9646

1.25

15.73

1.8

2.3

392.12

381.73

nmol/l

1.26

1502

8776

Vascular dementia

340

2055

1.65

15.72

1.8

2.0

401.64

389.11

nmol/l

0.51

304

1823

Calcific tendinitis of shoulder

274

1638

1.76

15.72

2.4

2.3

327.20

380.94

nmol/l

5.16

257

1511

Symptoms and signs involving emotional state

167

863

2.08

15.66

2.1

405.37

377.05

nmol/l

0.98

154

794

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

361

2.83

15.57

2.4

2.0

388.40

371.76

nmol/l

0.21

338

Follow-up examination after treatment for malignant neoplasms

393

2559

1.58

15.55

2.4

2.2

394.40

390.36

nmol/l

0.14

369

2354

Benign neoplasm: Rectum

769

5690

1.39

15.50

2.5

2.3

372.83

373.10

nmol/l

0.01

703

5222

Other predominantly sexually transmitted diseases, not elsewhere classified

873

6587

1.36

15.49

2.1

395.15

375.86

nmol/l

1.96

807

6068

Allergic purpura

171

896

2.06

15.48

2.4

2.0

337.13

375.54

nmol/l

1.91

157

831

Other and unspecified coagulation defects

274

1652

1.76

15.47

2.4

2.1

345.09

374.38

nmol/l

1.71

263

1525

Other surgical follow-up care

181

967

2.00

15.36

2.1

377.67

370.94

nmol/l

0.17

169

878

Other and unspecified psoriasis

320

2006

1.67

15.31

2.4

2.2

344.88

369.94

nmol/l

1.28

292

1847

Congenital malformations and deformations of the musculoskeletal system

478

3254

1.52

15.30

2.3

2.2

352.59

368.73

nmol/l

1.05

440

3016

Erythema nodosum

170

894

2.06

15.29

2.4

2.0

334.92

374.07

nmol/l

1.69

159

818

Intentional self-harm by sharp object

152

769

2.14

15.23

2.2

2.0

392.72

391.23

nmol/l

0.03

141

713

Residual foreign body in soft tissue

235

1358

1.82

15.21

2.4

2.2

344.28

377.45

nmol/l

1.92

225

1258

Retinal vascular occlusion

495

3406

1.50

15.18

2.1

2.2

387.85

376.46

nmol/l

0.47

445

3084

Other specified disorders of muscle

146

728

2.15

15.07

2.0

2.1

381.71

378.83

nmol/l

0.06

133

672

Inflammatory diseases of prostate (prostatitis)

482

3301

1.50

15.02

2.2

2.6

361.85

370.36

nmol/l

0.43

439

3086

Amputation of foot

135

658

2.23

14.99

2.0

2.2

386.85

372.35

nmol/l

0.39

128

592

Other fall from one level to another

1038

8046

1.32

14.99

2.2

2.3

382.07

370.60

nmol/l

0.80

967

7422

Haemorrhage in early pregnancy

1393

10896

1.27

14.98

2.1

364.75

377.24

nmol/l

1.68

1294

10036

Other benign neoplasms of skin

1692

13874

1.24

14.97

2.5

2.2

360.10

377.54

nmol/l

3.23

1526

12692

Dislocation, sprain and strain of joints and ligaments of knee

2972

23565

1.18

14.93

2.2

353.78

376.84

nmol/l

10.32

2766

21792

Nonpyogenic thrombosis of intracranial venous system

263

3.13

14.88

2.9

1.9

357.18

358.44

nmol/l

0.02

240

Disorders of speech understanding and production

241

1391

1.81

14.88

2.9

2.2

318.51

363.11

nmol/l

3.34

222

1294

Retinal vascular disorders

499

3452

1.49

14.86

2.1

2.2

388.09

377.39

nmol/l

0.44

449

3129

Disorder of pancreatic internal secretion, other and/or unspecified

204

3.52

14.81

1.8

426.44

362.52

nmol/l

1.60

190

Ulcerative proctitis

313

1969

1.67

14.79

2.2

2.1

335.82

377.27

nmol/l

3.54

288

1822

Melanocytic naevi of trunk

568

4035

1.46

14.79

3.6

2.1

368.49

373.18

nmol/l

0.23

531

3708

Other secondary coxarthrosis

182

989

1.98

14.76

2.3

2.2

377.93

367.90

nmol/l

0.09

166

902

In situ neoplasms

1735

14295

1.24

14.66

2.6

2.1

376.03

379.41

nmol/l

0.26

1597

13025

Other and unspecified injuries of lower leg

382

2519

1.58

14.64

2.1

2.0

353.21

377.14

nmol/l

1.60

350

2321

Other and unspecified epidermal thickening

149

760

2.12

14.63

2.0

359.72

375.50

nmol/l

0.36

135

701

Unspecified privation

505

3519

1.49

14.62

2.4

2.2

359.82

372.85

nmol/l

0.81

474

3215

Disorders of puberty, all

119

562

2.34

14.54

3.3

2.2

357.57

376.46

nmol/l

0.53

113

526

Maltreatment syndromes

278

1707

1.72

14.53

2.0

1.9

361.30

378.29

nmol/l

0.80

255

1581

Anogenital herpesviral [herpes simplex] infection

337

2169

1.63

14.51

2.0

2.1

378.72

376.43

nmol/l

0.08

309

2003

Nystagmus and other irregular eye movements

101

448

2.55

14.50

1.9

2.2

355.60

373.82

nmol/l

0.39

422

Acute and transient psychotic disorders

554

3931

1.46

14.49

1.9

2.1

387.53

371.33

nmol/l

1.07

506

3632

Erythema intertrigo

131

642

2.22

14.39

2.5

1.9

328.60

378.42

nmol/l

2.28

120

590

Postzoster neuralgia

384

2.63

14.39

2.8

1.9

345.30

400.88

nmol/l

1.54

346

Vasomotor rhinitis (mode)

351

2285

1.61

14.33

2.2

2.1

362.61

371.16

nmol/l

0.41

325

2089

Renal cell carcinoma of kidney

150

769

2.07

14.29

5.0

1.7

403.97

367.65

nmol/l

1.45

143

685

Malignant neoplasm of oral cavity, including Hilmo

202

1140

1.87

14.27

3.6

1.7

426.65

364.37

nmol/l

3.46

190

1017

Impotence

229

1339

1.80

14.27

2.1

2.4

348.85

372.73

nmol/l

1.30

215

1244

Other and/or unspecified nontoxic goitre

361

2363

1.59

14.26

2.3

2.0

376.88

377.15

nmol/l

0.01

335

2156

Neovascular glaucoma

197

1106

1.89

14.23

2.3

2.1

365.76

371.59

nmol/l

0.18

187

1010

Myeloproliferative diseases

374

2470

1.58

14.23

2.1

2.2

397.90

370.78

nmol/l

1.54

347

2238

Fall involving bed

163

865

2.02

14.19

1.8

1.9

369.32

371.15

nmol/l

0.04

145

782

Acute posthaemorrhagic anaemia

163

862

2.01

14.18

2.8

2.0

384.61

375.49

nmol/l

0.23

153

778

Amyloidosis, other/unspecified

404

2.54

14.16

2.4

2.0

383.60

364.04

nmol/l

0.34

368

Synovial cyst of popliteal space [Baker]

317

2017

1.64

14.13

2.0

2.2

365.76

386.35

nmol/l

0.95

294

1846

Other abnormal immunological findings in serum

123

594

2.27

14.12

2.3

2.1

342.64

374.66

nmol/l

1.23

117

554

Myopia

630

4598

1.41

13.98

2.3

2.1

377.71

376.35

nmol/l

0.06

580

4235

Achilles tendinitis

443

3033

1.51

13.97

2.1

2.3

351.96

377.65

nmol/l

1.73

403

2805

Follicular cysts of skin and subcutaneous tissue

823

6250

1.35

13.95

2.4

2.2

376.44

371.63

nmol/l

0.31

756

5753

Persistent delusional disorders

356

2337

1.59

13.93

1.8

2.1

390.88

372.96

nmol/l

0.85

325

2131

Malignant cancer of tonsil and base of tongue

104

471

2.41

13.91

4.2

1.6

396.87

360.61

nmol/l

0.98

430

Papillary adenocarcinoma of thyroid gland

251

1521

1.74

13.87

2.6

1.8

382.11

362.52

nmol/l

0.47

237

1376

Other noninflammatory disorders of vagina

368

2433

1.57

13.87

2.0

2.3

385.89

382.72

nmol/l

0.11

331

2215

Pre-eclampsia or eclampsia

1068

8413

1.30

13.79

2.0

2.1

353.08

377.41

nmol/l

3.90

976

7748

Scabies

237

1417

1.77

13.78

2.2

331.95

377.45

nmol/l

3.48

216

1321

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

221

1293

1.80

13.78

2.1

382.89

381.29

nmol/l

0.04

209

1199

Abnormality of white blood cells, not elsewhere classified

240

3.16

13.78

3.0

2.1

274.55

366.99

nmol/l

3.97

223

Urethritis and urethral syndrome

120

577

2.25

13.78

2.1

358.21

386.15

nmol/l

0.94

112

521

Pediculosis, acariasis and other infestations

293

1847

1.66

13.77

2.4

2.2

333.21

373.36

nmol/l

3.46

271

1718

Any dementia

1513

8545

1.25

13.76

1.8

2.2

400.99

382.11

nmol/l

1.84

1314

7742

Other and unspecified mononeuropathies, also in other diseases

150

782

2.05

13.75

1.9

2.1

396.62

382.32

nmol/l

0.41

136

720

Lichen ruber planus, wide definition including periferal and oral lichen planus

992

7744

1.31

13.73

2.4

2.2

371.76

374.06

nmol/l

0.14

896

7096

Glaucoma secondary to other eye disorders

197

1119

1.86

13.70

2.3

2.1

365.76

372.18

nmol/l

0.21

187

1024

Fracture of forearm

2682

21123

1.18

13.69

2.1

2.2

371.75

377.21

nmol/l

0.56

2475

19364

Congenital malformations of the respiratory system

128

638

2.23

13.69

2.8

2.4

314.03

358.51

nmol/l

1.86

116

600

Other congenital malformations

640

4700

1.41

13.68

2.4

2.2

365.19

369.80

nmol/l

0.23

598

4336

Other abnormal findings in urine

432

2.49

13.66

2.9

1.9

357.19

371.34

nmol/l

0.25

389

L01XX Other antineoplastic agents

263

1620

1.71

13.61

3.3

2.2

413.04

370.89

nmol/l

2.17

244

1467

Palmar fascial fibromatosis [Dupuytren]

576

4148

1.42

13.61

2.2

2.4

381.57

383.04

nmol/l

0.06

527

3814

Chondrocostal junction syndrome [Tietze]

200

1149

1.86

13.54

1.9

2.0

356.20

377.67

nmol/l

0.91

181

1048

Peritonsillar abscess

946

7344

1.32

13.51

2.2

2.1

364.69

377.54

nmol/l

1.09

882

6782

Granulomatous disorders of skin and subcutaneous tissue

143

740

2.08

13.50

2.4

2.0

384.77

374.77

nmol/l

0.25

132

682

Superficial injury of ankle and foot

585

4243

1.42

13.49

2.2

339.90

375.78

nmol/l

4.81

552

3920

Gestational diabetes (for exclusion)

1913

11114

1.22

13.49

1.9

2.0

365.99

380.68

nmol/l

2.90

1764

10295

Other noninfective disorders of lymphatic vessels and lymph nodes

188

1061

1.89

13.47

2.5

2.0

380.47

376.00

nmol/l

0.07

176

966

Causalgia

447

2.44

13.44

2.3

2.0

349.64

368.13

nmol/l

0.43

415

Secondary polycythaemia

126

624

2.19

13.44

2.8

2.0

345.14

370.99

nmol/l

0.90

120

578

Crystal arthropathies, rheuma endpoint

103

473

2.38

13.36

2.3

2.1

326.89

392.56

nmol/l

2.31

432

Lactose intolerance, other/unspecified

140

721

2.07

13.27

2.2

2.1

387.10

364.18

nmol/l

0.56

123

671

Other and unspecified aplastic anaemias

296

2.82

13.24

2.6

1.9

364.47

385.01

nmol/l

0.40

275

Disorders of puberty

424

2.46

13.23

2.8

2.1

367.59

386.65

nmol/l

0.43

396

Pre-eclampsia

995

7813

1.31

13.22

2.0

2.1

353.37

377.82

nmol/l

3.71

907

7198

Outcome of delivery

521

4485

0.70

13.13

2.0

380.34

388.06

nmol/l

0.48

488

4139

Monoarthritis, not elsewhere classified

203

1182

1.81

12.94

2.1

2.2

340.19

384.17

nmol/l

2.79

190

1081

Myelodysplastic syndrome, including Hilmo

132

671

2.09

12.94

2.0

1.7

349.60

364.14

nmol/l

0.38

126

599

Lichen planus, including avohilmo

839

6465

1.33

12.89

2.4

2.2

369.87

373.50

nmol/l

0.22

750

5913

Disorder of thyroid, unspecified

311

2.70

12.85

2.3

1.9

371.97

358.63

nmol/l

0.23

284

Congenital malformations of the nervous system

142

749

2.07

12.85

2.1

2.2

381.99

359.07

nmol/l

0.66

127

701

Late syphilis

451

2.40

12.80

2.4

1.9

385.28

360.49

nmol/l

0.63

418

Pediculosis, acariasis and other infestations

791

6052

1.34

12.80

2.1

2.2

354.26

373.59

nmol/l

2.05

722

5578

Male infertility

206

1207

1.79

12.74

2.5

2.2

351.24

358.83

nmol/l

0.28

190

1122

Impetigo

237

1448

1.73

12.74

3.0

2.2

323.32

369.20

nmol/l

3.05

226

1351

Valvular operations

537

3867

1.42

12.74

2.1

2.5

381.20

370.54

nmol/l

0.49

504

3549

Malignant neoplasm of mesothelium and soft tissue

175

981

1.89

12.73

3.4

1.8

419.62

366.68

nmol/l

2.66

167

882

Benign neoplasm: Caecum

462

3256

1.47

12.69

2.3

375.43

372.52

nmol/l

0.11

426

2960

Aortic aneurysm

855

6473

1.32

12.68

2.4

358.97

372.76

nmol/l

1.06

796

5933

Premenstrual syndrome

339

2.63

12.66

1.8

2.2

338.85

381.96

nmol/l

1.53

315

Open wound of wrist and hand

2057

17044

1.20

12.64

2.2

2.3

362.14

374.37

nmol/l

2.10

1909

15770

Other crystal arthropathies

103

485

2.31

12.59

2.3

326.89

387.76

nmol/l

2.08

437

Other and unspecified disorders of adult personality and behaviour

152

3.65

12.57

2.5

1.9

323.45

406.33

nmol/l

2.13

144

Brain glioblastoma

327

2.64

12.57

1.7

285.26

360.47

nmol/l

2.68

300

Thyrotoxicosis with toxic multinodular goitre

289

1859

1.63

12.56

2.2

359.68

374.58

nmol/l

0.64

270

1680

Chronic iridocyclitis

247

1532

1.70

12.51

2.3

2.1

342.83

376.14

nmol/l

2.33

227

1412

Other disorders of penis

380

2581

1.52

12.50

2.5

353.95

362.39

nmol/l

0.41

348

2410

Lichen simplex chronicus

170

953

1.90

12.49

2.7

2.0

359.94

371.89

nmol/l

0.30

162

878

Right bundle-branch block

157

855

1.93

12.47

2.8

2.3

320.51

371.11

nmol/l

2.70

146

776

Bronchitis, not specified as acute or chronic

367

2478

1.53

12.47

2.1

339.07

379.54

nmol/l

3.85

331

2272

Malignant neoplasm of oropharynx, including Hilmo

104

493

2.29

12.46

3.3

1.8

400.18

358.36

nmol/l

1.34

452

Ingrowing nail

264

1665

1.66

12.45

2.5

2.0

366.65

374.91

nmol/l

0.30

241

1537

Myasthenia gravis

101

476

2.34

12.45

2.0

351.02

376.54

nmol/l

0.65

442

Additional codes for the location of defect, injury or illness

281

1800

1.64

12.43

2.1

372.11

374.17

nmol/l

0.07

268

1648

Orchitis and epididymitis

351

2348

1.54

12.40

2.5

2.3

351.67

368.49

nmol/l

0.81

327

2181

Other autoimmune haemolytic anaemias

344

2.61

12.34

2.0

344.24

379.49

nmol/l

0.96

315

Third [oculomotor] nerve palsy

104

497

2.29

12.33

3.3

2.0

352.69

373.15

nmol/l

0.52

459

Malignant neoplasm of oral cavity

153

833

1.95

12.27

4.0

1.7

447.13

364.12

nmol/l

4.26

145

749

Scabies

677

5106

1.36

12.18

2.0

2.1

355.42

373.81

nmol/l

1.59

611

4717

Injury of unspecified body region

361

2452

1.53

12.09

2.1

366.23

376.93

nmol/l

0.45

334

2245

Unspecified visual impairment (binocular)

436

2.38

12.05

3.0

1.9

354.07

378.93

nmol/l

0.51

404

Dermatopolymyositis, unspecified

136

3.79

12.00

2.0

1.9

392.02

358.88

nmol/l

0.14

124

Dysplasia of cervi uteri

1128

6541

1.27

12.00

1.9

2.1

383.76

384.07

nmol/l

0.02

1048

6004

Acute lymphocytic leukaemia, helper endpoint

237

3.09

11.98

3.3

2.5

341.03

364.51

nmol/l

0.44

227

Acute lymphocytic leukaemia

237

3.09

11.98

3.3

2.5

341.03

364.51

nmol/l

0.44

227

Acute lymphocytic leukaemia, including Hilmo

237

3.09

11.98

3.3

2.5

341.03

364.51

nmol/l

0.44

227

Other or unspecified common variable immunodeficiency

103

4.54

11.98

2.7

2.3

332.61

373.24

nmol/l

0.59

Otitis media, unspecified

562

3798

1.40

11.97

2.7

2.0

362.75

379.96

nmol/l

1.24

534

3496

Other secondary gonarthrosis

251

1581

1.67

11.94

2.3

360.81

374.85

nmol/l

0.52

232

1445

Dementia in other diseases classified elsewhere

200

1188

1.77

11.90

1.9

2.1

368.48

370.97

nmol/l

0.06

160

1070

Schizoid personality disorder

100

477

2.29

11.89

2.0

2.1

380.74

369.51

nmol/l

0.19

451

Viral encephalitis, not elsewhere classified/unspecified

112

558

2.18

11.86

2.0

1.9

371.18

373.78

nmol/l

0.05

107

513

Infection due to other mycobacteria

386

2.43

11.83

2.0

1.8

302.71

374.07

nmol/l

2.73

347

Excessive earwax

2468

20831

1.17

11.82

2.2

2.3

367.56

376.58

nmol/l

1.38

2261

19141

Abscess of lung

413

2.39

11.81

2.5

2.1

374.30

364.24

nmol/l

0.11

382

Recurrent dislocation of patella

260

1653

1.64

11.80

2.3

1.9

364.74

386.72

nmol/l

1.06

237

1514

Ptosis of eyelid

470

3365

1.44

11.79

2.3

2.2

351.34

379.46

nmol/l

2.22

431

3076

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

4.52

11.78

3.0

2.4

311.97

342.21

nmol/l

0.47

Intermittent heterotropia

305

2013

1.58

11.75

2.4

2.2

346.80

373.11

nmol/l

1.57

280

1866

Simple and mucopurulent chronic bronchitis

180

1040

1.81

11.75

2.3

2.2

362.27

378.60

nmol/l

0.50

171

938

Acute nasopharyngitis (common cold)

498

3572

1.42

11.73

2.5

2.3

354.37

369.79

nmol/l

1.22

464

3327

Toxic effect of other and unspecified substances

358

2.50

11.65

1.7

1.9

377.60

369.21

nmol/l

0.14

335

Scleritis and episcleritis

297

1955

1.59

11.65

2.0

2.1

354.44

372.13

nmol/l

0.91

278

1807

Problems related to social environment

144

783

1.95

11.64

2.1

2.0

352.30

378.18

nmol/l

0.81

132

716

Personal history of certain other diseases

114

576

2.14

11.62

1.7

1.8

357.55

390.57

nmol/l

1.16

105

532

Ulcer of vagina/vulva

144

788

1.97

11.59

2.1

371.81

382.84

nmol/l

0.25

133

717

Mixed specific developmental disorders

140

700

2.00

11.58

3.0

2.7

325.51

351.49

nmol/l

0.90

132

667

Amputation of ankle bones

111

555

2.15

11.57

2.1

2.0

361.77

368.94

nmol/l

0.14

106

495

Complications of other internal prosthetic devices, implants and grafts

188

1108

1.79

11.56

2.3

2.0

378.77

369.05

nmol/l

0.24

167

999

Cystic kidney disease

166

948

1.87

11.56

2.9

2.1

353.76

369.78

nmol/l

0.48

161

881

Other and unspecified bullous disorders

305

2.67

11.56

3.5

1.8

334.49

387.27

nmol/l

1.55

278

Other ill-defined and unspecified causes of mortality

306

2024

1.57

11.55

2.9

2.0

380.26

378.20

nmol/l

0.06

281

1826

Dislocation, sprain and strain of joints and ligaments of head

215

1316

1.72

11.53

2.3

2.2

350.06

367.17

nmol/l

0.71

202

1216

Adult respiratory distress syndrome

322

2.57

11.50

1.7

2.0

326.27

381.49

nmol/l

1.60

290

Amiodarone users

407

2854

1.47

11.50

2.0

2.3

402.67

370.52

nmol/l

1.87

385

2613

Status post-ami

965

5815

1.29

11.49

2.1

2.5

382.90

383.50

nmol/l

0.02

858

5280

Beningn neoplasm: Meninges, unspecified

425

2.35

11.48

2.4

1.9

371.89

376.64

nmol/l

0.07

390

Benign neoplasm of middle ear and respiratory system

342

2326

1.53

11.37

2.5

2.2

361.84

370.02

nmol/l

0.26

329

2126

Congenital malformations of the urinary system

304

2024

1.57

11.34

2.7

2.2

359.97

370.63

nmol/l

0.40

289

1872

Sequelae of injuries of upper limb

443

3166

1.45

11.28

2.1

2.2

373.56

366.86

nmol/l

0.28

409

2905

Mantle cell lymphoma, including Hilmo

312

2.56

11.25

1.8

1.7

386.15

354.32

nmol/l

0.66

277

Toxic effects of substances chiefly nonmedicinal as to source

522

3834

1.40

11.24

2.1

2.2

376.81

374.61

nmol/l

0.09

479

3534

Hypotension due to drugs

357

2.46

11.23

2.1

1.9

344.93

376.03

nmol/l

0.75

319

Arthropathy in ulcerative colitis

379

2.43

11.14

2.7

2.1

303.95

362.46

nmol/l

2.12

353

Other forms of systemic lupus erythematosus

256

2.83

11.13

1.9

2.0

350.89

383.42

nmol/l

0.63

240

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2908

20211

1.15

11.06

2.1

368.27

375.76

nmol/l

1.29

2737

18600

Other and unspecified vascular occlusions

376

2616

1.48

11.05

2.1

2.2

384.57

373.96

nmol/l

0.45

339

2361

Hallux rigidus

560

4168

1.38

10.97

2.0

2.4

367.61

389.80

nmol/l

1.70

500

3810

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

250

2.77

10.94

3.5

1.8

400.77

374.22

nmol/l

0.48

220

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

356

2456

1.50

10.94

2.2

364.51

379.63

nmol/l

0.62

319

2269

Open wound of hip and thigh

165

955

1.83

10.91

2.0

2.1

373.04

377.11

nmol/l

0.10

154

891

Crossbite

365

2343

1.50

10.90

3.0

2.3

333.02

363.92

nmol/l

2.59

334

2201

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

182

1084

1.78

10.90

2.6

2.0

342.64

379.21

nmol/l

1.81

170

990

Congenital malformations of the urinary system

286

1897

1.58

10.89

2.8

2.3

356.17

369.96

nmol/l

0.54

273

1760

Alopecia areata

145

811

1.92

10.88

2.1

367.40

370.30

nmol/l

0.06

132

751

Dependent personality disorder

111

570

2.11

10.85

2.7

2.1

378.80

369.98

nmol/l

0.19

101

533

Other diseases of peritoneum

216

1346

1.69

10.82

2.2

2.1

363.89

372.86

nmol/l

0.28

191

1224

Panniculitis, unspecified

251

2.74

10.81

2.3

1.8

323.40

379.37

nmol/l

1.63

229

Primary open-angle glaucoma, strict

1038

8365

1.26

10.75

2.0

2.2

396.18

383.16

nmol/l

0.61

931

7575

Acute lymphadenitis

286

1901

1.57

10.73

2.2

2.1

360.47

376.68

nmol/l

0.86

270

1758

Arthropod-borne viral fevers and viral haemorrhagic fevers

410

2920

1.45

10.67

2.3

2.2

360.52

369.38

nmol/l

0.41

382

2690

Late syphilis

373

2.40

10.66

2.1

1.9

391.49

363.79

nmol/l

0.61

343

Congenital malformations of the respiratory system

113

591

2.10

10.66

2.9

2.4

309.74

356.72

nmol/l

1.93

103

555

Macular pucker

608

4606

1.35

10.65

2.3

375.75

376.33

nmol/l

0.02

551

4196

Medial epicondylitis

173

1020

1.78

10.64

2.4

2.1

354.49

378.31

nmol/l

0.99

157

951

Other and unspecified diseases of blood and blood-forming organs

132

722

1.96

10.62

2.5

2.0

334.96

377.65

nmol/l

1.90

125

666

Thoracic aortic aneurysm

544

4055

1.38

10.60

2.3

2.4

347.91

370.66

nmol/l

1.65

505

3749

Childhood allergy (age < 16)

729

4652

1.32

10.56

2.0

385.05

397.20

nmol/l

0.93

678

4294

Malignant neoplasm of oropharynx

379

2.35

10.55

3.5

1.7

400.38

355.53

nmol/l

1.18

348

Prolonged pregnancy

480

5684

0.72

10.55

1.9

2.0

386.63

384.36

nmol/l

0.11

457

5235

Malignant neoplasm of tonsil, including Hilmo

406

2.30

10.50

3.1

1.7

385.79

353.15

nmol/l

0.76

374

Single delivery by forceps and vacuum extractor

507

4110

0.72

10.42

1.9

2.0

400.46

390.36

nmol/l

0.56

471

3750

Other congenital malformations of the digestive system

230

1461

1.65

10.38

2.9

2.3

322.62

360.17

nmol/l

2.26

213

1366

Nontoxic diffuse goitre

149

850

1.86

10.37

2.3

1.9

353.42

379.42

nmol/l

0.96

138

769

Malignant neoplasm of stomach, including Hilmo

223

1407

1.64

10.37

2.7

1.8

394.61

370.40

nmol/l

0.99

211

1253

Other and unspecified intracranial injuries

144

814

1.87

10.32

1.9

2.1

379.43

368.61

nmol/l

0.23

132

751

Other orthopaedic follow-up care

245

1589

1.60

10.25

2.2

2.0

361.59

370.41

nmol/l

0.32

226

1434

Dementia due to Parkinsons disease, excluding more controls

380

2.28

10.24

1.6

2.4

394.72

411.65

nmol/l

0.29

346

Arterial embolism and thrombosis

231

1476

1.62

10.21

2.5

2.2

360.32

373.84

nmol/l

0.40

206

1331

Myeloproliferative diseases (CML excluded)

324

2231

1.51

10.20

2.1

2.2

400.85

370.75

nmol/l

1.59

300

2022

Sixth [abducent] nerve palsy

161

945

1.81

10.20

3.0

2.2

359.17

375.38

nmol/l

0.50

151

856

Benign neoplasm: Descending colon

300

2040

1.53

10.10

2.7

2.3

360.91

368.28

nmol/l

0.29

274

1854

Degenerative macular diseases

482

3556

1.39

10.10

2.0

2.2

390.17

377.04

nmol/l

0.54

432

3220

Secondary parkinsonism+Parkinsonism in other disease

127

696

1.94

10.10

1.9

2.0

403.52

375.37

nmol/l

0.81

112

630

Recurrent dislocation and subluxation of joint

312

2134

1.51

10.08

2.2

354.30

379.47

nmol/l

1.28

278

1973

Left bundle-branch block

280

1873

1.54

10.05

2.3

368.23

372.53

nmol/l

0.12

258

1708

Meralgia paraesthetica

162

956

1.79

10.04

2.0

2.1

339.58

376.31

nmol/l

1.93

151

887

Unspecified chronic bronchitis

148

848

1.82

9.99

2.3

2.1

324.38

385.27

nmol/l

4.20

125

763

Tongue abnormality

282

1901

1.55

9.98

2.3

2.2

355.64

373.42

nmol/l

0.79

247

1730

Juvenile rheumatoid arthirtis

117

628

1.99

9.97

2.1

1.9

313.42

384.66

nmol/l

3.60

109

582

Lesion of lateral popliteal nerve

217

1380

1.64

9.94

2.0

2.2

368.50

374.59

nmol/l

0.17

199

1269

Intussusception

110

580

2.03

9.92

2.2

340.80

370.43

nmol/l

0.89

100

525

Vascular dementia (undefined)

142

794

1.83

9.92

1.8

1.9

387.18

402.91

nmol/l

0.39

124

692

Other obstructive and reflux uropathy

199

1240

1.68

9.91

2.5

2.0

366.30

377.50

nmol/l

0.33

178

1130

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

180

1091

1.72

9.90

2.8

1.8

423.76

363.90

nmol/l

2.92

165

967

Primary open-angle glaucoma

1246

9994

1.22

9.89

2.0

2.2

393.51

383.47

nmol/l

0.52

1112

9069

Early lumbar disc prolapse operation

510

3812

1.38

9.89

2.1

355.08

366.19

nmol/l

0.68

472

3544

Isolated proteinuria with specified morphological lesion

314

2.48

9.85

1.9

1.8

350.49

370.65

nmol/l

0.32

287

Other superficial mycoses

116

625

1.99

9.85

2.3

2.0

380.52

371.74

nmol/l

0.10

583

Hydrocephalus

314

2163

1.50

9.83

2.5

2.1

387.83

378.23

nmol/l

0.15

288

1955

Iridocyclitis in diseases classified elsewhere

104

542

2.07

9.79

2.3

2.0

349.22

374.99

nmol/l

0.60

504

Ill-defined and unknown causes of mortality

326

2261

1.49

9.78

2.9

2.1

382.75

378.01

nmol/l

0.15

300

2043

Ankylosing spondylitis, ICD10

400

2884

1.43

9.77

2.2

338.88

366.94

nmol/l

1.99

369

2677

Mature T/NK-cell lymphomas, hilmo

354

2.36

9.72

3.1

1.9

368.59

384.03

nmol/l

0.24

326

Malignant neoplasm of tongue, including Hilmo

120

655

1.95

9.69

4.1

1.8

417.24

360.56

nmol/l

2.02

112

590

Exophthalmic conditions

284

2.54

9.69

3.0

1.9

310.49

387.57

nmol/l

2.66

264

Ménière disease

407

2948

1.43

9.67

2.1

2.2

374.26

374.05

nmol/l

0.01

371

2691

Post-traumatic wound infection, not elsewhere classified

135

766

1.88

9.66

2.3

2.1

322.46

375.76

nmol/l

2.93

125

705

Episcleritis

252

1671

1.58

9.66

2.0

2.1

353.55

371.91

nmol/l

0.85

237

1549

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

149

870

1.82

9.64

2.0

361.34

373.22

nmol/l

0.32

140

809

Benign lipomatous neoplasm

1275

10643

1.22

9.63

2.4

2.2

358.68

372.54

nmol/l

1.86

1185

9790

Superficial injury of shoulder and upper arm

497

3716

1.37

9.59

1.9

2.2

361.54

372.75

nmol/l

0.65

457

3418

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

753

5765

1.29

9.59

2.6

2.3

356.74

367.55

nmol/l

0.73

708

5333

Other specified/unspecified spondylopathies

111

592

1.99

9.59

2.3

2.1

334.66

391.89

nmol/l

2.53

102

539

Malignant neoplasm of small intestine, including Hilmo

134

759

1.87

9.58

2.4

1.8

409.67

360.15

nmol/l

1.06

122

678

Other disorders of bone density and structure

131

739

1.89

9.56

2.5

2.0

362.60

375.93

nmol/l

0.31

117

680

Unspecified dementia

378

2419

1.43

9.54

1.7

2.0

413.25

382.30

nmol/l

0.73

332

2137

Portal vein thrombosis

423

2.21

9.52

2.6

2.0

379.73

374.50

nmol/l

0.03

387

Urethral stricture

212

1351

1.63

9.52

2.3

2.4

353.94

370.41

nmol/l

0.42

192

1238

Other disorders of the genitourinary system

552

4200

1.35

9.51

2.1

378.76

378.97

nmol/l

0.01

500

3818

209

1321

1.62

9.49

1.8

2.0

411.85

384.66

nmol/l

0.34

192

1154

Acute bronchiolitis

308

1915

1.50

9.49

3.2

2.1

334.68

373.53

nmol/l

1.60

290

1770

Thyroiditis, unspecified

369

2.28

9.48

2.2

1.8

369.29

375.94

nmol/l

0.11

338

Atopic conjunctivitis

223

1447

1.61

9.45

2.4

2.0

363.19

381.82

nmol/l

0.76

209

1341

Senility

141

3.07

9.43

1.3

1.5

413.58

406.64

nmol/l

0.06

115

Malignant neoplasm, without specification of site, including Hilmo

180

1105

1.69

9.41

4.2

1.8

382.16

370.91

nmol/l

0.30

171

984

Medical abortion

3280

15859

1.13

9.37

2.1

2.0

380.77

384.99

nmol/l

0.56

2989

14531

Degeneration of the brain due to alcohol

103

543

2.03

9.31

2.0

2.2

399.71

362.41

nmol/l

0.82

497

Event of undetermined intent

296

2041

1.50

9.31

2.2

2.1

369.75

373.75

nmol/l

0.13

273

1900

Behavioural disorders, excluding more controls

456

2.10

9.28

2.2

2.0

361.13

376.89

nmol/l

0.37

428

Chronic lymphocytic leukaemia

118

649

1.92

9.27

1.8

1.7

419.09

364.17

nmol/l

2.34

111

571

Chronic lymphocytic leukaemia, helper endpoint

118

649

1.92

9.27

1.8

1.7

419.09

364.17

nmol/l

2.34

111

571

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

118

649

1.92

9.27

1.8

1.7

419.09

364.17

nmol/l

2.34

111

571

Hydrocele

409

2975

1.40

9.27

2.4

2.5

340.55

371.23

nmol/l

2.87

377

2768

Hepatocellular carcinoma, including Hilmo

113

612

1.94

9.27

3.1

1.7

397.30

370.64

nmol/l

0.66

105

546

Cyst of kidney

296

2044

1.50

9.23

2.3

2.2

331.99

371.24

nmol/l

2.69

277

1862

Open bite

275

1876

1.53

9.22

2.5

2.1

363.03

372.83

nmol/l

0.29

259

1737

Allergic contact dermatitis due to drugs in contact with skin

117

648

1.94

9.16

2.3

2.0

380.96

374.99

nmol/l

0.10

105

600

Meningitis

235

1554

1.58

9.14

2.7

2.1

358.77

371.42

nmol/l

0.38

220

1425

Sudden idiopathic hearing loss

416

3051

1.40

9.14

2.3

371.87

376.48

nmol/l

0.16

377

2800

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

386

2800

1.42

9.13

2.6

2.2

364.74

372.25

nmol/l

0.32

347

2568

Other disorders of binocular movement

124

700

1.89

9.11

2.3

2.0

383.90

380.78

nmol/l

0.06

112

646

Wet age-related macular degeneration

642

4853

1.31

9.05

1.9

2.1

374.39

386.36

nmol/l

0.66

567

4331

Other localized connective tissue disorders

104

557

2.01

9.05

2.3

1.9

327.29

383.70

nmol/l

2.13

515

Aortic arch syndrome [Takayasu]

5.82

9.05

3.1

2.2

451.70

387.07

nmol/l

0.17

Secondary parkinsonism

124

700

1.88

9.01

1.9

2.0

407.00

374.90

nmol/l

0.96

109

634

Other aneurysm

213

1379

1.60

9.00

2.5

2.2

362.61

369.33

nmol/l

0.18

195

1248

Pneumonia derived septicemia

160

970

1.73

8.99

2.9

2.1

380.97

376.92

nmol/l

0.03

145

887

Malignant neoplasm of stomach

188

1181

1.65

8.98

2.6

1.7

394.06

371.42

nmol/l

0.80

178

1050

Parkinson's disease, including avohilmo

589

4550

1.32

8.98

1.8

2.3

387.70

376.50

nmol/l

0.70

523

4148

Viral meningitis

181

1134

1.68

8.98

2.6

1.9

347.50

377.85

nmol/l

1.55

165

1055

Degeneration of nervous system due to alcohol

103

551

2.00

8.93

2.0

2.2

399.71

365.74

nmol/l

0.72

505

Atrophic disorders of skin

652

5117

1.30

8.89

2.1

368.35

376.95

nmol/l

0.56

598

4681

111

609

1.94

8.88

2.7

2.1

302.55

378.51

nmol/l

3.14

104

556

Burns and corrosions

608

4730

1.32

8.85

2.2

367.30

367.73

nmol/l

0.02

571

4364

Convergence insufficiency and excess

395

2.20

8.82

2.6

1.8

383.75

378.23

nmol/l

0.07

366

Abnormal findings in nipple discharge synovial fluid wound secretions

465

2.11

8.81

3.0

2.0

388.65

376.62

nmol/l

0.20

431

Other and unspecified nonscarring hair loss

210

2.76

8.80

1.9

1.8

406.25

390.79

nmol/l

0.21

195

Other disorders of Eustachian tube

144

856

1.78

8.79

2.9

2.1

349.55

372.98

nmol/l

0.87

128

790

Oesophageal obstruction

143

845

1.77

8.78

2.5

2.3

431.91

376.41

nmol/l

0.88

137

769

Deep endometriosis

464

3491

1.37

8.77

2.1

378.57

376.10

nmol/l

0.09

428

3192

Carcinoma in situ of skin of other and unspecified parts of face

323

2288

1.46

8.75

2.3

2.1

375.55

383.09

nmol/l

0.19

290

2052

Other/unspecified soft tissue disorders related to use, overuse and pressure

131

758

1.82

8.72

2.2

2.0

363.51

387.11

nmol/l

0.62

122

695

Amputation of thigh

120

676

1.86

8.69

1.6

2.0

347.37

382.88

nmol/l

0.93

109

602

Other bullous disorders

134

784

1.81

8.68

2.7

2.1

340.81

371.36

nmol/l

1.19

125

724

Collapsed vertebra, not elsewhere classified

180

2.85

8.68

2.2

2.1

330.85

402.21

nmol/l

1.01

159

Other/unspecified reactive arthropathies

301

2113

1.48

8.67

2.2

2.1

349.08

370.39

nmol/l

1.15

279

1946

Vertigo of central origin

432

2.13

8.65

2.0

1.8

370.82

380.71

nmol/l

0.15

388

Hordeolum and other deep inflammation of eyelid

269

1850

1.51

8.63

2.6

2.1

354.40

375.08

nmol/l

0.86

251

1711

Pustular psoriasis

217

1430

1.59

8.63

2.3

2.1

365.31

370.14

nmol/l

0.15

197

1311

Arnold-Chiari syndrome

281

2.47

8.62

1.9

2.0

382.56

389.32

nmol/l

0.09

263

Vertical strabismus

163

1006

1.71

8.62

2.2

2.1

353.96

376.44

nmol/l

0.80

147

927

Malignant neoplasm of pancreas, including Hilmo

302

2117

1.47

8.59

2.6

1.8

419.45

365.02

nmol/l

3.52

283

1884

Allergic colitis

129

750

1.83

8.55

2.9

2.2

318.44

375.49

nmol/l

2.74

123

705

Paraplegia, diplegia of upper limbs

108

596

1.93

8.53

2.1

313.45

379.53

nmol/l

2.99

544

Other disorders of thyroid

380

2.21

8.53

2.3

2.0

370.83

364.93

nmol/l

0.10

347

Pre-eclampsia or poor fetal growth

1480

12615

1.19

8.51

2.0

2.1

361.52

377.64

nmol/l

2.70

1359

11647

Malignant neoplasm of liver and intrahepatic bile ducts

112

622

1.89

8.51

3.2

1.8

423.87

359.15

nmol/l

2.22

105

550

Other or unspecified immunodeficiency

111

3.61

8.49

2.8

2.4

365.33

378.76

nmol/l

0.15

102

Herpesviral keratitis and keratoconjunctivitis

196

1267

1.62

8.49

2.4

2.0

336.59

372.66

nmol/l

1.91

186

1158

Myotonic disorders

226

2.63

8.45

1.7

2.0

349.83

363.54

nmol/l

0.23

210

Malignant neoplasm of tonsil

340

2.26

8.43

3.2

1.7

394.17

354.67

nmol/l

0.85

311

Other papulosquamous disorders

302

2.37

8.42

2.7

2.0

308.33

368.93

nmol/l

1.59

282

Alcohol-induced acute pancreatitis

158

972

1.71

8.42

2.1

2.3

342.20

363.79

nmol/l

0.80

143

911

Exposure to other and unspecified inanimate mechanical forces

333

2393

1.44

8.39

2.5

2.1

353.42

372.52

nmol/l

1.03

312

2216

Use of levodopa decarboxylase inhibitor

512

3922

1.34

8.37

1.8

2.2

389.15

375.29

nmol/l

0.81

453

3570

Injury of muscle and tendon at shoulder and upper arm level

1424

12152

1.19

8.36

2.3

2.4

359.26

372.71

nmol/l

1.92

1342

11241

Glucosamine medication

1991

13876

1.16

8.33

2.1

2.2

372.62

380.25

nmol/l

0.94

1793

12650

Poisoning by narcotics and psychodysleptics [hallucinogens]

444

2.08

8.33

2.2

1.9

338.23

392.09

nmol/l

1.70

410

Dilated cardiomyopathy

453

3419

1.36

8.26

2.3

391.83

368.59

nmol/l

1.56

429

3142

Other congenital malformations of nervous system

319

2.33

8.26

1.9

2.1

384.26

383.59

nmol/l

0.01

299

Pustulosis palmaris et plantaris

196

1277

1.61

8.23

2.3

2.1

367.89

371.86

nmol/l

0.11

178

1178

Other congenital malformations of the digestive system

254

1734

1.52

8.23

2.7

2.3

328.11

358.22

nmol/l

1.71

232

1615

Other/unspecified disorders of vestibular function

183

1174

1.63

8.23

1.8

2.0

362.52

375.26

nmol/l

0.41

168

1068

Other renal tubulo-interstitial diseases

118

676

1.85

8.22

2.4

1.9

415.83

377.68

nmol/l

0.70

109

619

Idiopathic urticaria

117

671

1.86

8.21

2.1

1.9

378.71

376.63

nmol/l

0.04

112

621

Other disorders of pigmentation

195

1271

1.60

8.15

2.5

2.1

359.52

374.75

nmol/l

0.43

182

1162

Endometriosis ASRM stages 3,4

1079

9027

1.22

8.14

2.0

2.1

376.97

377.66

nmol/l

0.04

998

8249

Other contact dermatitis

354

2581

1.41

8.13

2.2

2.0

349.51

376.46

nmol/l

1.81

319

2362

Other and unspecified glaucoma

280

1961

1.47

8.12

2.0

2.1

372.44

382.23

nmol/l

0.36

258

1764

Dislocation, sprain and strain of joints and ligaments of thorax

157

975

1.69

8.08

2.1

358.99

372.64

nmol/l

0.43

147

901

Other and unspecified injuries of ankle and foot

206

1362

1.58

8.08

2.0

2.1

390.69

381.43

nmol/l

0.26

193

1263

Encephalopathy

262

2.44

8.06

1.9

485.10

383.24

nmol/l

0.41

238

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

190

1237

1.61

8.05

3.4

2.1

320.50

369.17

nmol/l

3.41

184

1154

Dislocation, sprain and strain of joint and ligaments of hip

159

991

1.68

8.05

2.0

2.1

357.66

380.71

nmol/l

0.67

144

899

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

274

2.38

8.04

2.1

383.21

379.69

nmol/l

0.04

256

Pilonidal cyst

379

2798

1.39

8.04

2.2

2.1

366.26

372.60

nmol/l

0.26

351

2581

Other chondrocalcinosis

335

2.25

8.03

2.4

1.8

326.93

375.23

nmol/l

1.10

302

UC patients in KELA-register (code 208), prior to 1994

193

1261

1.60

8.01

2.3

2.2

337.07

371.58

nmol/l

1.57

181

1164

Lagophthalmos

335

2.25

8.01

2.0

1.9

389.86

383.86

nmol/l

0.09

311

Superficial injury of forearm

434

3274

1.36

7.99

2.1

363.80

377.98

nmol/l

0.89

396

3002

Perioral dermatitis

115

662

1.85

7.97

2.3

2.0

336.84

382.95

nmol/l

1.80

105

618

Cardiomyopathy, Hypertrophic obstructive

415

2.07

7.96

2.6

2.3

435.49

370.63

nmol/l

0.89

390

Viral haemorrhagic fevers, not elsewhere classified/unspecified

332

2407

1.42

7.95

2.2

365.94

372.22

nmol/l

0.23

311

2224

Stenosis and insufficiency of lacrimal passages

399

2977

1.38

7.94

2.4

2.1

373.36

378.81

nmol/l

0.23

365

2720

Other nonthrombocytopenic purpura

265

2.43

7.91

2.2

2.0

349.23

373.74

nmol/l

0.32

242

Use of antiglaucoma preparations and miotics

313

2246

1.43

7.90

2.1

383.41

377.52

nmol/l

0.21

280

2012

Benign neoplasm: Small intestine

177

1139

1.63

7.89

2.4

2.2

347.80

373.56

nmol/l

0.89

162

1039

Obstructive hydrocephalus

440

2.06

7.89

3.8

2.2

341.21

375.98

nmol/l

1.02

410

Memory loss

356

2612

1.40

7.88

2.0

2.2

395.52

376.56

nmol/l

0.85

317

2367

Acquired absence of organs, not elsewhere classified

317

2.27

7.86

2.9

2.1

336.44

382.21

nmol/l

1.15

286

Galactorrhea

305

2.32

7.86

2.2

2.1

370.35

365.52

nmol/l

0.09

284

Complications of genitourinary prosthetic devices, implants and grafts

117

678

1.82

7.84

1.7

2.0

382.42

368.47

nmol/l

0.35

112

613

Other facial nerve disorders

129

768

1.77

7.83

1.9

2.1

362.95

378.00

nmol/l

0.40

118

710

Chondropathies

675

5405

1.28

7.82

2.3

2.2

357.66

372.65

nmol/l

1.15

627

4967

Other nonscarring hair loss

286

2.36

7.81

2.3

2.0

411.35

384.68

nmol/l

0.45

265

Melanoma in situ

191

1254

1.59

7.79

3.5

2.1

410.15

372.44

nmol/l

0.92

176

1137

Pneumococcal septicemia

155

971

1.68

7.74

2.9

2.1

336.17

371.68

nmol/l

1.07

140

892

Parkinson's disease

557

4361

1.30

7.73

1.7

2.3

390.66

375.65

nmol/l

1.02

494

3979

Progressive systemic sclerosis

140

3.11

7.71

1.8

1.9

359.22

383.90

nmol/l

0.27

131

Lesion of radial nerve

160

1010

1.65

7.68

2.2

2.1

362.59

378.31

nmol/l

0.46

144

924

Contusion of other and unspecified parts of foot

243

1679

1.50

7.68

2.1

320.60

379.26

nmol/l

5.87

230

1551

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

355

2578

1.40

7.68

3.0

2.1

329.87

369.70

nmol/l

4.30

343

2387

Lesion of plantar nerve

257

1795

1.48

7.65

2.0

2.2

357.96

375.18

nmol/l

0.80

230

1639

Overexertion and strenuous or repetitive movements

430

3264

1.35

7.63

2.1

2.2

389.21

371.33

nmol/l

0.87

391

3014

Abrasion of teeth

1527

13210

1.17

7.63

2.1

2.2

366.75

372.29

nmol/l

0.55

1388

12196

Other and unspecified pemphigus

3.70

7.60

1.6

2.0

347.11

381.28

nmol/l

0.30

Eustachian salpingitis and obstruction

373

2777

1.38

7.59

2.1

359.69

363.00

nmol/l

0.15

344

2573

Other otitis externa (chronic)

288

2057

1.45

7.58

2.1

387.04

373.03

nmol/l

0.56

251

1900

Bicipital tendinitis

191

1258

1.57

7.57

1.9

2.3

356.57

374.95

nmol/l

0.74

171

1165

Pleural plaque with presence of asbestos

252

1753

1.48

7.57

2.5

2.3

352.60

379.18

nmol/l

1.24

230

1596

Benign neoplasm: Other/unspecified site

433

2.04

7.52

3.0

2.0

351.21

375.54

nmol/l

0.59

398

Other prurigo

303

2.27

7.52

2.0

1.8

313.53

384.20

nmol/l

2.26

279

Viral hepatitis

324

2363

1.41

7.51

2.4

2.1

347.94

371.17

nmol/l

1.52

298

2187

Spermatocele

266

1872

1.46

7.47

2.6

2.5

348.36

374.95

nmol/l

1.59

244

1738

Universal erythroderma, KELA reimbursement

371

2.12

7.47

2.9

2.0

270.16

384.05

nmol/l

6.38

343

Benign neoplasm of other and unspecified sites

154

974

1.66

7.44

2.8

2.1

353.96

376.31

nmol/l

0.76

142

891

Bacterial, viral and other infectious agents

396

2983

1.36

7.42

2.4

2.2

365.67

368.09

nmol/l

0.08

369

2762

Sulfonylureas

1276

8654

1.19

7.42

1.8

2.3

391.71

380.18

nmol/l

0.99

1147

7867

Other specified disorders of kidney and ureter

149

935

1.67

7.42

2.2

377.78

371.27

nmol/l

0.13

137

859

Embedded and impacted teeth

1277

8993

1.19

7.41

2.1

2.0

389.89

383.44

nmol/l

0.47

1189

8301

Chronic conjunctivitis

149

937

1.68

7.40

2.4

2.0

377.06

367.57

nmol/l

0.23

137

866

Background retinopathy and retinal vascular changes

535

1.90

7.38

2.0

1.9

387.56

379.81

nmol/l

0.13

486

Hypothermia

485

1.96

7.37

1.9

2.0

463.78

370.14

nmol/l

0.58

445

Injury of other and unspecified intrathoracic organs

254

1781

1.47

7.36

2.3

2.2

370.88

375.26

nmol/l

0.12

239

1642

Crowding of teeth, including avohilmo

453

2871

1.34

7.34

2.5

2.1

383.75

376.91

nmol/l

0.27

422

2653

Psoriasis (vulgaris), strict definition

150

945

1.66

7.33

2.6

2.2

306.30

369.81

nmol/l

4.52

141

888

malignant neoplasm of male genital organs

891

4465

1.23

7.30

2.5

1.8

366.48

359.45

nmol/l

0.39

828

4054

Impacted teeth

922

6820

1.22

7.29

2.2

2.0

385.42

389.55

nmol/l

0.21

857

6293

Chronic Coagulation defects

124

748

1.76

7.28

2.4

2.0

357.68

371.44

nmol/l

0.41

116

691

Schizophrenia

679

5484

1.26

7.28

1.7

2.2

396.35

369.46

nmol/l

2.54

611

5072

Benign neoplasm: Tongue

130

794

1.73

7.25

2.9

2.2

378.90

372.97

nmol/l

0.11

112

728

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

173

1129

1.60

7.25

3.1

2.2

367.89

369.68

nmol/l

0.04

167

1030

Malignant neoplasm of tongue

489

1.94

7.19

4.4

1.8

431.76

359.72

nmol/l

2.23

446

Pseudomembranous colitis

230

2.45

7.18

2.4

1.8

387.60

374.69

nmol/l

0.14

214

Personality and behavioural disorders due to brain disease, damage and dysfunction

390

2.06

7.16

1.8

2.1

358.52

369.08

nmol/l

0.18

363

Burns and corrosions of external body surface, specified by site

470

3644

1.32

7.15

2.0

2.2

369.15

369.14

nmol/l

0.00

440

3377

Divergent concomitant strabismus

340

2521

1.39

7.14

2.0

2.1

378.33

371.51

nmol/l

0.27

321

2319

Other conditions related to polyarteritis nodosa

4.13

7.13

3.2

1.8

246.26

403.17

nmol/l

3.09

Hypertrophic disorders of skin

264

1879

1.45

7.13

2.1

2.0

386.64

378.46

nmol/l

0.27

249

1731

Benign neoplasm: Duodenum

121

730

1.76

7.11

2.5

2.1

321.12

372.27

nmol/l

2.08

108

673

Polycythaemia vera

138

858

1.68

7.10

2.1

1.8

411.91

363.05

nmol/l

1.55

129

761

Bacterial, viral and other infectious agents

368

2764

1.37

7.07

2.5

2.2

361.83

366.64

nmol/l

0.17

343

2559

101

580

1.85

7.07

1.8

368.17

397.51

nmol/l

0.93

534

Acute epiglottitis

400

2.03

7.02

1.6

1.9

347.03

373.66

nmol/l

0.55

371

Mental and behavioural disorders due to cannabinoids

141

884

1.67

7.02

1.9

381.34

374.65

nmol/l

0.14

121

828

Guillain-Barre syndrome

429

2.00

7.02

2.5

2.0

334.39

379.67

nmol/l

1.32

399

Disorders of purine and pyrimidine metabolism

122

3.03

7.01

1.9

2.0

334.50

377.07

nmol/l

0.46

112

Other diseases of spinal cord

135

839

1.69

7.00

2.2

2.0

311.92

368.40

nmol/l

2.32

130

772

Undefined dementia

382

2648

1.35

7.00

1.7

1.9

414.32

389.36

nmol/l

0.55

334

2317

Primary coxarthrosis, bilateral

1118

9505

1.19

6.99

2.2

370.95

381.81

nmol/l

1.00

1011

8661

All dysplastic lesions of the vulva

208

1427

1.52

6.95

2.1

2.0

373.75

373.86

nmol/l

0.00

192

1306

Acute nephritic syndrome

101

583

1.84

6.95

2.6

2.2

340.23

374.84

nmol/l

0.88

542

Malignant neoplasm of colon, including Hilmo

637

5125

1.26

6.95

2.6

1.7

407.81

369.27

nmol/l

3.79

598

4570

Disturbances of smell and taste

177

1173

1.57

6.91

2.2

2.1

347.50

371.03

nmol/l

0.86

166

1069

Alzheimer’s disease (Atypical or mixed)

344

2542

1.37

6.88

1.7

1.9

387.51

391.85

nmol/l

0.15

280

2249

Other drug-induced secondary parkinsonism

254

2.34

6.88

1.6

1.9

412.15

368.41

nmol/l

0.67

234

Female infertility, tubal origin

211

1449

1.50

6.87

2.3

366.24

372.69

nmol/l

0.18

199

1345

Scar conditions and fibrosis of skin

186

1251

1.55

6.81

2.4

2.0

362.15

374.97

nmol/l

0.43

181

1153

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

249

1761

1.45

6.79

2.1

368.19

377.91

nmol/l

0.33

213

1592

Chronic myeloproliferative disease

357

2.09

6.78

2.1

1.9

407.90

383.87

nmol/l

0.34

321

Fistulae involving female genital tract

449

1.95

6.75

2.2

2.3

427.94

382.95

nmol/l

1.01

406

Aortic valve malfunction, age under 60 years

383

2914

1.35

6.75

2.4

2.3

368.15

364.34

nmol/l

0.10

357

2727

Occupational exposure to risk-factors

148

950

1.63

6.74

2.5

2.2

377.89

365.49

nmol/l

0.32

137

881

Varicella [chickenpox]

205

1409

1.51

6.71

2.8

2.3

359.65

364.54

nmol/l

0.14

196

1325

Periodontal disease, other/unspecified

124

764

1.71

6.70

2.2

2.0

357.91

384.72

nmol/l

0.94

117

706

Blindness, monocular

237

2.36

6.67

2.3

1.8

354.35

376.72

nmol/l

0.24

219

Left ventricular outflow tract obstruction (LVOTO), broad definition

416

3211

1.33

6.60

2.4

369.10

362.69

nmol/l

0.18

390

3005

Certain conditions originating in the perinatal period

408

2782

1.33

6.59

2.6

2.1

367.80

383.70

nmol/l

0.62

383

2585

Preterm labour and delivery

1179

10128

1.18

6.57

2.1

367.37

374.29

nmol/l

0.46

1079

9330

Mixed disorders of conduct and emotions

123

762

1.70

6.51

2.0

2.1

347.44

394.07

nmol/l

1.88

109

703

Short stature starting before birth

174

2.78

6.51

2.3

3.0

289.13

326.37

nmol/l

0.65

169

Biomechanical lesions, not elsewhere classified

213

1485

1.49

6.51

2.1

368.89

372.65

nmol/l

0.11

193

1356

Epiphora

105

626

1.78

6.48

1.9

2.0

383.57

380.56

nmol/l

0.06

100

573

Retinal detachment with retinal break

489

3859

1.29

6.48

2.3

379.13

372.11

nmol/l

0.33

459

3530

Malignant neoplasm, without specification of site

116

706

1.71

6.45

5.3

1.7

360.97

379.74

nmol/l

0.46

111

624

Abscess of Bartholin gland

139

891

1.64

6.44

1.7

2.0

374.52

376.24

nmol/l

0.03

126

825

Abnormal reflex

147

2.79

6.42

2.3

2.1

349.00

374.86

nmol/l

0.35

138

Thyrotoxicosis with toxic single thyroid nodule

262

2.27

6.41

1.8

1.9

403.31

376.33

nmol/l

0.51

242

Benign neoplasm: Anus and anal canal

123

765

1.69

6.40

2.3

2.1

357.75

373.37

nmol/l

0.42

114

693

Disorder of external ear, unspecified

146

946

1.61

6.40

2.6

2.2

364.85

369.79

nmol/l

0.12

137

872

Spirochaetal infections, other/unspecified

364

2775

1.35

6.39

2.5

2.2

378.67

370.07

nmol/l

0.39

336

2543

Cystic fibrosis, other manifestations/unspecified

6.39

1.9

2.1

341.65

370.67

nmol/l

0.12

Erythema multiforme

108

651

1.75

6.38

2.2

2.0

304.82

369.70

nmol/l

2.83

100

601

Fracture of neck

233

1655

1.45

6.37

2.2

2.1

380.27

371.76

nmol/l

0.16

215

1506

Examination and encounter for administrative purposes

169

1126

1.55

6.37

2.5

2.2

381.12

385.76

nmol/l

0.10

157

1043

HSIL lesion of the vulva

511

1.87

6.35

2.6

2.1

366.64

371.22

nmol/l

0.07

473

Other congenital malformations of limb(s)

250

2.30

6.34

1.9

2.1

392.17

386.27

nmol/l

0.06

233

Nephropathy induced by other drugs, medicaments and biological substances

4.83

6.32

3.6

2.5

424.24

374.34

nmol/l

0.45

Membranous nephropathy

125

2.99

6.32

2.1

2.0

326.00

367.94

nmol/l

0.51

116

Other salmonella infections

160

1060

1.57

6.31

2.0

2.1

336.79

372.50

nmol/l

1.51

150

977

Bursitis of shoulder

108

652

1.74

6.30

2.9

2.2

339.65

382.26

nmol/l

1.32

601

Malignant neoplasm of prostate, including Hilmo

875

4335

1.21

6.30

2.5

1.8

370.35

357.72

nmol/l

0.85

814

3937

Postmenopausal atrophic vaginitis

1115

5243

1.19

6.29

2.0

2.3

369.80

380.49

nmol/l

1.01

1026

4793

Shoulder region

403

1.97

6.26

1.5

2.0

374.27

364.93

nmol/l

0.16

378

Sexual dysfunction

409

1.95

6.26

2.2

1.9

380.52

364.77

nmol/l

0.28

384

Idiopathic hypercalciuria

174

2.61

6.26

2.5

2.0

345.65

382.61

nmol/l

0.54

161

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

352

2.03

6.26

1.8

2.1

395.93

374.57

nmol/l

0.24

323

Melanocytic naevi of lower limb, including hip

200

1390

1.50

6.25

3.4

2.0

366.30

374.56

nmol/l

0.27

187

1283

Bitten or struck by other mammals

510

4069

1.28

6.24

2.1

364.21

373.14

nmol/l

0.49

470

3740

Mental retardation

195

1342

1.51

6.23

2.6

2.5

356.99

349.99

nmol/l

0.18

185

1274

Malignant neoplasm of prostate

840

4179

1.22

6.22

2.5

1.8

366.10

358.37

nmol/l

0.42

781

3793

Mitochondrial myopathy

126

2.95

6.21

2.4

2.0

443.69

366.42

nmol/l

1.15

118

Hepatocellular carcinoma

452

1.88

6.19

3.5

1.7

410.25

368.33

nmol/l

0.98

400

Abnormal spermatozoa

410

3184

1.31

6.19

2.3

2.5

317.16

371.22

nmol/l

7.50

384

2947

Malignant neoplasm of small intestine

543

1.81

6.17

2.4

1.7

385.00

364.96

nmol/l

0.35

489

Dermatitis due to ingested food

183

1202

1.52

6.14

2.4

2.3

319.16

369.21

nmol/l

3.54

172

1132

Sequelae of injuries of lower limb

395

3060

1.32

6.14

2.3

2.2

352.49

368.49

nmol/l

0.91

366

2812

Deep bite

522

3664

1.28

6.12

2.6

2.2

352.57

369.23

nmol/l

0.96

490

3416

Use of bromocriptine

6.02

6.12

4.8

1.9

286.53

347.09

nmol/l

0.60

314

2.08

6.08

1.8

2.0

377.27

370.87

nmol/l

0.09

288

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

472

1.86

6.05

2.2

1.8

350.64

381.35

nmol/l

0.79

426

Assault by blunt object

385

1.96

6.05

2.2

2.1

402.66

372.55

nmol/l

0.20

362

Other specific arthropathies, wide

561

1.78

6.04

1.9

2.1

326.10

387.29

nmol/l

2.47

522

Other lack of coordination

451

1.89

6.03

2.5

2.2

377.91

372.15

nmol/l

0.09

420

Other viral hepatitis

276

2039

1.39

6.01

2.3

2.1

355.81

369.04

nmol/l

0.60

250

1893

Granuloma annulare

423

1.92

6.01

2.2

1.9

385.93

376.04

nmol/l

0.18

394

Special screening examination for neoplasms

193

1336

1.48

6.00

2.4

2.5

400.95

378.58

nmol/l

0.83

176

1239

Entropion and trichiasis of eyelid

300

2242

1.37

5.97

2.2

2.1

373.49

380.91

nmol/l

0.25

277

2030

Major anomalies of jaw size

130

836

1.63

5.95

2.5

2.2

380.08

368.24

nmol/l

0.29

119

777

Effects of foreign body entering through natural orifice

1008

8622

1.18

5.94

2.4

2.3

355.32

368.70

nmol/l

1.60

932

7961

Retinal haemorrhage

106

648

1.72

5.93

2.2

1.9

381.53

376.75

nmol/l

0.08

584

Amblyopia ex anopsia

189

1314

1.49

5.91

2.3

2.2

365.85

372.52

nmol/l

0.17

172

1215

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

535

1.79

5.90

3.5

1.8

410.70

364.04

nmol/l

1.20

484

Inflammation of lacrimal passages (acute and unspecified)

514

1.82

5.90

3.6

1.9

321.82

373.91

nmol/l

1.92

469

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

127

813

1.63

5.88

2.5

2.1

387.39

379.89

nmol/l

0.19

119

752

Sequelae of infectious and parasitic diseases

310

2337

1.36

5.88

2.1

359.45

371.30

nmol/l

0.49

289

2133

Patellar tendinitis

424

1.89

5.87

1.9

319.06

375.28

nmol/l

2.17

397

Heart failure and hypertrophic cardiomyopathy

485

1.84

5.87

2.6

2.0

426.28

380.57

nmol/l

0.59

444

Other cranial nerve disorders in other disorders

3.61

5.83

3.3

1.7

333.82

384.03

nmol/l

0.67

Dementia in Alzheimer disease

575

3937

1.25

5.83

1.6

2.1

389.41

383.49

nmol/l

0.28

466

3534

Malignant neoplasm of breast, ER-negative, including Hilmo

889

7180

1.20

5.83

2.4

1.8

390.87

370.42

nmol/l

2.29

820

6481

Gestational [pregnancy-induced] hypertension

1210

10494

1.17

5.82

2.0

362.79

378.87

nmol/l

2.32

1133

9691

Artificial joint re-operation

283

2112

1.38

5.81

2.0

2.2

370.43

372.87

nmol/l

0.07

256

1909

Other and unspecified nail disorders

103

630

1.72

5.81

3.4

2.1

321.94

367.71

nmol/l

1.77

588

Other congenital malformations of skin

183

1272

1.50

5.76

2.3

2.1

359.16

372.27

nmol/l

0.37

172

1180

Tooth eruption problems

675

5455

1.23

5.74

2.3

2.0

377.19

387.26

nmol/l

0.62

633

5031

Other protozoal intestinal diseases

103

632

1.71

5.72

1.7

2.0

383.44

376.85

nmol/l

0.14

589

Mental retardation, wide definition

201

1415

1.47

5.72

2.6

2.5

358.90

351.03

nmol/l

0.21

190

1338

Seronegative juvenile rheumatoid arthritis

603

1.74

5.72

2.6

2.2

322.76

379.13

nmol/l

2.06

564

Other diseases of gallbladder

182

1264

1.49

5.70

1.9

2.0

341.30

372.61

nmol/l

1.52

164

1148

Other disorders of binocular vision

379

1.94

5.69

2.0

1.8

359.75

380.26

nmol/l

0.34

358

Complications of cardiac and vascular prosthetic devices, implants and grafts

503

1.80

5.68

2.1

346.75

363.96

nmol/l

0.26

455

Peroneal tendinitis

422

1.88

5.68

2.8

2.0

353.65

380.99

nmol/l

0.55

392

Unspecified event, undetermined intent

115

727

1.66

5.66

1.8

2.1

357.49

373.30

nmol/l

0.36

102

679

Perforation of oesophagus

125

2.77

5.64

1.8

2.1

369.00

355.11

nmol/l

0.10

114

Essential (haemorrhagic) thrombocythaemia

153

1030

1.54

5.64

1.9

1.8

435.13

362.65

nmol/l

3.29

141

924

Parkinson's disease, strict definition

502

4044

1.26

5.62

1.8

2.3

389.91

375.95

nmol/l

0.84

443

3686

Varicella [chickenpox]

238

1737

1.41

5.62

2.8

2.3

355.31

363.77

nmol/l

0.30

228

1634

Inflammatory disease of cervix uteri

269

2007

1.38

5.56

2.2

2.1

384.95

376.16

nmol/l

0.31

237

1820

Sequelae of other and unspecified infectious and parasitic diseases

239

1751

1.41

5.55

2.1

355.76

366.59

nmol/l

0.38

224

1618

Haemangioma, any site

361

2811

1.32

5.48

2.2

359.11

368.73

nmol/l

0.44

331

2579

Pleural plaque without asbestos

133

874

1.58

5.47

1.8

2.1

359.39

373.60

nmol/l

0.34

122

781

Other congenital malformations of circulatory system

122

790

1.62

5.47

2.2

2.0

380.25

366.13

nmol/l

0.35

115

737

Pyoderma

548

1.75

5.47

3.0

2.0

362.80

376.16

nmol/l

0.19

508

Generalized epilepsy

196

1393

1.46

5.47

1.9

2.1

384.75

365.53

nmol/l

0.64

184

1294

Coxarthrosis, primary, with hip surgery

1857

15567

1.13

5.45

2.1

2.3

372.10

378.00

nmol/l

0.43

1704

14231

Dronedarone medication

108

678

1.66

5.44

2.1

2.4

313.54

367.14

nmol/l

1.90

623

Social disorders starting during childhood or adolecense, excluding more controls

177

2.37

5.39

2.8

2.0

320.88

381.15

nmol/l

1.10

164

Hypertrophic scar

236

1734

1.40

5.39

2.1

2.0

385.11

376.10

nmol/l

0.29

221

1591

Antenatal screening

863

5695

0.84

5.39

1.8

2.0

387.58

386.42

nmol/l

0.06

803

5265

Oral lichen planus

121

786

1.62

5.37

2.4

2.1

404.19

368.38

nmol/l

1.07

114

720

Family history of malignant neoplasm

478

3859

1.26

5.33

2.9

2.1

390.89

372.94

nmol/l

1.07

443

3544

Oral lichen planus and hypothyroidism or thyroxine medication

531

1.76

5.32

2.5

2.1

375.89

367.32

nmol/l

0.16

488

Degenerative diseases of the nervous system

1256

8064

1.16

5.31

1.7

2.1

403.50

383.99

nmol/l

2.48

1076

7274

Contact with heat and hot substances

228

1670

1.41

5.31

2.1

363.30

369.33

nmol/l

0.16

207

1541

Torsion of ovary, ovarian pedicle and fallopian tube

106

668

1.66

5.30

2.3

2.2

353.48

383.24

nmol/l

0.95

623

False labour

1495

8241

1.14

5.30

2.0

382.50

382.11

nmol/l

0.02

1385

7612

Vascular dementia (mixed)

379

1.88

5.27

1.7

2.0

421.87

382.36

nmol/l

0.81

334

Mental and behavioural disorders due to use of other stimulants, including caffeine

127

835

1.58

5.27

1.9

2.0

374.47

367.65

nmol/l

0.15

109

782

Arthropod-borne viral fevers and viral haemorrhagic fevers

739

6230

1.20

5.25

2.3

370.11

369.17

nmol/l

0.04

685

5739

Hypertrophic cardiomyopathy

170

1187

1.48

5.24

2.4

2.2

400.99

367.05

nmol/l

0.86

161

1089

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

324

1.97

5.23

2.3

1.8

344.41

384.82

nmol/l

0.85

290

Pityriasis rubra pilaris

3.57

5.23

5.6

1.8

252.05

373.45

nmol/l

1.74

Arterial embolism and thrombosis of lower extremity artery

130

858

1.57

5.23

2.5

2.1

388.78

374.44

nmol/l

0.27

115

778

Congenital malformations of the circulatory system

626

5048

1.22

5.22

2.6

2.3

356.98

365.37

nmol/l

0.50

583

4671

Injury of eye and orbit

570

4694

1.23

5.21

1.9

2.3

380.30

369.31

nmol/l

0.58

532

4326

Other disorders of iris and ciliary body

110

702

1.63

5.20

1.9

2.0

378.43

381.14

nmol/l

0.05

104

642

Mental and behavioural disorders associated with the puerperium

326

1.97

5.18

2.1

383.21

378.64

nmol/l

0.06

305

Single spontaneous delivery

1604

9539

0.88

5.15

2.0

385.22

391.34

nmol/l

0.52

1472

8644

Spasmodic torticollis

143

971

1.54

5.14

2.7

2.0

367.20

373.27

nmol/l

0.14

132

896

Perforation of tympanic membrane

409

3262

1.28

5.11

2.4

2.1

368.83

371.81

nmol/l

0.10

376

2985

Perineal laceration during delivery

604

6064

0.82

5.10

1.8

2.0

390.90

385.54

nmol/l

0.22

565

5572

Other and unspecified mononeuropathies of lower limb

115

746

1.61

5.09

1.9

2.0

383.76

381.05

nmol/l

0.05

681

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

160

1112

1.50

5.05

2.6

2.3

334.86

357.74

nmol/l

0.83

153

1049

Complications associated with artificial fertilization

529

1.73

5.05

1.9

2.2

373.73

381.87

nmol/l

0.14

490

Separation of retinal layers (serosa)

167

1171

1.47

5.03

2.8

2.2

367.96

370.71

nmol/l

0.06

157

1081

Other specified/unspecified disorders of bone/cartilage

114

740

1.60

5.03

2.2

2.1

357.63

369.46

nmol/l

0.28

104

682

Other other unspecified disorders of the circulatory system

153

1058

1.50

4.99

2.3

2.2

354.23

370.05

nmol/l

0.52

142

966

Non-allergic asthma

354

2781

1.30

4.99

2.1

2.2

361.33

371.29

nmol/l

0.41

336

2552

Contraceptive management

1923

12148

1.12

4.98

2.0

2.2

367.27

371.14

nmol/l

0.41

1792

11268

Haemangioma and lymphangioma, any site

382

3035

1.29

4.96

2.2

361.01

368.34

nmol/l

0.32

350

2786

Family history of certain disabilities and chronic diseases leading to disablement

214

1570

1.40

4.96

1.9

2.0

363.63

378.88

nmol/l

0.55

194

1440

Malignant neoplasm of colon

481

3914

1.25

4.92

2.6

1.8

407.32

370.91

nmol/l

2.73

449

3486

Drug-induced acute pancreatitis

3.94

4.92

6.4

2.2

360.24

390.56

nmol/l

0.26

Use of rotigotine

318

1.97

4.92

2.3

1.8

392.04

378.65

nmol/l

0.20

296

Vascular dementia (subcortical)

113

734

1.59

4.92

1.8

2.0

390.25

385.91

nmol/l

0.08

105

647

Injury of intra-abdominal organs

108

697

1.62

4.91

1.8

2.0

333.82

370.09

nmol/l

0.99

100

649

Other nutritional anaemias

246

2.08

4.89

2.1

2.0

437.16

378.70

nmol/l

0.90

219

Carcinoma in situ of skin of trunk

121

802

1.57

4.87

3.3

2.1

356.20

376.38

nmol/l

0.50

112

721

Superficial injuries involving multiple body regions

120

795

1.57

4.86

2.4

1.9

375.55

378.50

nmol/l

0.06

110

733

Habitual aborter

612

1.66

4.86

1.5

1.9

396.07

380.91

nmol/l

0.30

569

Benign neoplasm: Nasopharynx

234

2.13

4.85

1.8

2.0

329.23

363.78

nmol/l

0.46

211

Vestibular neuronitis

356

2814

1.29

4.83

2.3

2.2

355.25

370.65

nmol/l

0.82

320

2596

Other injuries of upper limb, level unspecified

341

1.91

4.83

2.8

1.9

314.22

389.34

nmol/l

2.04

311

Other acute skin changes due to ultraviolet radiation

140

958

1.51

4.82

2.5

2.1

369.24

377.33

nmol/l

0.17

131

871

Traumatic ischaemia of muscle

363

1.87

4.81

2.3

1.9

347.54

370.89

nmol/l

0.42

342

Toxic effect of carbon monoxide

483

1.75

4.81

2.0

1.9

372.32

386.91

nmol/l

0.29

444

Injury of nerves and spinal cord at thorax level

142

2.51

4.80

1.5

2.0

364.47

372.79

nmol/l

0.08

129

Malignant neoplasm of vulva, including Hilmo

394

1.84

4.80

2.7

1.8

383.64

369.39

nmol/l

0.24

350

Other and unspecified injuries of wrist and hand

172

1225

1.45

4.80

1.8

2.1

348.63

373.50

nmol/l

0.94

165

1123

Perichondritis of external ear

484

1.74

4.78

1.8

1.9

381.18

377.22

nmol/l

0.06

444

Other factor of the environment

358

1.88

4.73

3.4

1.9

322.40

383.94

nmol/l

1.67

331

Other arterial embolism and thrombosis

105

678

1.60

4.73

2.5

2.1

322.12

373.91

nmol/l

1.85

619

Colorectal cancer

762

6352

1.19

4.72

2.4

1.7

405.79

368.98

nmol/l

4.50

709

5680

Dislocation of lens

327

1.89

4.71

1.8

1.9

400.75

373.11

nmol/l

0.38

289

Other misadventures during surgical and medical care

105

683

1.61

4.67

2.1

384.81

372.48

nmol/l

0.28

637

Other salmonella infections

176

1264

1.43

4.66

1.9

2.1

337.95

369.70

nmol/l

1.39

164

1164

Drug-induced dystonia

3.04

4.64

2.0

2.1

363.64

362.49

nmol/l

0.01

Leiomyoma of uterus

3013

15747

1.09

4.64

2.1

371.40

374.64

nmol/l

0.37

2738

14475

Right hemicolectomy

215

1596

1.38

4.63

2.4

2.1

393.98

370.38

nmol/l

0.95

202

1444

Benign neoplasm of bone and articular cartilage

349

2769

1.29

4.62

2.3

2.1

345.84

370.84

nmol/l

1.70

324

2544

Ankylosing spondylitis, strict definition

186

1352

1.42

4.61

2.0

2.1

337.47

366.28

nmol/l

1.37

171

1265

Carcinoma in situ of skin of upper limb, including shoulder

102

661

1.62

4.61

3.0

2.0

389.72

384.89

nmol/l

0.04

593

Assault by unspecified means

606

1.64

4.58

1.6

2.0

369.19

364.62

nmol/l

0.09

574

L02BA Anti-estrogens

509

6129

0.82

4.56

2.1

406.67

373.80

nmol/l

2.61

463

5599

Injuries involving multiple body regions

159

1129

1.45

4.52

2.2

2.0

373.24

373.12

nmol/l

0.00

147

1039

Other bursitis of hip

545

1.67

4.52

2.3

2.1

399.40

391.82

nmol/l

0.09

494

Malignant neoplasm of oesophagus, including Hilmo

122

822

1.53

4.52

3.3

1.6

422.11

364.78

nmol/l

2.27

116

735

Follow-up care involving plastic surgery

158

1121

1.46

4.51

2.4

2.0

377.95

368.84

nmol/l

0.23

133

1016

Motor neuron disease (with DMD)

338

1.84

4.50

1.7

2.4

420.77

392.59

nmol/l

0.59

316

Polyglandular hyperfunction

18.65

4.49

4.3

1.3

406.57

354.13

nmol/l

—

Myelodysplastic syndrome

240

2.03

4.47

2.2

1.6

358.30

371.07

nmol/l

0.14

211

Overjet

134

924

1.51

4.44

2.6

2.4

346.02

366.12

nmol/l

0.58

122

878

Haemophagocytic lymphohistiocytosis

4.27

4.44

3.3

2.5

280.71

352.43

nmol/l

0.90

malignant neoplasm of female genital organs

582

4858

1.21

4.43

2.9

1.8

416.65

372.62

nmol/l

4.63

539

4343

Convergent concomitant strabismus

251

1922

1.34

4.42

2.6

2.1

366.18

373.55

nmol/l

0.24

234

1783

Other appendicitis

338

2686

1.28

4.41

2.5

2.2

372.84

370.29

nmol/l

0.08

316

2460

Other demyelinating diseases of the central nervous system

169

1221

1.43

4.39

2.2

2.1

359.92

372.92

nmol/l

0.43

155

1142

Benign neoplasm of urinary organs

187

1372

1.40

4.39

2.2

404.54

372.42

nmol/l

1.26

169

1241

Chalazion

451

3700

1.24

4.39

2.1

2.2

370.76

373.90

nmol/l

0.12

410

3407

Prepatellar bursitis

162

1159

1.44

4.38

2.2

2.5

347.78

377.64

nmol/l

1.22

148

1076

Chronic viral hepatitis

223

1683

1.36

4.35

2.2

2.1

352.76

366.12

nmol/l

0.54

200

1568

Malignant neoplasm of pancreas

218

1636

1.36

4.35

2.5

1.8

432.83

366.28

nmol/l

3.46

202

1453

Monoplegia

436

1.75

4.34

2.3

1.8

366.92

374.42

nmol/l

0.10

403

Foreign body in alimentary tract

221

1667

1.36

4.33

2.3

2.2

355.65

374.14

nmol/l

0.86

203

1538

Other specified and unspecified disorders of eye and adnexa

156

1114

1.45

4.32

2.5

2.0

393.46

377.42

nmol/l

0.29

144

1015

Other and unspecified injuries of shoulder and upper arm

132

915

1.50

4.32

2.3

2.0

375.01

375.60

nmol/l

0.01

123

853

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

542

4536

1.21

4.32

2.2

2.3

375.00

368.43

nmol/l

0.37

500

4178

Congenital malformations of anterior segment of eye

246

2.03

4.27

3.5

2.0

377.93

368.26

nmol/l

0.08

230

Disorders of optic nerve, not elsewhere classified

579

1.63

4.24

2.6

2.1

358.79

373.54

nmol/l

0.29

533

Cryoglobulinemia

3.97

4.23

2.3

1.6

338.00

409.08

nmol/l

0.66

Pyogenic granuloma

501

1.68

4.21

2.6

1.9

381.08

379.52

nmol/l

0.03

459

Scleritis

364

1.81

4.20

2.0

1.8

329.86

379.82

nmol/l

1.22

342

Combined immunodeficiencies

290

1.91

4.20

4.3

1.8

324.68

384.13

nmol/l

1.41

262

Other and unspecified paralytic syndromes

410

1.75

4.18

2.6

1.9

351.70

376.77

nmol/l

0.44

379

Carcinoma in situ of skin

313

2485

1.29

4.16

2.2

2.1

360.11

377.34

nmol/l

0.70

292

2228

Motor neuron disease

317

1.83

4.16

1.6

2.4

428.83

399.19

nmol/l

0.60

296

Malignant neoplasm of breast, HER-negative

770

6531

1.17

4.13

2.3

1.8

389.55

369.94

nmol/l

1.85

708

5880

Other infective otitis externa

241

1854

1.33

4.13

2.4

2.1

388.09

374.02

nmol/l

0.47

220

1711

Conductive hearing loss, unspecified

331

2648

1.28

4.12

2.4

2.2

353.26

375.14

nmol/l

1.42

309

2432

Abdominal aortic aneurysm (AAA)

291

2267

1.29

4.10

2.6

2.3

362.12

378.45

nmol/l

0.56

269

2049

Other and unspecified mononeuropathies of upper limb

122

842

1.50

4.09

1.8

2.1

377.70

369.16

nmol/l

0.22

114

782

Injury of muscle and tendon at wrist and hand level

530

4449

1.21

4.08

2.4

2.3

365.52

370.30

nmol/l

0.23

497

4101

Viral haemorrhagic fevers, not elsewhere classified/unspecified

644

5495

1.19

4.08

2.2

2.3

373.71

368.98

nmol/l

0.20

598

5055

Infectious mononucleosis

371

3010

1.26

4.07

2.1

2.0

364.70

385.79

nmol/l

1.37

338

2768

Benign neoplasm: Kidney

141

1002

1.46

4.06

2.1

409.44

372.85

nmol/l

1.17

128

906

Benign neoplasm: Skin of eyelid, including canthus

607

5160

1.19

4.06

2.1

2.2

360.49

376.40

nmol/l

1.14

545

4709

Benign neoplasm: Skin, unspecified

163

1188

1.42

4.04

2.4

2.1

357.63

371.00

nmol/l

0.41

149

1093

Medicines for HER+ breast cancer

1306

13795

0.89

4.04

2.1

386.66

376.53

nmol/l

0.95

1194

12596

Open wound of abdomen, lower back and pelvis

130

911

1.48

4.03

2.2

2.1

342.68

371.63

nmol/l

0.99

119

852

Other acquired deformities of musculoskeletal system and connective tissue

185

1377

1.38

4.01

2.3

2.2

412.94

371.29

nmol/l

1.53

169

1272

Tuberculosis, IBD comorbidity

238

1832

1.32

4.00

2.1

374.00

377.12

nmol/l

0.06

209

1656

Other complications of labour and delivery, not elsewhere classified

403

4491

0.81

4.00

1.8

1.9

399.74

386.90

nmol/l

0.65

371

4133

Schizotypal disorder

102

684

1.55

3.98

1.6

2.0

367.67

356.94

nmol/l

0.27

640

Maternal care for known or suspected fetal abnormality and damage

558

5661

0.84

3.97

2.2

2.0

390.63

381.94

nmol/l

0.58

520

5221

Impacted cerumen

375

3058

1.25

3.93

2.2

2.1

373.63

374.25

nmol/l

0.02

309

2782

Phantom limb syndrome with pain

3.17

3.93

2.1

2.6

425.41

427.09

nmol/l

0.01

Syphilis

110

752

1.52

3.92

2.3

2.1

386.20

361.84

nmol/l

0.62

703

Syphilis

110

752

1.52

3.92

2.3

2.1

386.20

361.84

nmol/l

0.62

703

Endovascular or surgical operations to intracerebral aneurysms

235

1816

1.32

3.90

2.3

2.2

379.72

369.95

nmol/l

0.37

219

1655

Moderate visual impairment, monocular

116

2.48

3.90

2.8

1.9

365.19

359.16

nmol/l

0.06

104

Exposure to smoke, fire and flames

102

687

1.54

3.90

1.8

2.0

357.19

379.48

nmol/l

0.66

636

Injury of muscle and tendon at lower leg level

571

4847

1.19

3.88

2.5

2.3

346.37

371.09

nmol/l

2.56

536

4474

Embedded teeth, including avohilmo

406

3345

1.24

3.87

2.1

2.0

389.83

385.45

nmol/l

0.16

384

3077

Nonspecific lymphadenitis

245

1908

1.31

3.85

2.4

2.1

373.22

374.25

nmol/l

0.03

230

1760

Vascular dementia (other)

142

2.26

3.83

1.8

1.7

447.00

402.77

nmol/l

0.40

126

Mental and behavioural disorders of puerperium, not classified elsewhere

360

1.77

3.82

2.1

2.0

383.21

379.07

nmol/l

0.05

331

Tuberculosis, wide

245

1907

1.31

3.81

2.1

372.57

376.70

nmol/l

0.08

216

1726

Open wound of shoulder and upper arm

546

1.60

3.79

3.3

2.1

332.64

378.08

nmol/l

0.85

512

Endometriosis diagnosis and infertility diagnosis occurring together

475

3984

1.21

3.78

2.0

2.1

380.37

372.87

nmol/l

0.40

446

3675

Haemorrhagic disorder due to circulating anticoagulants

314

1.81

3.78

1.8

1.7

387.87

391.72

nmol/l

0.04

278

Benign neoplasm of major salivary glands

367

3001

1.25

3.77

2.4

2.2

376.65

371.66

nmol/l

0.17

335

2739

Oral lichen planus, including avohilmo , including avohilmo

268

2119

1.30

3.77

2.4

2.1

378.77

370.84

nmol/l

0.29

253

1946

Other and unspecified acute skin changes due to ultraviolet radiation

643

1.55

3.76

2.5

2.0

390.66

369.43

nmol/l

0.39

582

Subarachnoid haemorrhage

366

2990

1.24

3.76

1.9

2.2

366.92

375.46

nmol/l

0.37

328

2728

Complications predominantly related to the puerperium

1173

10499

1.13

3.75

2.0

2.1

369.93

377.28

nmol/l

0.76

1074

9671

Ectopic pregnancy

753

6555

1.16

3.74

2.1

2.2

362.96

373.20

nmol/l

0.79

697

6057

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

315

2538

1.27

3.74

2.5

2.1

371.62

368.74

nmol/l

0.10

297

2334

Labour and delivery complicated by fetal stress [distress]

956

7083

0.87

3.73

1.9

2.0

380.82

382.62

nmol/l

0.11

883

6525

Other mycoses, not elsewhere classified/unspecified

478

1.65

3.73

2.4

2.0

367.40

384.71

nmol/l

0.34

447

Varicose veins of other sites

241

1881

1.31

3.71

2.4

2.2

358.79

369.00

nmol/l

0.40

221

1725

Immunodeficiency associated with other major defects

2.77

3.71

3.4

2.4

337.33

387.30

nmol/l

0.82

Contact with sharp glass

165

1224

1.39

3.69

2.3

2.1

370.85

369.20

nmol/l

0.04

151

1136

Corneal scars and opacities

111

770

1.49

3.68

2.7

2.1

356.71

372.12

nmol/l

0.41

103

710

Other and unspecified types of non-Hodgkin lymphoma, hilmo

154

1130

1.40

3.68

2.9

2.1

368.62

368.70

nmol/l

0.00

147

1023

Acute thyroiditis

106

2.50

3.68

2.1

405.29

363.02

nmol/l

0.30

Other specified and unspecified retinal disorders

137

987

1.43

3.67

2.2

2.1

396.46

374.14

nmol/l

0.76

125

896

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

375

3087

1.24

3.66

1.9

2.2

354.67

375.22

nmol/l

1.54

354

2836

Malignant neoplasm of ureter, including Hilmo

208

2.01

3.66

4.8

1.8

378.92

365.13

nmol/l

0.14

184

Dissocial personality disorder

417

1.68

3.65

2.1

2.0

360.52

359.37

nmol/l

0.01

387

Supervision of normal pregnancy

849

5526

0.87

3.65

2.0

383.11

386.20

nmol/l

0.19

785

5113

Hyphaema and other vascular disorders of iris and ciliary body

520

1.60

3.63

2.0

1.9

351.52

381.88

nmol/l

0.80

479

Contusion of ankle

159

1176

1.39

3.62

2.4

2.1

360.63

376.42

nmol/l

0.42

150

1087

Xerosis cutis

419

1.68

3.61

2.1

2.0

365.56

387.40

nmol/l

0.37

384

Calcaneal spur

296

1.81

3.61

1.8

2.0

353.93

388.10

nmol/l

0.48

273

Other superficial mycoses

430

3589

1.22

3.61

2.1

2.0

380.21

376.25

nmol/l

0.13

383

3295

Other and unspecified iridocyclitis

184

1393

1.36

3.60

2.9

2.1

355.45

377.43

nmol/l

0.99

177

1285

Unspecific neurodegenerative disorder

1499

9279

1.11

3.60

1.8

2.2

398.19

382.61

nmol/l

2.09

1290

8397

Other diseases of appendix

320

1.78

3.58

2.2

2.0

379.88

365.70

nmol/l

0.18

296

Mandibular retrognathia

288

2304

1.27

3.58

2.2

354.77

374.84

nmol/l

0.99

271

2142

Other intracranial haemorrhages

107

740

1.49

3.57

2.0

2.2

355.94

368.72

nmol/l

0.34

668

Malignant neoplasm of nasopharynx, including Hilmo

114

2.40

3.56

2.2

1.6

396.28

362.27

nmol/l

0.42

100

Tuberculosis of other organs, strict

594

1.55

3.56

2.0

1.8

382.50

381.47

nmol/l

0.01

527

Inguinal hernia

2454

15192

1.09

3.55

2.4

2.3

365.85

373.14

nmol/l

0.92

2285

14017

Tuberculosis of other organs

531

1.58

3.54

2.0

1.8

389.99

384.05

nmol/l

0.05

473

Benign neoplasm of eye and adnexa

386

3196

1.23

3.54

2.5

2.2

354.86

373.52

nmol/l

1.20

344

2931

Campylobacter enteritis

114

802

1.47

3.53

3.2

2.1

339.26

370.65

nmol/l

0.93

106

741

Injury of muscle and tendon at hip and thigh level

370

3051

1.23

3.53

2.2

2.3

357.41

370.89

nmol/l

0.65

348

2817

Obstructed labour due to malposition and malpresentation of fetus

833

8810

0.87

3.52

2.1

2.0

367.48

375.81

nmol/l

0.66

770

8130

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

663

1.53

3.52

2.1

2.0

375.74

383.15

nmol/l

0.17

621

Actinomycosis

2.52

3.52

3.4

1.8

479.86

378.85

nmol/l

0.83

Other disorders of cornea

373

3080

1.23

3.51

2.4

2.1

361.61

371.97

nmol/l

0.45

331

2825

Other and unspecified degenerative diseases of nervous system

645

1.52

3.51

1.8

2.1

428.90

380.95

nmol/l

1.03

579

Use of biperiden

202

1555

1.33

3.51

1.6

2.1

399.96

371.28

nmol/l

1.25

175

1430

Demyelinating diseases of the central nervous system

367

3029

1.23

3.50

2.0

2.1

353.97

372.51

nmol/l

1.16

335

2806

Benign lipomatous neoplasm of other sites/unspecified

321

2612

1.25

3.49

2.4

2.1

337.15

368.34

nmol/l

2.16

295

2389

Benign neoplasm: Skin of other and unspecified parts of face

407

3391

1.22

3.49

2.7

2.1

364.44

374.38

nmol/l

0.49

356

3092

Unspecified lump in breast

647

5605

1.17

3.48

2.0

2.1

384.57

378.83

nmol/l

0.32

591

5121

Benign neoplasm: Liver/bile ducts

113

797

1.47

3.47

1.9

2.0

395.67

379.23

nmol/l

0.31

740

Other melanin hyperpigmentation

608

1.54

3.45

2.4

1.9

400.66

381.08

nmol/l

0.31

552

Malignant neoplasm of gum, including Hilmo

249

1.88

3.44

4.6

1.8

445.52

374.92

nmol/l

1.50

221

Benign neoplasm: Parotid gland

298

2411

1.26

3.44

2.4

2.2

380.81

370.73

nmol/l

0.34

275

2207

Crohn's disease (strict) with PSC

3.35

3.43

2.5

1.7

266.86

420.50

nmol/l

2.32

Delivery

1657

9573

0.91

3.43

2.0

383.42

391.30

nmol/l

0.80

1522

8674

Brain medulloblastoma, including Hilmo

10.20

3.43

5.9

2.4

320.00

351.62

nmol/l

—

Brain medulloblastoma

10.20

3.43

5.9

2.4

320.00

351.62

nmol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

173

1310

1.36

3.41

2.4

2.1

344.75

380.58

nmol/l

1.77

163

1230

Other specified/unspecified hearing loss

303

2457

1.25

3.40

2.1

2.2

375.58

374.22

nmol/l

0.03

276

2237

Congenital malformations of breast

546

1.57

3.40

1.8

2.0

393.58

381.55

nmol/l

0.20

505

Congenital malformations of genital organs

424

3537

1.21

3.40

2.1

2.2

363.27

370.76

nmol/l

0.32

399

3260

Uterine polyps

368

3045

1.23

3.39

2.1

2.3

404.73

379.12

nmol/l

1.15

346

2790

Benign neoplasm of other and unspecified female genital organs

179

1365

1.35

3.38

2.0

2.1

380.05

371.39

nmol/l

0.24

153

1245

Other puerperal infections

352

2906

1.23

3.37

1.9

2.1

359.12

382.76

nmol/l

1.77

322

2686

Respiratory tuberculosis, confirmed

441

1.62

3.37

2.1

2.0

386.31

377.56

nmol/l

0.16

401

2.62

3.36

1.5

1.9

404.20

360.40

nmol/l

0.61

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2366

16598

1.08

3.35

2.0

2.1

377.46

376.45

nmol/l

0.09

2227

15259

Dyshidrosis [pompholyx]

451

1.62

3.35

2.0

1.9

384.53

366.25

nmol/l

0.40

419

Malignant neoplasm of bone and articular cartilage

259

1.85

3.34

4.1

1.9

370.22

364.21

nmol/l

0.09

240

Adenocarcinoma and Papillary adenocarcinoma of kidney

266

1.83

3.34

2.8

1.7

410.34

362.49

nmol/l

1.00

241

Implicit parasitic Sepsis

131

2.25

3.34

2.3

1.9

356.86

373.08

nmol/l

0.18

119

Other bursal cyst

396

1.66

3.33

1.7

2.1

350.88

388.32

nmol/l

0.86

366

Optic neuritis

181

1388

1.34

3.29

2.7

2.0

365.18

371.52

nmol/l

0.10

169

1287

Other and unspecified injuries of thorax

509

1.58

3.28

1.7

2.0

383.34

374.80

nmol/l

0.17

469

Generalized epilepsy, mode (most common among epilepsy diagnosis)

134

983

1.41

3.28

1.7

2.1

393.57

370.30

nmol/l

0.63

125

916

Respiratory tuberculosis, bacteriologically and histologically confirmed

460

1.60

3.28

2.1

2.0

389.85

377.40

nmol/l

0.24

419

Benign neoplasm: Skin of lower limb, including hip

114

815

1.45

3.26

2.8

2.1

306.96

371.90

nmol/l

3.57

105

754

Benign neoplasm: Rectosigmoid junction

152

1138

1.37

3.25

2.1

2.2

390.63

370.78

nmol/l

0.63

138

1038

Benign neoplasm: Skin of ear and external auricular canal

143

1061

1.38

3.23

2.8

2.1

379.17

374.19

nmol/l

0.11

127

965

Alopecia universalis

2.67

3.23

1.7

2.6

275.58

376.43

nmol/l

1.83

Disorders of eyelid in diseases classified elsewhere

127

926

1.41

3.22

2.0

363.51

376.12

nmol/l

0.34

118

852

Foreign body or object entering through skin

244

1947

1.28

3.21

2.0

2.1

363.49

373.21

nmol/l

0.34

232

1799

Other maltreatment syndromes

126

918

1.41

3.21

2.1

377.21

360.47

nmol/l

0.43

117

863

Neuroendocrine tumor and carcinoma of small intestine

346

1.70

3.21

2.2

1.6

375.43

368.36

nmol/l

0.08

310

Benign neoplasm: Liver

102

718

1.47

3.20

2.0

405.83

377.95

nmol/l

0.57

667

Paranoid personality disorder

521

1.56

3.18

2.1

1.8

341.31

379.12

nmol/l

0.94

485

Follicular lymphoma, hilmo

159

1204

1.36

3.17

2.4

2.1

378.42

369.41

nmol/l

0.25

150

1084

Measles

348

1.70

3.16

1.9

2.2

320.12

366.36

nmol/l

1.50

328

Mild mental retardation

110

787

1.45

3.15

2.3

392.17

363.17

nmol/l

0.69

103

745

Carcinoma in situ of other and unspecified sites

123

895

1.41

3.15

3.4

2.2

352.80

368.54

nmol/l

0.33

117

814

Other deformities of toe(s)

136

1006

1.39

3.15

2.2

2.3

387.68

388.40

nmol/l

0.01

123

912

Melanoma in situ, other sites/unspecified

2.54

3.15

3.4

1.9

551.90

400.93

nmol/l

0.50

Other and unspecified hydrocephalus

531

1.55

3.14

2.4

2.0

384.86

384.96

nmol/l

0.00

489

Malignant neoplasm of eye and adnexa

212

1.91

3.14

4.3

1.6

364.92

371.28

nmol/l

0.08

194

Colon adenocarcinoma

360

2996

1.22

3.12

2.7

1.7

406.38

368.17

nmol/l

2.61

335

2671

Pedal cyclist injured in other and unspecified transport accidents

443

3761

1.20

3.12

2.0

2.1

371.39

373.18

nmol/l

0.07

419

3452

Other abnormal auditory perceptions

326

1.72

3.11

2.6

2.1

410.48

370.67

nmol/l

1.00

307

Cutis laxa senilis

221

1.89

3.10

2.0

1.7

362.26

372.44

nmol/l

0.11

197

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

142

2.14

3.09

3.7

1.8

382.61

361.83

nmol/l

0.25

131

Retinal breaks without detachment

600

5218

1.16

3.09

2.2

2.3

377.75

371.45

nmol/l

0.37

562

4795

Disorder of mineral metabolism, other/unspecified

3.04

3.07

2.7

2.3

394.43

390.56

nmol/l

0.03

Failed attempted abortion

423

1.62

3.06

2.0

357.48

375.72

nmol/l

0.38

391

LSIL lesion of the vulva

127

937

1.40

3.05

1.9

2.0

385.34

371.84

nmol/l

0.30

119

869

Seminoma of testis

177

1.97

3.05

2.3

1.7

379.00

376.54

nmol/l

0.03

163

Malignant neoplasm of corpus uteri, including Hilmo

342

2846

1.22

3.04

2.5

1.7

400.47

373.43

nmol/l

1.53

313

2527

Malignant neoplasm of testis, including Hilmo

421

1.60

3.03

2.5

1.8

366.05

362.83

nmol/l

0.05

387

Calcinosis cutis

3.08

3.02

2.2

1.9

313.29

369.94

nmol/l

0.48

Severe visual impairment, monocular

245

1.81

3.00

1.6

1.9

364.42

380.32

nmol/l

0.23

226

Procedures for purposes other than remedying health state

702

1.46

2.99

1.9

2.0

362.49

373.40

nmol/l

0.19

642

Pedal cyclist injured in transport accident

915

8193

1.13

2.98

2.1

2.2

376.87

371.85

nmol/l

0.35

858

7532

Malignant neoplasm of gum

110

2.28

2.97

4.0

1.8

439.87

360.20

nmol/l

1.08

Actinomycosis

2.53

2.96

3.9

1.9

487.11

375.94

nmol/l

0.75

Malignant immunoproliferative diseases

277

1.76

2.96

2.8

1.9

342.67

385.96

nmol/l

0.84

253

Other acute viral hepatitis

378

1.64

2.95

2.9

2.1

371.72

383.54

nmol/l

0.18

353

Central retinal artery occlusion

521

1.53

2.95

2.2

2.0

370.84

383.55

nmol/l

0.25

464

Use of other anti-dementia drugs

879

6500

1.13

2.93

1.7

2.1

394.77

388.85

nmol/l

0.39

745

5833

Use of memantine

879

6500

1.13

2.93

1.7

2.1

394.77

388.85

nmol/l

0.39

745

5833

Malignant neoplasm of testis

377

1.62

2.93

2.3

1.8

372.06

360.81

nmol/l

0.19

350

Polyhydramnios

215

1714

1.28

2.93

1.9

2.1

375.76

378.29

nmol/l

0.06

192

1573

Pregnancy with abortive outcome

3264

16042

1.07

2.91

2.0

378.19

385.75

nmol/l

1.32

2972

14688

Foreign body in respiratory tract

208

1652

1.29

2.91

2.5

2.2

349.37

376.03

nmol/l

1.25

191

1514

Conduct disorder

639

1.47

2.90

2.1

364.24

379.34

nmol/l

0.37

595

Erosion and ectropion of cervix uteri

112

816

1.41

2.90

1.8

2.4

352.49

378.49

nmol/l

0.37

745

therapeutic use

117

859

1.40

2.89

2.2

2.1

374.48

363.90

nmol/l

0.18

101

783

Adenocarcinoma and papillary adenocarcinoma of stomach

613

1.47

2.88

2.2

1.7

374.57

371.38

nmol/l

0.06

549

Benign neoplasm: Tonsil

341

1.66

2.88

2.8

2.0

388.69

368.66

nmol/l

0.35

313

Carcinoma in situ, bladder

113

826

1.41

2.86

3.4

2.3

352.16

369.35

nmol/l

0.34

107

754

Desensitization to allergens

234

1889

1.26

2.84

2.2

2.1

353.89

376.10

nmol/l

1.11

215

1742

Malignant neoplasm of cervix uteri, including Hilmo

106

769

1.43

2.84

4.6

1.9

382.54

369.04

nmol/l

0.30

101

692

Normotensive glaucoma

304

2520

1.23

2.84

2.1

2.2

418.87

375.97

nmol/l

0.90

274

2268

Phantom limb syndrome

2.60

2.84

2.1

1.8

425.41

350.59

nmol/l

0.61

Presbyopia

256

2091

1.25

2.79

2.4

2.2

350.61

367.06

nmol/l

0.77

241

1939

Need for immunization against other single viral diseases

562

1.50

2.79

2.3

2.1

318.85

362.48

nmol/l

1.41

526

Cysts of oral region, not elsewhere classified

222

1786

1.27

2.78

2.8

2.2

341.82

369.79

nmol/l

1.53

202

1648

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

358

3021

1.20

2.78

1.9

2.1

379.07

368.95

nmol/l

0.46

336

2801

Benign neoplasm: salivary glands, exclude unknown (D119)

323

2701

1.22

2.76

2.4

2.2

378.60

368.51

nmol/l

0.35

298

2466

Impacted maxillary molar

251

2048

1.25

2.76

2.2

1.9

378.67

398.10

nmol/l

0.82

232

1875

Malignant neoplasm of other connective and soft tissue, including Hilmo

146

1116

1.34

2.75

2.3

1.8

374.77

364.18

nmol/l

0.25

136

1001

Benign neoplasm of breast

493

4274

1.17

2.74

1.9

2.1

372.58

378.64

nmol/l

0.28

441

3911

Deficiency of other/unspecified nutrient elements

7.50

2.71

5.8

2.1

365.33

411.42

nmol/l

—

Trichomoniasis

269

1.73

2.70

2.6

2.1

342.51

368.96

nmol/l

0.31

250

Glaucoma-related operations

204

1633

1.28

2.69

2.0

2.1

373.44

377.32

nmol/l

0.10

179

1472

Other noninflammatory disorders of cervix uteri

183

1446

1.29

2.69

2.2

2.3

355.43

379.25

nmol/l

0.55

163

1321

Prolapse and hernia of ovary and fallopian tube

132

988

1.35

2.68

1.6

2.0

393.88

395.35

nmol/l

0.03

119

863

Malignant neoplasm of other connective and soft tissue

624

1.45

2.68

2.2

1.9

378.45

369.17

nmol/l

0.16

558

Use of donepezil

511

5617

0.86

2.68

1.6

2.0

398.00

387.43

nmol/l

0.53

422

5005

L02BG Aromatase inhibitors

1040

11426

0.90

2.68

2.2

2.1

381.17

378.34

nmol/l

0.16

953

10405

Other inflammation of vagina/vulva

156

1211

1.32

2.67

2.1

362.14

381.33

nmol/l

0.60

140

1121

Other protozoal intestinal diseases

428

1.56

2.67

1.9

2.0

372.14

370.26

nmol/l

0.03

399

Dislocation, sprain and strain of joints and ligaments of elbow

258

2121

1.24

2.66

2.4

2.1

365.82

374.13

nmol/l

0.22

238

1967

Other benign neoplasms of connective and other soft tissue

377

3209

1.19

2.65

2.2

368.01

370.89

nmol/l

0.10

344

2939

Abnormal findings in peritoneal fluid saliva

2.29

2.64

1.4

2.0

293.85

375.75

nmol/l

1.02

Delivery, wide proxy

1390

8034

0.91

2.63

1.9

2.0

390.28

395.90

nmol/l

0.43

1273

7250

Burns and corrosions confined to eye and internal organs

109

805

1.39

2.63

2.5

2.1

354.14

366.34

nmol/l

0.31

104

750

Medullary carcinoma of thyroid gland, including Hilmo

2.79

2.63

1.9

1.6

492.86

409.23

nmol/l

0.20

Injury of nerves at wrist and hand level

145

1116

1.33

2.63

2.0

2.1

370.62

371.74

nmol/l

0.03

136

1031

Benign neoplasm: Pelvic bones, sacrum and coccyx

116

2.15

2.62

1.9

2.0

444.65

376.97

nmol/l

0.98

107

Acute otitis externa, noninfective

454

1.53

2.61

2.0

339.15

371.88

nmol/l

0.73

423

Bacterial meningitis

134

1022

1.35

2.61

2.4

2.1

351.51

370.26

nmol/l

0.38

122

950

Malignant neoplasm of nasopharynx

2.47

2.60

2.0

1.6

390.24

367.00

nmol/l

0.20

Acute inflammation of orbit

173

1.90

2.60

1.8

347.62

371.44

nmol/l

0.29

158

Polypectomy (DHB20)

239

1954

1.24

2.60

2.4

2.2

311.31

370.90

nmol/l

4.73

224

1806

Other disorders of male genital organs

126

951

1.35

2.60

2.2

2.3

355.63

363.50

nmol/l

0.23

115

881

Paget disease

116

2.13

2.60

2.9

1.7

287.74

386.47

nmol/l

1.23

107

Exposure to other and unspecified animate mechanical forces

127

963

1.36

2.58

2.6

2.1

348.79

374.17

nmol/l

0.75

117

890

Benign neoplasm: Vulva

622

1.45

2.58

2.1

367.15

372.31

nmol/l

0.08

574

Malignant neoplasm of corpus uteri

292

2439

1.22

2.56

2.3

1.7

401.75

372.22

nmol/l

1.56

267

2156

Multiple delivery

266

3196

0.82

2.56

2.4

2.1

368.05

377.87

nmol/l

0.45

252

2923

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

138

1061

1.34

2.55

2.5

2.2

369.37

369.06

nmol/l

0.01

131

988

Enteropathogenic Escherichia coli infection

2.28

2.55

2.4

1.8

391.30

368.39

nmol/l

0.18

Other injuries of spine and trunk, level unspecified

258

1.72

2.54

2.1

2.0

351.19

386.03

nmol/l

0.58

242

Other disorders of choroid

368

1.58

2.53

2.4

1.8

353.31

380.96

nmol/l

0.44

332

Burn and corrosion of trunk

113

845

1.37

2.52

2.4

2.1

378.16

368.38

nmol/l

0.26

101

786

Chronic myringitis

132

2.04

2.51

1.8

2.1

409.04

395.14

nmol/l

0.14

121

Mandibular prognathia

475

1.51

2.51

2.4

2.2

412.64

361.66

nmol/l

0.45

442

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

2.33

2.49

2.3

2.0

352.00

336.39

nmol/l

0.20

Car occupant injured in noncollision transport accident

139

1073

1.33

2.49

2.0

374.14

373.03

nmol/l

0.02

130

994

Coronary artery bypass grafting

840

5627

1.12

2.48

2.0

2.6

391.90

382.05

nmol/l

0.63

769

5109

Behavioural disorders

662

1.42

2.43

2.2

2.1

361.13

379.44

nmol/l

0.48

612

Progressive vascular leukoencephalopathy

124

945

1.34

2.43

1.7

2.0

420.59

390.62

nmol/l

0.77

105

841

LSIL lesion of the cervix uteri, vagina or vulva

618

5492

1.14

2.41

2.1

383.69

374.21

nmol/l

0.54

580

5053

Colorectal adenocarcinoma

594

5243

1.14

2.41

2.4

1.8

406.95

368.48

nmol/l

4.35

554

4682

Other retinal artery occlusion

587

1.44

2.41

1.8

2.0

419.29

372.42

nmol/l

0.50

529

Complications following abortion and ectopic and molar pregnancy

142

1107

1.32

2.40

2.0

2.1

378.46

369.32

nmol/l

0.24

126

1011

Psoas tendinitis

120

2.06

2.39

1.7

1.8

331.35

402.71

nmol/l

0.99

112

Malignant neoplasm of rectum, including Hilmo

366

3133

1.18

2.39

1.9

1.8

405.34

365.66

nmol/l

3.45

340

2802

Diseases of thymus

2.44

2.37

2.0

1.6

347.13

387.10

nmol/l

0.39

Lichen sclerosus et atrophicus

393

3396

1.17

2.33

2.0

2.1

372.87

377.32

nmol/l

0.18

350

3114

Spontaneous abortion

2148

13592

1.07

2.33

2.0

2.1

373.07

380.16

nmol/l

0.91

1975

12528

Anisometropia and aniseikonia

125

962

1.33

2.33

2.2

2.1

364.91

379.34

nmol/l

0.34

113

870

Benign neoplasm: Vagina

385

1.55

2.32

1.5

1.9

398.71

369.36

nmol/l

0.60

355

Parapsoriasis

533

1.45

2.32

2.9

2.0

297.03

377.29

nmol/l

3.04

498

Infections of genitourinary tract in pregnancy

395

3417

1.17

2.32

2.3

2.1

381.07

381.35

nmol/l

0.01

367

3135

Anomalies of pupillary function

652

1.41

2.31

1.8

2.1

375.88

374.10

nmol/l

0.03

608

Fall on and from ladder

256

2135

1.22

2.31

2.3

347.19

368.90

nmol/l

1.21

240

1973

Labyrinthitis

2.31

2.3

487.94

364.34

nmol/l

0.71

Contact with other and unspecified heat and hot substances

173

1.83

2.29

1.5

2.0

356.43

382.26

nmol/l

0.38

159

Maxillary retrognathism

560

1.44

2.29

2.1

332.00

372.24

nmol/l

1.05

522

Cyst of Bartholin Gland

159

1265

1.29

2.29

1.8

2.1

389.74

374.00

nmol/l

0.45

144

1164

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

196

1.78

2.28

3.0

1.6

346.03

377.30

nmol/l

0.49

176

Contusion of toe(s) without damage to nail

103

774

1.37

2.27

1.9

2.0

320.51

375.92

nmol/l

2.45

721

Embolic stroke with flimmer

542

1.43

2.25

2.0

2.1

400.98

372.34

nmol/l

0.53

487

Spinal enthesopathy

540

1.43

2.25

2.0

1.8

376.61

406.69

nmol/l

0.62

474

Familial erythrocytosis

123

1.99

2.24

3.3

2.0

321.57

372.29

nmol/l

0.74

112

Crystalline deposits in vitreous body

244

1.68

2.23

2.8

2.0

357.33

379.50

nmol/l

0.29

223

Other degenerative diseases of the basal ganglia

480

1.47

2.22

1.9

2.1

397.53

379.84

nmol/l

0.36

437

Long labour

946

8859

0.91

2.21

2.1

2.0

375.31

378.12

nmol/l

0.17

877

8171

Malignant neoplasm of ureter

2.48

2.20

6.5

1.6

388.71

386.81

nmol/l

0.01

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.15

2.19

2.7

2.0

390.58

384.43

nmol/l

0.05

Viral infections of central nervous system, not elsewhere classified/unspecified

325

1.57

2.18

2.9

2.0

356.35

377.89

nmol/l

0.32

298

Abnormal findings on antenatal screening of mother

356

3074

1.17

2.16

1.9

384.43

390.93

nmol/l

0.25

324

2835

Alzheimer’s disease (Early onset), excluding more controls

657

1.36

2.16

1.6

2.4

415.24

397.55

nmol/l

0.33

601

Atypical virus infections of central nervous system

262

1.64

2.16

2.8

1.9

356.44

374.83

nmol/l

0.26

247

Maternal care for known or suspected abnormality of pelvic organs

1182

7418

1.09

2.15

2.0

371.63

378.92

nmol/l

0.65

1113

6831

Precocious puberty

147

1.88

2.15

3.1

2.2

413.19

403.75

nmol/l

0.08

137

Benign neoplasm: Skin of trunk

157

1257

1.28

2.15

2.9

2.1

376.32

374.21

nmol/l

0.04

144

1150

Benign leiomyoma with endometriosis

627

5622

1.13

2.14

2.1

372.90

377.79

nmol/l

0.24

569

5132

Enterohaemorrhagic Escherichia coli infection

2.79

2.14

3.0

2.2

353.09

429.49

nmol/l

0.54

Acute alcohol intoxication ICD-9

112

859

1.33

2.13

2.4

2.2

362.15

370.94

nmol/l

0.18

103

795

Sleep terrors [night terrors]

2.39

2.13

1.6

2.1

338.33

378.38

nmol/l

0.35

Persons encountering health services in circumstances related to reproduction

2644

16867

1.06

2.13

2.3

369.61

369.44

nmol/l

0.02

2482

15640

Pathological resorption of teeth

133

1046

1.30

2.12

2.2

2.1

346.71

373.03

nmol/l

0.86

125

966

Suppurative otitis media, unspecified

101

765

1.35

2.12

1.9

2.0

371.39

374.44

nmol/l

0.05

701

Torsion of testis

508

1.44

2.12

2.5

2.0

364.73

353.03

nmol/l

0.19

471

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

358

3100

1.17

2.12

1.9

2.1

379.07

374.24

nmol/l

0.18

336

2850

Dementia due to Parkinson's disease

602

1.40

2.11

1.6

2.0

394.72

383.04

nmol/l

0.21

537

Other specified/unspecified nutritional deficiencies

201

1.73

2.11

2.5

2.0

455.67

388.72

nmol/l

0.63

186

Hypertrophy of tongue papillae

369

1.52

2.10

2.9

1.8

378.27

363.37

nmol/l

0.24

343

Circumscribed brain atrophy

518

1.43

2.09

1.7

2.0

386.95

372.92

nmol/l

0.21

472

Other secondary gout

2.25

2.08

2.3

2.2

358.50

379.13

nmol/l

0.10

Congenital malformations of heart and great arteries

520

4479

1.14

2.07

2.7

2.3

351.96

362.75

nmol/l

0.60

486

4148

Chronic mastoiditis

691

1.37

2.06

2.7

2.1

403.99

378.04

nmol/l

0.38

631

Myocardial infarction, with ST-elevation

552

4920

1.13

2.06

2.4

2.3

396.15

375.49

nmol/l

0.64

502

4479

Other disorders of optic disc

413

1.48

2.04

2.3

1.8

378.87

374.87

nmol/l

0.05

377

Calculus of lower urinary tract

168

1363

1.25

2.04

2.5

2.2

348.24

370.26

nmol/l

0.76

157

1240

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

113

1.99

2.04

2.4

1.7

340.00

359.80

nmol/l

0.20

101

Burn and corrosion of shoulder and upper limb, except wrist and hand

633

1.38

2.03

1.8

2.1

355.85

371.58

nmol/l

0.40

591

Ovarian hyperstimulation (induction)

591

1.40

2.03

2.0

2.1

379.48

381.34

nmol/l

0.03

553

Defect, injury or illness of neck

173

1.78

2.02

3.3

1.8

370.97

408.75

nmol/l

0.68

158

Injury of nerves and spinal cord at neck level

599

1.39

2.02

2.5

2.2

376.68

373.87

nmol/l

0.04

556

Viral agents as the cause of diseases classified to other chapters

102

782

1.34

2.01

2.7

2.1

361.62

365.32

nmol/l

0.07

727

Motorcycle rider injured in other and unspecified transport accidents

214

1783

1.22

2.01

2.2

2.1

401.34

371.63

nmol/l

0.42

207

1668

Other specified disorders of external ear

125

984

1.30

1.99

2.4

2.1

347.76

369.11

nmol/l

0.60

116

914

Embolic stroke

141

1123

1.27

1.99

2.3

2.1

383.45

379.14

nmol/l

0.09

126

1009

Guttate psoriasis

407

1.48

1.98

1.7

1.9

342.02

372.59

nmol/l

0.57

375

Sequelae of inflammatory diseases of the central nervous system

2.15

1.97

2.8

1.6

276.18

385.34

nmol/l

2.58

Inguinal or femoral hernia, bilateral

334

2892

1.17

1.96

2.8

2.4

378.46

372.34

nmol/l

0.23

310

2680

Use of pergolide

0.00

1.96

0.0

1.8

—

403.04

—

Other vitreous opacities

142

1139

1.27

1.95

2.3

2.1

385.07

373.44

nmol/l

0.26

129

1035

Other and specified injuries of hip and thigh

594

1.38

1.95

2.0

1.9

348.45

384.38

nmol/l

0.89

541

All dysplastic lesions of the vagina

109

848

1.32

1.94

2.3

2.1

383.07

375.89

nmol/l

0.15

788

Puerperal sepsis

510

4554

1.13

1.92

2.1

2.2

369.42

370.02

nmol/l

0.02

461

4198

Congenital malformations of eye, ear, face and neck

262

2235

1.19

1.91

2.4

2.1

359.87

373.79

nmol/l

0.50

242

2072

Malignant neoplasm of thymus

2.20

1.90

3.8

1.8

312.67

373.94

nmol/l

0.78

Qualitative platelet defects

109

1.98

1.89

3.0

2.4

391.10

370.85

nmol/l

0.26

100

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

289

2489

1.18

1.88

1.9

2.1

370.17

372.19

nmol/l

0.07

269

2329

Malignant neoplasm of vulva

256

1.59

1.87

3.0

1.8

381.72

367.47

nmol/l

0.16

229

Juvenile cataract

132

1.87

1.86

3.6

2.3

426.09

356.14

nmol/l

0.88

125

Inflammatory disorders of breast

261

2233

1.19

1.85

2.0

2.1

364.09

384.40

nmol/l

0.87

244

2034

Secondary lactase deficiency

3.01

1.82

2.1

2.8

333.75

395.04

nmol/l

—

Schistosomiasis [bilharziasis]

2.06

1.81

2.5

2.1

368.47

380.00

nmol/l

0.10

109

833

1.31

1.80

3.5

2.7

320.37

348.65

nmol/l

0.75

104

799

Mixed conductive and sensorineural hearing loss

422

3742

1.14

1.79

2.3

368.63

379.48

nmol/l

0.45

374

3430

Fourth [trochlear] nerve palsy

630

1.35

1.78

2.2

2.1

363.61

375.39

nmol/l

0.20

582

Pemphigus vulgaris

2.40

1.78

1.8

2.1

401.00

402.73

nmol/l

0.01

Struck by thrown, projected or falling objec

186

1551

1.22

1.78

1.9

2.2

368.67

368.36

nmol/l

0.01

174

1439

Cytomegaloviral hepatitis

2.15

1.75

2.1

1.9

361.60

389.80

nmol/l

0.19

Congenital malformations of ovaries, fallopian tubes and broad ligaments

233

1987

1.19

1.75

2.1

368.42

375.85

nmol/l

0.23

218

1835

Benign mammary dysplasia

547

4936

1.12

1.73

2.0

2.1

388.23

380.61

nmol/l

0.41

502

4487

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

495

1.39

1.71

2.3

1.7

393.08

359.60

nmol/l

0.63

445

Viral conjunctivitis

626

1.34

1.71

2.5

1.9

352.07

368.86

nmol/l

0.38

576

Communicating hydrocephalus

600

1.35

1.70

2.4

2.0

458.84

376.21

nmol/l

0.44

549

Melanoma in situ of trunk

403

1.44

1.70

5.3

1.9

437.08

379.89

nmol/l

0.34

374

Benign neoplasm: Other and unspecified parts of mouth

123

989

1.27

1.70

2.5

2.1

393.48

377.79

nmol/l

0.36

105

911

Porphyria cutanea tarda

3.10

1.68

1.0

1.6

423.29

455.48

nmol/l

—

Oral leukoplakia, including avohilmo

777

1.30

1.68

2.6

2.1

390.11

371.51

nmol/l

0.37

721

Viral conjunctivitis

146

1198

1.24

1.68

2.2

1.9

360.31

375.87

nmol/l

0.53

134

1107

Other and unspecified corneal deformities and disorders

118

946

1.27

1.67

2.1

2.0

340.24

372.78

nmol/l

1.08

105

872

Other specified/unspecified deforming dorsopathies

463

1.39

1.67

2.1

1.8

348.91

379.03

nmol/l

0.41

432

Contact with other hot metals

447

1.41

1.67

1.7

2.1

393.48

360.87

nmol/l

0.70

413

Spirochaetal infections, other/unspecified

1061

11393

0.93

1.66

2.2

373.56

372.24

nmol/l

0.08

977

10475

Burn and corrosion of wrist and hand

142

1163

1.24

1.66

1.9

2.1

367.15

370.18

nmol/l

0.06

131

1080

Hand

152

1.74

1.66

1.6

1.7

374.56

381.78

nmol/l

0.08

139

Viral agents as the cause of diseases classified to other chapters

691

1.32

1.66

2.9

2.1

350.51

363.02

nmol/l

0.24

646

Contact with other hot fluids

119

957

1.27

1.65

2.6

2.1

353.17

364.23

nmol/l

0.19

111

884

Lyme disease

1051

11285

0.93

1.65

2.2

374.03

372.34

nmol/l

0.10

968

10376

Superficial injury of neck

605

1.34

1.62

2.3

2.0

372.40

371.71

nmol/l

0.01

561

Birth asphyxia

210

1.62

1.61

3.6

2.6

260.69

359.70

nmol/l

2.74

200

Other benign neoplasms of uterus

190

1606

1.20

1.61

1.9

2.0

422.70

383.52

nmol/l

1.75

172

1435

Beta thalassaemia

3.34

1.60

2.8

1.4

365.83

396.94

nmol/l

—

Vascular syndromes of brain in cerebrovascular disorders

141

1158

1.24

1.60

2.2

345.47

370.49

nmol/l

0.92

120

1047

Squamous cell neoplasms and carcinoma of cervix

183

0.47

1.59

1.3

1.7

381.67

370.02

nmol/l

—

169

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

2.87

1.58

2.9

2.2

449.57

421.48

nmol/l

—

Femoral hernia

145

1196

1.23

1.58

2.5

2.1

363.94

376.24

nmol/l

0.30

134

1089

Social disorders starting during childhood or adolescence

267

1.53

1.58

2.8

2.2

320.88

380.02

nmol/l

1.13

248

2.16

1.57

1.7

1.4

371.08

417.27

nmol/l

0.35

Rare circulating lymphoid malignancy

131

1.76

1.57

2.1

1.8

361.27

348.81

nmol/l

0.10

113

Inguinal hernia, bilateral

323

2844

1.15

1.57

2.8

2.4

375.56

372.43

nmol/l

0.11

300

2637

Unspecified parasitic disease

235

1.56

3.0

2.1

341.29

372.94

nmol/l

0.46

216

Distal bite

166

1385

1.21

1.54

3.0

2.4

311.01

370.56

nmol/l

4.12

153

1305

Alzheimer disease

1023

6970

1.08

1.53

1.7

2.1

401.89

386.54

nmol/l

1.48

866

6261

Other spirochaetal diseases

1084

11585

0.93

1.52

2.2

374.79

372.48

nmol/l

0.14

998

10648

120

933

1.26

1.52

3.4

2.6

321.87

349.87

nmol/l

0.84

115

893

Epileptic seizures related to drugs

2.05

1.52

1.6

2.0

346.71

400.83

nmol/l

0.46

Chronic suppurative otitis media, including avohilmo

295

2592

1.15

1.51

2.2

371.32

370.48

nmol/l

0.02

272

2377

Carcinoma in situ of other and unspecified digestive organs

113

915

1.26

1.50

2.8

2.2

368.27

370.02

nmol/l

0.03

106

835

Pregnancy examination and test

755

4322

1.09

1.49

2.0

389.89

391.89

nmol/l

0.09

695

3978

Lesion of sciatic nerve

132

1087

1.23

1.48

2.1

405.12

385.36

nmol/l

0.39

121

979

Benign neoplasm of ovary

673

6191

1.10

1.48

2.0

2.1

395.09

378.07

nmol/l

1.01

627

5644

Disorders of acoustic nerve

756

1.28

1.47

2.7

2.2

374.21

375.26

nmol/l

0.02

698

Varus deformity, not elsewhere classified

296

1.46

3.4

2.2

388.78

371.73

nmol/l

0.24

274

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

139

1154

1.23

1.46

2.6

2.1

384.82

369.10

nmol/l

0.45

125

1072

Maternal care for cervical incompetence

155

1301

1.21

1.46

2.3

2.0

391.79

379.02

nmol/l

0.27

146

1179

Bilateral sagittal split ramus osteotomy operation

130

1073

1.23

1.45

2.0

364.72

369.91

nmol/l

0.10

117

997

Other obstetric trauma

166

1959

0.84

1.45

2.1

2.0

397.41

377.57

nmol/l

0.82

153

1808

Macular hole

194

1660

1.19

1.45

2.2

379.40

370.84

nmol/l

0.23

172

1503

Rheumatic fever with heart involvement

119

1.77

1.45

1.8

2.1

332.75

350.18

nmol/l

0.21

106

Other spirochaetal diseases

1070

11415

0.93

1.44

2.2

373.98

372.35

nmol/l

0.10

985

10492

All dysplastic lesions of the cervix uteri, vagina or vulva

1310

12169

1.07

1.44

2.0

2.1

381.78

374.61

nmol/l

0.68

1216

11230

Left hemicolectomy

608

1.31

1.43

2.9

2.0

400.82

373.10

nmol/l

0.55

552

Benign neoplasm of thyroid gland

122

1005

1.24

1.40

2.8

2.0

352.56

374.90

nmol/l

0.59

106

920

Complications of labour and delivery

2745

15897

0.96

1.40

2.2

2.1

375.95

381.24

nmol/l

0.68

2558

14594

Mechanical strabismus

2.11

1.40

2.8

2.1

382.17

353.64

nmol/l

0.18

Use of interferon beta-1a

741

0.74

1.39

1.9

2.1

313.06

372.13

nmol/l

1.70

692

Glaucoma, exfoliation

340

3030

1.13

1.39

1.9

2.1

381.34

381.00

nmol/l

0.01

293

2697

Wilms' tumor, including Hilmo

160

1.63

1.39

3.1

2.0

362.68

357.24

nmol/l

0.06

140

Lumbosacral plexus disorders

1.92

1.38

2.0

2.2

354.07

354.21

nmol/l

0.00

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

701

1.28

1.38

2.4

2.0

359.27

370.58

nmol/l

0.21

641

Postdysenteric arthropathy

267

1.47

1.37

2.2

2.1

334.82

384.41

nmol/l

0.92

246

Unspecified abortion

195

1679

1.18

1.37

2.4

2.2

348.96

369.23

nmol/l

0.87

181

1550

Hereditary corneal dystrophies

116

954

1.24

1.36

2.8

2.1

392.39

375.58

nmol/l

0.35

105

871

LSIL lesion of the cervix uteri

476

4331

1.11

1.36

2.0

2.1

383.04

377.11

nmol/l

0.25

450

3991

Effects of other deprivation

2.02

1.36

4.7

2.2

394.23

361.94

nmol/l

0.27

Other specified and unspecified disorders of iris and ciliary body

114

1.76

1.36

1.6

2.2

448.63

365.63

nmol/l

1.08

104

Disorders of globe

675

1.28

1.36

2.1

2.0

360.03

378.67

nmol/l

0.43

610

Benign neoplasm: Choroid

214

1857

1.17

1.35

2.5

2.2

343.04

370.75

nmol/l

1.51

191

1692

Other obstructed labour

307

2731

1.14

1.34

2.3

2.1

382.60

375.95

nmol/l

0.30

288

2504

Congenital malformations of cardiac septa

274

2344

1.15

1.33

2.9

2.3

347.40

360.11

nmol/l

0.42

258

2188

Foreign body entering into or through eye or natural orifice

287

2543

1.14

1.33

2.7

2.2

358.30

371.82

nmol/l

0.69

273

2357

Melanocytic naevi of other and unspecified parts of face

215

1870

1.16

1.32

2.3

2.1

378.87

378.12

nmol/l

0.02

199

1715

Other disorders of breast and lactation associated with childbirth

582

1.30

1.31

1.7

1.9

402.28

380.97

nmol/l

0.53

538

Lower leg

187

1.56

1.31

1.7

1.9

402.52

363.63

nmol/l

0.60

174

Neuromyelitis optica

1.92

1.29

1.9

2.0

259.64

355.06

nmol/l

1.07

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

227

1987

1.16

1.28

2.7

2.2

347.73

370.16

nmol/l

1.10

211

1831

Serous carcinoma of ovary

201

0.53

1.28

1.4

1.7

770.45

379.38

nmol/l

1.14

186

Carcinoma in situ of oral cavity and pharynx

2.36

1.28

2.5

2.1

398.75

346.71

nmol/l

—

Other disorders of amniotic fluid and membranes

598

5385

1.09

1.27

2.0

353.82

379.62

nmol/l

3.13

557

4954

Operations 1 for CAVS

1.84

1.26

1.8

2.5

411.56

327.59

nmol/l

1.02

LeFortI or BSSO operation

156

1330

1.19

1.26

1.9

2.1

370.30

372.17

nmol/l

0.04

142

1242

Benign neoplasm: Peripheral nerves and autonomic nervous system

444

1.34

1.26

2.6

1.8

355.36

378.00

nmol/l

0.37

412

Intrahepatic Cholestasis of Pregnancy (ICP)

289

2576

1.13

1.25

1.9

2.1

370.17

374.14

nmol/l

0.14

269

2379

Medullary cystic kidney disease, nephronophthisis

2.20

1.25

2.1

2.2

289.20

360.66

nmol/l

—

Other disorders of skin and subcutaneous tissue related to radiation

2.20

1.24

1.7

1.8

374.90

346.98

nmol/l

—

Other specified/unspecified disorders of middle ear and mastoid

2.01

1.24

3.2

1.8

294.75

362.54

nmol/l

0.44

Obstructed labour due to maternal pelvic abnormality

509

5539

0.91

1.23

2.0

2.2

378.54

369.66

nmol/l

0.36

480

5091

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

368

1.37

1.22

2.1

2.0

377.77

382.31

nmol/l

0.06

337

Helminthiases

151

1288

1.19

1.22

2.2

2.1

364.70

371.50

nmol/l

0.17

141

1197

Chromomycosis and phaeomycotic abscess

2.26

1.22

3.7

1.6

377.25

385.90

nmol/l

—

Benign neoplasm: Other parts of oropharynx

257

1.45

1.22

2.3

1.8

384.31

371.09

nmol/l

0.16

236

Respiratory tuberculosis, clinically confirmed

273

1.42

1.21

2.2

2.0

375.84

372.52

nmol/l

0.03

244

Other lesions of median nerve

749

1.25

1.21

1.6

2.0

364.70

390.30

nmol/l

0.63

674

Benign neoplasm: Lip

579

1.29

1.21

2.9

1.9

361.44

375.72

nmol/l

0.24

533

Other diseases caused by chlamydiae

491

1.32

1.21

2.4

2.0

356.10

381.43

nmol/l

0.41

458

Benign neoplasm: Short bones of upper limb

438

1.33

1.21

2.8

2.1

335.10

366.80

nmol/l

0.66

409

Other sexually transmitted chlamydial diseases

254

2250

1.14

1.21

1.8

2.0

398.64

380.46

nmol/l

0.71

223

2072

Hereditary motor and sensory neuropathy

232

1.47

1.21

2.8

1.9

338.33

361.29

nmol/l

0.27

217

Carcinoma in situ of skin of lower limb, including hip

562

1.29

1.21

3.3

1.8

366.61

383.71

nmol/l

0.23

496

Other nonautoimmune haemolytic anaemias

2.07

1.20

2.6

1.8

358.36

371.46

nmol/l

0.10

Hypertensive encephalopathy

103

1.74

1.19

1.4

2.0

443.94

386.54

nmol/l

0.76

Disease of thymus, other/unspecified

2.15

1.19

1.2

1.8

373.90

414.56

nmol/l

—

Kidney diseases associated to Fabry's disease

2.14

1.16

2.9

2.3

268.00

374.63

nmol/l

—

Congenital deformities of feet

790

1.24

1.16

2.5

2.0

333.12

367.08

nmol/l

0.98

733

Benign neoplasm: Conjunctiva

114

954

1.21

1.16

2.6

2.2

360.56

372.67

nmol/l

0.25

103

877

Pedestrian injured in collision with car, pick-up truck or van

710

1.25

1.14

1.9

422.32

374.54

nmol/l

0.66

649

Exposure to uncontrolled fire, not in building or structure

2.00

1.13

1.5

1.8

338.09

381.73

nmol/l

0.45

HSIL lesion of the vagina

417

1.33

1.13

2.3

2.1

360.82

372.24

nmol/l

0.16

392

Down's syndrome

121

1.66

1.13

3.4

2.5

346.37

350.57

nmol/l

0.04

110

Osteosarcoma, including Hilmo

1.73

1.12

3.2

2.4

328.31

356.96

nmol/l

0.33

Failed induction of labour

251

2237

1.13

1.12

1.6

1.9

387.10

381.30

nmol/l

0.18

231

2057

Contact with nonpowered hand tool

145

1244

1.18

1.11

2.3

2.2

376.64

371.12

nmol/l

0.10

135

1162

Enteritis due to Yersinia enterocolitica

137

1.60

1.11

2.9

2.2

399.95

394.62

nmol/l

0.04

124

Septal defects

256

2237

1.13

1.11

2.8

2.4

352.29

357.27

nmol/l

0.13

240

2088

Sphingolipidosis, other/unspecified

2.09

1.09

2.7

2.2

266.89

417.52

nmol/l

—

Motorcycle rider injured in noncollision transport accidents

107

897

1.21

1.08

1.8

2.1

437.27

377.75

nmol/l

0.42

101

840

Other osteochondropathies

248

2213

1.13

1.08

2.7

2.1

352.31

372.25

nmol/l

0.74

232

2045

Persistent hyperplasia of thymus

2.54

1.08

3.0

1.3

309.00

336.41

nmol/l

—

Foreign body on external eye

511

4723

1.09

1.08

2.3

355.78

366.37

nmol/l

0.76

479

4381

Orthopaedic devices associated with adverse incidents

510

1.28

1.06

2.0

2.1

346.58

368.81

nmol/l

0.51

464

Disorders of sexual preference

2.01

1.06

2.6

1.8

341.00

359.09

nmol/l

—

Other benign neoplasm of uterus: Other parts/unspecified

139

1195

1.18

1.06

1.8

2.0

420.04

389.47

nmol/l

0.99

126

1070

Meretoja disease

1.74

1.06

2.7

2.3

351.87

357.74

nmol/l

0.04

Macrocephaly

2.03

1.05

1.7

2.5

381.89

330.46

nmol/l

—

Crushing injury of ankle and foot

1.70

1.05

1.6

2.0

344.09

370.45

nmol/l

0.26

Use of amantadine

484

1.29

1.05

2.4

1.8

352.67

377.90

nmol/l

0.47

441

Hip and thigh

1.82

1.05

2.3

1.8

310.08

378.00

nmol/l

0.42

Systemic atrophies primarily affecting the central nervous system

136

1168

1.18

1.05

2.0

2.2

380.66

365.67

nmol/l

0.43

120

1077

Sequelae of poisoning by drugs, medicaments and biological substances

1.98

1.04

1.6

2.0

420.22

428.26

nmol/l

—

Other congenital malformations of upper alimentary tract

206

1.46

1.04

2.9

2.1

325.23

363.88

nmol/l

0.54

195

Pedestrian injured in transport accident

238

2125

1.13

1.04

2.0

2.1

396.71

375.73

nmol/l

0.54

219

1943

Legal intervention and operations of war

2.09

1.02

2.6

1.7

376.14

419.90

nmol/l

—

Diaper [napkin] dermatitis

1.94

1.02

3.6

2.6

285.67

359.29

nmol/l

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

2.10

1.02

1.4

1.9

257.29

366.33

nmol/l

—

Benign neoplasm: Skin of scalp and neck

730

1.23

1.02

2.3

2.0

365.20

372.22

nmol/l

0.13

675

L02BX Other hormone antagonists and related agents

152

1320

1.16

1.02

2.5

2.4

373.21

373.65

nmol/l

0.01

146

1202

Benign neoplasm: Bladder

232

1.42

1.01

2.5

2.0

375.48

381.90

nmol/l

0.06

212

Other and unspecified neuropathies

100

1.67

1.01

3.4

2.2

286.75

363.42

nmol/l

0.95

Acquired atrophy of ovary and fallopian tube

1.83

1.01

1.2

2.1

326.00

333.75

nmol/l

0.05

Toxic effect of other gases, fumes and vapours

157

1.52

1.01

2.3

2.1

300.04

390.90

nmol/l

1.82

146

ILD medications: nintedanib

116

1.61

1.01

2.1

2.3

331.78

389.01

nmol/l

0.70

110

Cardiomyopathy due to drugs and other external agents

1.91

1.00

3.3

2.2

414.27

348.72

nmol/l

0.68

Maternal care for other known or suspected fetal problems

1110

6674

1.06

1.00

1.9

2.0

387.58

384.75

nmol/l

0.19

1017

6148

Benign neoplasm: Long bones of lower limb

116

989

1.19

0.99

2.0

2.1

345.81

372.07

nmol/l

0.89

106

921

Ulcer of oesophagus, drug-induced

125

1.58

0.99

2.3

2.0

317.21

386.94

nmol/l

0.85

109

Relapsing polychondritis

1.79

0.98

3.5

2.1

286.31

358.76

nmol/l

0.66

Malignant neoplasm of breast, ER-positive, including Hilmo

1174

9502

0.95

0.98

2.2

1.8

384.23

366.60

nmol/l

2.05

1073

8623

Inhalation and ingestion of other objects causing obstruction of respiratory tract

175

1.48

0.98

2.6

1.9

360.24

378.67

nmol/l

0.21

161

Cyclic neutropenia

1.95

0.97

1.8

2.0

328.00

385.53

nmol/l

—

Primary angle-closure glaucoma

139

1204

1.17

0.97

2.1

2.0

363.65

377.09

nmol/l

0.34

124

1088

Malignant neoplasm of other and unspecified urinary organs

1.81

0.97

6.0

1.7

500.50

361.52

nmol/l

1.08

Toxic encephalopathy

1.83

0.96

1.3

1.7

314.22

377.22

nmol/l

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

1.83

0.96

1.2

1.5

430.44

411.57

nmol/l

—

Acute hepatitis A

118

1.59

0.96

2.9

1.9

312.83

390.86

nmol/l

1.20

109

Other superficial injuries of ankle and foot

193

1.45

0.95

2.3

2.2

361.74

371.96

nmol/l

0.10

179

Laparoscopic right hemicolectomy

187

1658

1.14

0.95

2.9

2.1

393.75

372.41

nmol/l

0.78

178

1505

Tuberculosis

176

1554

1.14

0.93

2.1

377.49

376.99

nmol/l

0.01

155

1392

228

1.40

0.93

2.4

2.0

378.83

356.17

nmol/l

0.20

207

Benign lipomatous neoplasm of of intra-abdominal organs

1.67

0.93

3.1

2.0

294.60

378.12

nmol/l

0.80

Malignant neoplasm of breast, HER-positive

1150

9396

0.95

0.92

2.2

1.8

383.73

366.64

nmol/l

1.90

1049

8527

Ectropion of eyelid

113

968

1.18

0.92

2.7

2.0

407.52

379.06

nmol/l

0.67

102

866

Placenta praevia

147

1675

0.87

0.91

1.9

2.1

364.52

371.93

nmol/l

0.20

136

1548

Malignant neoplasm of peripheral nerves and autonomic nervous system

2.15

0.91

1.7

2.1

407.00

396.92

nmol/l

—

LSIL lesion of the vagina

477

1.26

0.90

2.4

2.1

393.98

370.65

nmol/l

0.45

443

Congenital lactase deficiency

1.81

0.90

2.6

386.18

379.24

nmol/l

0.04

Carcinoma in situ of breast, lobular

216

0.63

0.90

2.3

2.0

325.21

363.97

nmol/l

0.31

206

Blood alcohol or alcohol intoxication level

695

1.21

0.89

1.9

2.1

374.32

374.89

nmol/l

0.01

647

Calcium deposit in bursa

1.91

0.89

1.6

1.4

459.00

369.89

nmol/l

—

conjunctival degenerations and deposits

614

1.23

0.89

2.0

361.03

373.25

nmol/l

0.22

564

Neurofibromatosis, type 2

1.83

0.88

2.5

1.9

344.73

386.03

nmol/l

0.40

Alzheimer’s disease (Early onset)

1106

0.84

0.88

1.6

1.9

415.24

385.79

nmol/l

0.65

979

Cardiomyopathies, Secondary/extrinsic

162

1.46

0.88

2.6

2.3

425.61

372.86

nmol/l

1.00

153

Pedestrian injured in collision with two- or three-wheeled motor vehicle

115

0.50

0.87

2.3

1.9

537.50

375.88

nmol/l

—

103

Retinoschisis and retinal cysts

625

1.22

0.86

2.5

2.1

411.94

374.13

nmol/l

0.82

569

Alzheimer disease, including avohilmo

1190

8009

1.05

0.86

1.7

2.1

398.69

385.22

nmol/l

1.38

1024

7202

Malignant neoplasm of thymus, including Hilmo

105

1.58

0.85

5.1

1.7

324.25

368.52

nmol/l

0.55

Toxic effect of ethanol

137

1200

1.15

0.85

2.1

371.15

378.38

nmol/l

0.13

125

1114

Glanders and melioidosis

0.00

0.84

0.0

2.0

—

336.33

—

Pregnancy, childbirth and the puerperium

1263

6887

0.95

0.84

1.9

2.0

385.72

400.29

nmol/l

1.57

1151

6188

Contact with machinery

343

3161

1.09

0.84

2.3

349.38

366.21

nmol/l

0.97

319

2926

Injury of nerves at hip and thigh level

114

1.56

0.84

2.8

2.0

333.06

356.81

nmol/l

0.18

106

Noninfective disorders of pinna

1.82

0.84

2.2

2.5

362.00

365.02

nmol/l

—

Mumps

756

1.19

0.84

2.2

2.1

339.09

363.95

nmol/l

0.68

704

Mandibular retrognathia AND surgery (BSSO)

803

1.19

0.83

1.9

2.0

364.14

372.78

nmol/l

0.15

750

Carcinoma in situ of lip, oral cavity and pharynx

1.76

0.83

2.1

2.5

334.00

330.77

nmol/l

0.02

Labyrinthine fistula

0.50

0.83

1.8

480.40

340.95

nmol/l

—

Personal history of malignant neoplasm

235

2132

1.11

0.82

2.5

2.2

395.54

379.03

nmol/l

0.65

222

1955

Benign lipomatous neoplasm of spermatic cord

1.93

0.82

1.3

1.6

313.50

384.41

nmol/l

—

Malignant neoplasm of bone and articular cartilage of limbs

123

1.52

0.82

4.6

2.1

335.00

352.08

nmol/l

0.16

114

Disorder of bilirubin metabolism, other/unspecified

1.91

0.81

4.2

1.9

390.17

369.32

nmol/l

—

Other haemoglobinopathies

1.81

0.80

3.9

2.1

226.60

385.70

nmol/l

—

Effects of air pressure and water pressure

149

1.46

0.79

1.8

2.0

309.05

371.68

nmol/l

0.77

141

Corneal degeneration

458

1.25

0.79

2.3

2.0

318.95

380.48

nmol/l

1.64

416

Crushed, pushed or stepped on by crowd or human stampede

274

2510

1.10

0.79

2.2

2.1

378.70

373.84

nmol/l

0.16

253

2329

Perioral dermatitis, drug-induced

2.02

0.79

2.7

2.1

209.14

364.67

nmol/l

—

Undescended testis, unilateral

271

1.33

0.78

2.2

2.5

313.17

334.36

nmol/l

0.33

256

Schistosomiasis [bilharziasis]

2.00

0.78

1.7

366.86

350.50

nmol/l

—

Acute disseminated encephalitis/encephalomyelitis

1.74

0.77

3.8

2.0

228.33

380.08

nmol/l

—

Carcinoma in situ of skin of ear and external auricular canal

324

1.29

0.77

2.3

2.0

345.37

377.37

nmol/l

0.55

289

Cyst of spleen

1.73

0.77

2.3

2.0

337.91

395.21

nmol/l

0.46

Other diseases caused by chlamydiae

370

1.27

0.77

2.6

2.0

354.49

374.68

nmol/l

0.28

345

Foreign body in ear

588

1.21

0.77

2.2

2.1

360.42

381.63

nmol/l

0.32

544

Acute poliomyelitis

388

1.26

0.77

2.7

1.9

377.50

387.25

nmol/l

0.12

355

Other fusion of spine

1.95

0.76

2.9

1.5

343.71

400.91

nmol/l

—

Postpartum hemorraghe, parous women as controls

1073

8750

1.05

0.76

2.0

376.23

372.21

nmol/l

0.32

1018

8123

Respiratory tuberculosis

151

1343

1.13

0.76

2.1

365.11

374.34

nmol/l

0.26

133

1204

Respiratory tuberculosis, confirmed and not-confirmed

151

1343

1.13

0.76

2.1

365.11

374.34

nmol/l

0.26

133

1204

Hypospadias

117

1.51

0.76

2.2

2.1

365.00

336.37

nmol/l

0.30

110

Other congenital malformations of peripheral vascular system

425

1.25

0.75

2.4

2.0

379.20

377.57

nmol/l

0.02

398

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.70

0.75

1.5

2.5

325.55

387.17

nmol/l

0.55

Malignant neoplasm of breast, including Hilmo

1782

11162

1.04

0.73

2.3

1.8

384.68

365.48

nmol/l

3.45

1650

10157

Chronic suppurative otitis media

231

2111

1.10

0.72

2.2

372.42

370.13

nmol/l

0.06

211

1932

Left side

110

1.51

0.72

1.7

2.1

328.81

363.78

nmol/l

0.31

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

1.64

0.71

3.9

2.5

332.58

332.75

nmol/l

0.00

Other and unspecified firearm discharge, undetermined intent

1.74

0.71

3.6

1.6

287.43

383.03

nmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1780

11162

1.04

0.70

2.3

1.8

384.29

365.48

nmol/l

3.34

1648

10157

Sequelae of injuries involving multiple and unspecified body regions

1.72

0.70

1.6

2.0

409.14

398.97

nmol/l

—

Use of rasagiline

687

1.18

0.70

1.6

2.1

385.97

369.65

nmol/l

0.29

631

Labour and delivery complicated by umbilical cord complications

191

1736

1.11

0.69

1.9

2.1

368.41

370.90

nmol/l

0.07

173

1604

Carcinoma in situ of prostate

154

1.41

0.68

2.3

2.1

461.76

364.86

nmol/l

0.84

140

Carcinoma in situ of breast, intraductal

259

2806

0.92

0.68

2.4

2.2

382.78

374.07

nmol/l

0.30

231

2577

Inflammatory myopathy

1.67

0.68

3.7

1.8

274.57

402.14

nmol/l

—

Other abnormal products of conception

1456

9312

1.04

0.68

2.0

372.90

377.52

nmol/l

0.38

1366

8617

Vascular dementia (sudden onset)

1.65

0.66

2.8

1.4

430.20

410.40

nmol/l

—

Severe mental retardation

1.54

0.66

2.0

2.6

357.86

320.13

nmol/l

0.29

Benign neoplasm: Floor of mouth

104

1.50

0.66

3.8

1.9

387.20

350.86

nmol/l

0.48

Sequelae of tuberculosis

377

1.23

0.65

2.0

1.8

368.50

388.51

nmol/l

0.25

329

206

2251

0.91

0.65

1.8

2.3

446.83

368.66

nmol/l

2.47

194

2067

Benign neoplasm: Short bones of lower limb

288

1.28

0.65

2.9

2.0

320.50

377.26

nmol/l

1.70

267

Butylpyrazolidines

0.00

0.64

0.0

2.1

—

432.95

—

Other and unspecified disorders of psychological development

400

1.23

0.63

2.5

324.31

347.33

nmol/l

0.33

382

Pedal cyclist injured in noncollision transport accidents

415

3908

1.07

0.63

2.2

381.51

370.95

nmol/l

0.59

389

3601

Atrial septal defect, secundum type

113

1002

1.14

0.62

3.4

2.6

341.05

349.63

nmol/l

0.14

104

944

Injury of urinary and pelvic organs

555

1.19

0.62

1.8

2.0

323.17

374.43

nmol/l

1.46

515

Drug-induced myopathy

1.59

0.62

3.4

2.2

404.00

362.93

nmol/l

0.24

Tick-borne viral encephalitis

140

1.41

0.62

2.2

1.9

283.53

366.87

nmol/l

1.64

129

Burn and corrosion of respiratory tract

1.88

0.61

2.2

1.8

378.33

444.83

nmol/l

—

Muscle wasting and atrophy, not elsewhere classified

131

1.41

0.61

1.4

1.8

364.56

411.50

nmol/l

0.69

122

Other and unspecified heterotropia

1.54

0.60

1.8

324.92

362.47

nmol/l

0.35

Rickettsioses

1.58

0.60

2.5

369.18

367.08

nmol/l

0.02

Carcinoma in situ of oral cavity

1.53

0.59

2.4

1.9

400.50

336.91

nmol/l

—

Other sexually transmitted chlamydial diseases

384

3616

1.07

0.59

1.8

1.9

406.25

388.14

nmol/l

0.88

333

3333

Bus occupant injured in other and unspecified transport accidents

176

1.34

0.59

1.7

1.8

370.47

378.97

nmol/l

0.07

166

Tick-borne viral encephalitis

159

1.36

0.58

2.0

1.8

300.43

371.90

nmol/l

1.26

146

Sleepwalking [somnambulism]

1.50

0.58

1.3

2.1

369.38

400.46

nmol/l

0.34

Right side

159

1.36

0.58

2.6

2.0

381.57

388.61

nmol/l

0.07

149

Carcinoma in situ of rectum

293

1.25

0.58

3.2

1.9

397.53

375.57

nmol/l

0.33

271

Abnormalities of forces of labour

368

3906

0.94

0.58

2.3

2.1

352.49

371.62

nmol/l

1.26

350

3608

Use of galantamine

222

2052

1.09

0.58

2.0

401.67

389.07

nmol/l

0.43

188

1824

Colorectal neuroendocrine tumor and carcinoma

366

1.22

0.57

2.3

2.0

325.39

375.20

nmol/l

1.14

334

Hereditary factor VIII deficiency

1.53

0.57

3.2

2.1

322.92

364.93

nmol/l

0.33

Oesophagitis, drug-induced

1.56

0.57

1.8

2.4

408.44

358.00

nmol/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

151

1.36

0.56

2.3

2.2

277.80

370.86

nmol/l

1.25

139

Haemorrhagic and haematological disorders of fetus and newborn

761

1.15

0.56

3.5

2.9

322.99

335.82

nmol/l

0.28

734

Hereditary ataxia

358

1.22

0.56

2.5

2.1

358.16

380.12

nmol/l

0.36

328

Chondromalacia

834

1.14

0.56

2.1

350.18

372.31

nmol/l

0.53

765

MS-disease / Multiple Sclerosis

271

2531

1.08

0.55

2.0

2.1

350.48

372.93

nmol/l

1.26

246

2344

Other mosquito-borne viral fevers

1.59

0.55

1.6

2.2

274.20

383.75

nmol/l

—

Malignant neoplasm of penis

1.53

0.55

2.7

1.5

381.64

373.17

nmol/l

0.04

Use of rivastigmine

443

4188

1.06

0.55

1.6

2.0

402.48

386.73

nmol/l

0.98

383

3712

Shigellosis

100

1.45

0.54

1.5

1.8

338.36

378.03

nmol/l

0.33

Embolism and thrombosis of abdominal aorta

1.59

0.54

2.8

1.7

376.00

419.36

nmol/l

—

Other and unspecified disease of Bartholin gland

874

1.13

0.54

1.7

2.1

404.77

374.34

nmol/l

0.81

788

Inguinal of femoral hernia, unilateral

732

1.15

0.54

3.0

2.1

370.32

375.04

nmol/l

0.07

666

Inguinal hernia, unilateral

732

1.15

0.54

3.0

2.1

370.32

375.04

nmol/l

0.07

666

Femoral hernia, unilateral

732

1.15

0.54

3.0

2.1

370.32

375.04

nmol/l

0.07

666

Toxic effect of contact with venomous animals

141

1283

1.11

0.54

2.3

2.1

389.20

376.94

nmol/l

0.34

133

1187

Fetus and newborn affected by maternal complications of pregnancy

291

0.77

0.54

3.0

2.9

295.74

348.99

nmol/l

0.83

278

Congenital ovarian cysts

167

1533

1.10

0.53

2.0

380.26

381.25

nmol/l

0.02

156

1421

Coarctation of the aorta

367

0.80

0.52

3.2

2.5

371.13

352.12

nmol/l

0.26

346

Benign neoplasm: Cranial nerves

830

1.13

0.52

2.8

2.1

362.82

375.28

nmol/l

0.22

766

Atrial septal defect

145

1317

1.10

0.51

3.1

2.4

334.44

354.19

nmol/l

0.48

135

1240

Generalized epilepsy, strict definition

699

1.14

0.50

1.7

2.1

407.00

369.67

nmol/l

0.75

659

Sequelae of poliomyelitis

208

1.27

0.50

2.7

1.9

372.19

362.13

nmol/l

0.09

192

HSIL lesion of the cervix uteri, vagina or vulva

837

8080

1.04

0.50

2.0

384.32

375.55

nmol/l

0.66

770

7454

Melanocytic naevi of scalp and neck

700

1.14

0.50

2.5

1.9

351.42

381.63

nmol/l

0.72

650

Benign neoplasm: Connective and other soft tissue of abdomen

1.47

0.49

1.2

2.2

342.42

359.43

nmol/l

0.10

Macular cyst

776

1.13

0.49

2.5

2.1

380.23

369.64

nmol/l

0.16

698

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

153

1663

0.91

0.49

1.9

2.2

368.20

370.74

nmol/l

0.06

146

1531

Congenital malformations of ear causing impairment of hearing

117

0.66

0.48

1.4

2.6

447.88

357.85

nmol/l

—

107

Lens-induced iridocyclitis

1.48

0.48

5.3

1.9

408.14

403.09

nmol/l

—

Malignant neoplasm of breast

1724

10973

1.03

0.47

2.3

1.8

384.21

365.33

nmol/l

3.22

1594

9983

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

1.47

0.47

2.0

1.7

308.71

375.48

nmol/l

—

Benign neoplasm: other/unspecified salivary gland

722

1.13

0.47

2.2

2.1

355.45

375.37

nmol/l

0.34

658

Pityriasis lichenoides chronica

112

1.38

0.47

2.0

2.2

316.87

374.27

nmol/l

0.49

102

Scissor bite

110

989

1.11

0.46

2.3

344.59

372.78

nmol/l

0.96

932

Congenital malformation syndromes predominantly affecting facial appearance

1.42

0.46

1.5

2.7

224.77

348.80

nmol/l

2.56

Use of selegiline

131

1200

1.10

0.46

1.7

2.2

376.99

369.36

nmol/l

0.18

112

1080

Chondrosarcoma, including Hilmo

122

1.34

0.44

2.5

1.6

300.25

380.82

nmol/l

1.30

110

Disorders of ornithine metabolism

0.00

0.44

0.0

3.7

—

282.14

—

Taeniasis

0.00

0.44

0.0

1.9

—

374.07

—

Intentional self-harm by drowning and submersion

1.45

0.44

1.3

1.7

476.38

378.88

nmol/l

—

Malignant neoplasm of other and unspecified male genital organs

0.00

0.42

0.0

1.6

—

350.33

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.41

0.42

1.6

2.8

321.42

390.43

nmol/l

0.74

Carcinoma in situ of cervix uteri

369

3521

1.05

0.41

1.9

2.0

391.80

378.48

nmol/l

0.61

343

3236

Duodenal ulcer - Acute with haemorrhage, drug-induced

1.50

0.41

1.4

1.6

308.20

422.32

nmol/l

—

Toxic effect of alcohol

588

1.13

0.41

2.4

2.1

382.44

364.99

nmol/l

0.25

544

Congenital malformations of pulmonary and tricuspid valves

298

1.20

0.41

3.5

2.8

357.70

346.49

nmol/l

0.13

284

Carcinoma in situ of oesophagus

1.48

0.41

1.8

308.80

338.97

nmol/l

—

Use of ropinirole

110

1008

1.10

0.40

2.1

2.3

380.45

370.27

nmol/l

0.18

100

920

Rheumatic fever incl heart disease

788

1.11

0.40

1.7

1.9

345.43

373.41

nmol/l

0.84

716

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.40

0.40

3.0

1.8

401.33

384.00

nmol/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

149

1385

1.08

0.40

2.0

2.2

360.94

367.52

nmol/l

0.17

131

1277

Malignant neoplasm of ovary, including Hilmo

203

1908

1.07

0.39

3.2

1.8

454.54

369.36

nmol/l

4.32

193

1711

Keratoconus

694

1.12

0.39

2.4

2.1

354.18

365.95

nmol/l

0.19

653

Deep bite that required surgery

373

1.17

0.39

1.8

2.1

385.14

372.38

nmol/l

0.11

351

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

152

1.28

0.38

1.8

456.00

378.19

nmol/l

1.25

139

Drowning and submersion while in natural water

111

0.71

0.38

4.0

2.2

340.38

401.99

nmol/l

—

101

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

161

1.27

0.38

1.8

2.0

387.95

375.74

nmol/l

0.11

145

Bicuspidal aortic valve syndrome

1080

0.91

0.38

2.3

367.15

360.29

nmol/l

0.14

1009

Brain mixed glioma

1.49

0.37

1.2

1.9

488.33

434.43

nmol/l

—

Glaucoma secondary to eye inflammation

217

1.22

0.37

3.5

1.8

312.92

363.49

nmol/l

0.77

200

Caught, crushed, jammed or pinched in or between objects

168

1575

1.07

0.36

2.3

2.2

350.35

371.47

nmol/l

0.74

154

1474

378

3627

1.05

0.36

1.8

2.0

376.42

382.36

nmol/l

0.27

344

3352

Ventricular septal defect, a heart condition

794

1.10

0.35

3.5

2.5

383.25

354.48

nmol/l

0.47

750

Eclampsia

0.66

0.35

2.0

1.8

318.67

388.29

nmol/l

—

Unspecified hairloss

1.35

0.34

1.3

2.0

407.33

370.05

nmol/l

—

Medical treatment for female infertility

898

8699

1.03

0.34

2.2

2.0

369.91

376.40

nmol/l

0.43

853

8048

Idiopathic progressive neuropathy

1.34

0.34

2.5

1.7

389.33

358.27

nmol/l

—

Malignant neoplasm of breast, HER2-negative

1689

10842

1.02

0.34

2.3

1.8

383.62

365.41

nmol/l

2.97

1559

9857

Airway disease due to specific organic dust

1.37

0.34

1.7

325.55

353.27

nmol/l

0.18

Malignant neoplasm of rectum

252

2399

1.05

0.33

1.9

1.8

405.67

368.02

nmol/l

2.41

231

2159

Erectile dysfunction

211

2000

1.06

0.33

2.2

2.4

360.59

367.39

nmol/l

0.20

197

1840

Congenital obstruction of the pelviureteric junction

239

1.19

0.32

2.2

1.9

420.29

381.30

nmol/l

0.32

220

Assault by other and unspecified firearm discharge

1.31

0.31

1.0

2.5

318.29

403.56

nmol/l

—

Fibrosarcoma, including Hilmo

207

0.81

0.31

2.5

1.8

356.88

381.20

nmol/l

0.17

188

Enterobiasis

708

1.10

0.30

1.7

2.1

375.26

375.22

nmol/l

0.00

665

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

795

1.09

0.29

3.7

1.8

420.38

362.62

nmol/l

1.67

711

Rickettsioses

1.33

0.29

3.0

2.0

370.63

370.11

nmol/l

—

Benign neoplasm: Vertebral column

1.35

0.29

1.8

2.1

365.70

389.41

nmol/l

—

Toxoplasmosis

158

1.22

0.29

4.7

1.9

349.89

385.75

nmol/l

0.39

142

Adhesive middle ear disease

469

1.12

0.29

2.0

1.8

372.72

381.51

nmol/l

0.11

428

Malignant neoplasm of ovary

147

1388

1.06

0.28

3.0

1.8

481.71

368.59

nmol/l

4.80

139

1239

Open wounds involving multiple body regions

119

0.74

0.28

1.1

2.0

321.44

412.75

nmol/l

—

111

Aortic stenosis

1.25

0.28

2.8

476.62

341.50

nmol/l

—

Postpartum haemorrhage due to anatomy

376

3890

0.96

0.28

2.0

1.9

389.45

378.93

nmol/l

0.54

354

3612

Other endophthalmitis

150

1.22

0.27

1.4

1.9

411.72

361.68

nmol/l

0.92

133

Malignant neoplasm of lip

159

1.21

0.27

3.3

1.6

399.74

359.91

nmol/l

0.75

140

Infections specific to the perinatal period

443

1.12

0.27

2.2

2.7

374.05

350.88

nmol/l

0.34

424

Disorder of visual pathways, unspecified

1.29

0.27

2.4

370.00

372.82

nmol/l

—

Congenital malformations of aortic and mitral valves

136

1284

1.06

0.27

2.6

2.4

359.44

360.66

nmol/l

0.03

124

1201

Benign neoplasm of male genital organs

510

1.11

0.27

1.7

2.3

384.66

365.01

nmol/l

0.35

462

Congenital malformations of cardiac chambers and connections

235

1.17

0.27

3.3

2.8

353.04

337.64

nmol/l

0.15

222

Gonococcal infection

104

974

1.07

0.26

1.9

2.2

378.35

369.31

nmol/l

0.17

901

Benign neoplasm: Skin of upper limb, including shoulder

559

1.10

0.26

2.6

1.9

335.96

381.74

nmol/l

1.22

520

Maternal care for known or suspected malpresentation of fetus

783

5800

0.98

0.26

2.0

393.28

379.86

nmol/l

0.88

728

5345

Other specified transport accidents

170

1.19

0.25

2.1

2.0

394.20

385.20

nmol/l

0.07

157

Accidental poisoning by and exposure to alcohol

512

1.10

0.25

1.8

1.9

377.52

394.71

nmol/l

0.19

464

Complications specific to multiple gestation

133

1.23

0.25

3.3

2.0

447.69

396.48

nmol/l

0.60

124

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.29

0.25

5.6

1.9

333.45

394.55

nmol/l

0.66

Congenital aortic valve stenosis

161

1.20

0.25

2.7

2.6

418.74

361.56

nmol/l

0.43

151

Malignant neoplasm of other and unspecified major salivary glands

0.73

0.25

2.5

1.9

437.00

349.52

nmol/l

—

Pneumoconiosis due to asbestos and other mineral fibres

426

1.11

0.25

2.3

2.1

373.65

373.41

nmol/l

0.00

378

Respiratory tuberculosis, not confirmed

973

0.93

0.25

2.0

2.1

351.27

374.29

nmol/l

0.55

872

Acute appendicitis, with complications

687

6716

1.02

0.24

2.2

2.3

385.22

368.68

nmol/l

0.67

642

6172

Congenital malformations of oesophagus

157

0.81

0.23

1.8

2.4

347.46

379.37

nmol/l

0.24

145

Explosion of other materials

0.74

0.23

1.4

2.2

414.71

390.48

nmol/l

—

All dysplastic lesions of the cervix uteri

1105

10773

1.02

0.23

2.0

381.92

375.94

nmol/l

0.48

1028

9945

Discharge from other and unspecified firearms

0.75

0.23

2.0

1.9

244.43

378.96

nmol/l

—

Antepartum haemorrhage, not elsewhere classified

340

3296

1.03

0.23

1.9

2.0

369.95

376.67

nmol/l

0.18

317

3040

Other transitory neonatal endocrine disorders

0.00

0.23

0.0

4.3

—

242.10

—

Exposure to excessive natural cold

276

1.13

0.23

1.9

2.0

373.04

371.74

nmol/l

0.01

250

Noise effects on inner ear

101

1071

0.94

0.23

2.4

2.2

443.91

363.69

nmol/l

1.39

999

Sequelae of burns, corrosions and frostbite

135

1.20

0.22

1.3

2.1

400.88

379.98

nmol/l

0.21

126

Alzheimer’s disease (Late onset)

663

5457

1.02

0.22

1.7

2.0

411.72

386.46

nmol/l

2.33

555

4883

Hereditary spherocytosis

1.28

0.21

5.1

2.1

441.80

373.53

nmol/l

—

Dissection of aorta

770

1.07

0.21

2.1

2.2

366.96

367.26

nmol/l

0.00

697

Evidence of alcohol involvement determined by level of intoxication

297

1.12

0.21

2.0

1.9

377.08

378.85

nmol/l

0.02

274

Toxic erythema

1.27

0.21

2.5

2.2

327.17

411.21

nmol/l

—

Brucellosis

0.00

0.21

0.0

2.4

—

301.00

—

Intrauterine hypoxia

0.00

0.21

0.0

1.5

—

279.79

—

Endometriosis in cutaneous scar

1.24

0.20

2.9

2.2

373.36

370.82

nmol/l

0.02

Toxic effect of other noxious substances eaten as food

1.24

0.20

1.8

2.2

331.82

376.60

nmol/l

0.36

Otosclerosis

226

2338

0.96

0.20

2.4

2.2

349.59

370.30

nmol/l

0.95

208

2143

Assault by drugs, medicaments and biological substances

1.17

0.20

1.7

2.2

332.50

395.72

nmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

254

2459

1.03

0.19

1.8

410.08

367.67

nmol/l

2.67

236

2206

Gonococcal infection

109

1037

1.06

0.19

1.9

2.2

376.59

371.23

nmol/l

0.10

104

960

Single delivery by caesarean section

843

4756

1.02

0.19

2.0

376.21

388.76

nmol/l

1.05

788

4346

Premature rupture of membranes

914

6642

0.98

0.18

2.0

383.55

383.48

nmol/l

0.00

844

6117

Epidermolysis bullosa

1.15

0.18

1.4

2.2

379.71

346.00

nmol/l

—

Haemophilus septicemia

0.75

0.18

3.8

2.2

1635.20

439.20

nmol/l

—

Other parasitologically confirmed or unspecified malaria

1.21

0.17

3.9

2.7

273.38

374.92

nmol/l

—

Acne varioliformis

1.21

0.17

2.6

1.8

379.63

373.34

nmol/l

—

Fibrosarcoma

173

0.86

0.17

2.7

1.8

326.73

387.12

nmol/l

0.47

159

Traumatic amputation of wrist and hand

111

1159

0.95

0.16

2.2

397.18

367.84

nmol/l

0.75

102

1073

Early syphilis

370

0.91

0.16

2.2

2.0

323.83

373.44

nmol/l

0.78

345

Other infestations

0.78

0.16

3.2

2.3

353.00

408.29

nmol/l

—

Alcoholic cardiomyopathy

130

0.84

0.16

2.1

2.0

426.36

350.97

nmol/l

1.06

116

Eccrine sweat disorders

0.79

0.16

6.3

1.9

355.33

370.68

nmol/l

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.23

0.16

1.3

1.9

342.40

365.78

nmol/l

—

Carcinoma in situ of skin of lip

1.18

0.16

1.1

1.6

471.11

404.31

nmol/l

—

Alzheimer’s disease, strict definition

714

5972

0.98

0.15

1.7

2.1

413.54

385.83

nmol/l

2.90

597

5351

Pterygium

771

1.05

0.15

2.1

362.28

367.75

nmol/l

0.07

709

Postpartum haemorrhage

1073

9141

0.99

0.15

2.0

376.23

379.13

nmol/l

0.21

1018

8435

Reduction defects of upper limb

0.82

0.14

2.1

2.2

411.38

353.87

nmol/l

—

Myocardial infarction, unclassifiable

634

5742

0.98

0.14

2.1

2.2

381.45

378.19

nmol/l

0.12

580

5147

Other congenital malformations of face and neck

929

0.95

0.14

2.8

2.1

357.03

370.65

nmol/l

0.29

867

Adenocarcinoma and papilloma adenocarcinoma of rectum

242

2361

1.03

0.13

1.8

407.81

367.91

nmol/l

2.37

226

2119

Benign neoplasm: Appendix

304

0.92

0.13

3.1

1.9

367.14

380.63

nmol/l

0.17

277

Left ventricular outflow tract obstruction, narrow definition

161

1563

1.03

0.13

2.6

2.4

365.07

360.35

nmol/l

0.10

149

1467

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1993

11603

1.01

0.12

2.1

374.84

377.75

nmol/l

0.26

1860

10685

Certain zoonotic bacterial diseases

865

0.96

0.12

2.4

2.0

360.05

376.61

nmol/l

0.39

799

Pedal cyclist injured in collision with motor vehicle

934

1.04

0.12

1.6

2.0

366.23

372.63

nmol/l

0.12

865

Other operation for atrial fibrillation

124

1.14

0.11

2.4

2.1

346.14

386.39

nmol/l

0.52

112

Contact with other sharp object(s)

227

2221

1.02

0.11

2.0

2.1

384.89

374.26

nmol/l

0.39

211

2061

Supervision of high-risk pregnancy

902

5370

1.01

0.11

2.1

2.0

366.12

384.51

nmol/l

2.35

851

4969

Granulosa cell carcinoma of ovary

115

1.14

0.11

1.8

1.7

371.92

338.26

nmol/l

0.39

107

Infections of breast associated with childbirth

129

1256

1.03

0.10

2.0

373.38

381.19

nmol/l

0.18

119

1158

Retained placenta and membranes, without haemorrhage

446

4519

0.99

0.10

2.3

2.1

356.72

371.94

nmol/l

0.95

419

4154

Discontinuity and dislocation of ear ossicles

155

1.11

0.09

3.6

2.0

378.47

378.87

nmol/l

0.00

144

Acute hepatitis B

126

1.12

0.09

1.7

2.1

366.07

372.66

nmol/l

0.04

114

Poor fetal growth

477

4826

0.99

0.09

2.1

2.0

382.47

380.67

nmol/l

0.08

445

4450

Abscess of mediastinum

0.82

0.08

1.8

1.6

449.80

355.81

nmol/l

—

Multiple congenital exostoses

0.81

0.08

2.4

2.2

336.60

381.64

nmol/l

—

Normal-pressure hydrocephalus

132

1291

1.02

0.08

2.2

2.1

361.93

377.73

nmol/l

0.43

117

1156

Bradycardia, unspecified, drug-induced

0.82

0.08

1.5

1.8

406.33

384.63

nmol/l

—

Mental and behavioural disorders due to use of volatile solvents

1.04

0.07

1.4

1.8

274.50

360.18

nmol/l

—

Twin gestation

339

3350

1.01

0.07

2.3

2.1

366.79

372.55

nmol/l

0.27

327

3086

Choroidal haemorrhage and rupture

0.86

0.07

3.1

1.7

400.38

384.72

nmol/l

—

Benign neoplasm: Scrotum

0.85

0.07

1.3

1.8

390.75

362.22

nmol/l

—

Adenocarcinoma and ductal carcinoma of pancreas

832

0.97

0.07

2.0

1.7

434.44

360.36

nmol/l

2.10

743

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

138

1.09

0.06

2.7

2.0

378.93

360.74

nmol/l

0.12

128

Placental disorders

315

0.95

0.06

2.3

2.0

327.92

381.93

nmol/l

1.28

291

Cholesteatoma of middle ear

150

1475

1.02

0.06

2.1

2.2

386.78

371.28

nmol/l

0.46

131

1347

L02BB Anti-androgens

221

2181

1.01

0.06

2.6

2.3

368.61

372.91

nmol/l

0.10

209

1987

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

100

1.11

0.05

1.7

2.1

335.18

406.15

nmol/l

0.75

Postpartum care and examination

613

3907

0.99

0.05

2.1

2.0

391.53

392.28

nmol/l

0.03

569

3590

Tetralogy of Fallot, a congenital heart defect.

140

0.92

0.04

2.8

332.92

345.50

nmol/l

0.09

132

Carcinoma in situ of vagina

150

0.93

0.04

2.9

1.8

290.93

370.67

nmol/l

0.83

141

Defect, injury or illness of lumbar spine

1.11

0.04

2.4

1.8

350.30

398.64

nmol/l

—

Maternal care for (suspected) damage to fetus from alcohol

109

0.91

0.04

2.1

1.8

416.30

385.43

nmol/l

—

104

Congenital nasolacrimal duct obstruction or stenosis

159

0.94

0.03

1.8

2.6

320.13

375.74

nmol/l

0.58

151

Multiple gestation

350

3478

1.01

0.03

2.3

2.1

367.98

373.21

nmol/l

0.24

338

3205

Postpartum haemorrhage due to retained placenta

458

4557

1.01

0.03

1.9

2.0

377.58

374.05

nmol/l

0.16

432

4240

Cholinergic urticaria

132

1.07

0.02

3.4

1.8

370.07

385.81

nmol/l

0.17

119

Carcinoma in situ of endometrium

138

0.94

0.02

2.2

2.0

425.62

370.66

nmol/l

0.86

131

Postpartum hemorraghe, all women as controls

1073

10534

1.00

0.02

2.0

376.23

378.66

nmol/l

0.18

1018

9718

Premature separation of placenta [abruptio placentae]

790

0.99

0.02

2.7

2.1

418.04

373.63

nmol/l

0.56

726

Rheumatic fever without mention of heart involvement

1.08

0.02

1.9

2.0

333.20

392.42

nmol/l

—

Laparoscopic left hemicolectomy

482

1.02

0.01

1.9

2.0

354.28

374.57

nmol/l

0.13

445

Pedal cyclist injured in collision with pedestrian or animal

193

1.04

0.01

2.3

1.9

346.40

376.91

nmol/l

0.38

179

Transient global amnesia

280

2791

1.00

0.01

2.4

2.3

364.50

371.69

nmol/l

0.26

251

2545

Use of levodopa decarbox-comt-inhibitor

827

0.99

0.01

1.7

2.1

425.84

367.08

nmol/l

2.07

744

Retrobulbar neuritis in diseases classified elsewhere

114

1.06

0.01

2.3

2.0

331.92

372.78

nmol/l

0.27

104

HSIL lesion of the cervix uteri

737

7361

1.00

0.00

2.0

387.42

376.65

nmol/l

0.81

681

6792

Complications of the puerperium, not elsewhere classified

143

1437

0.99

0.00

2.0

377.62

379.45

nmol/l

0.05

130

1330

N06DA Anticholinesterases

1073

8461

1.00

0.00

1.7

2.1

397.46

385.51

nmol/l

1.15

912

7609

Use of anticholinesterases

1073

8461

1.00

0.00

1.7

2.1

397.46

385.51

nmol/l

1.15

912

7609

Maternal care for known or suspected disproportion

159

1585

1.00

0.00

1.9

2.1

376.19

365.21

nmol/l

0.39

149

1462

Crushing injury of wrist and hand

393

0.99

0.00

1.5

2.2

403.59

356.74

nmol/l

0.85

365

Operations for atrial fibrillation

407

1.01

0.00

3.0

2.3

415.69

370.34

nmol/l

0.96

377

Carcinoma in situ of breast, other/unspecified

398

1.01

0.00

1.7

1.9

373.91

374.21

nmol/l

0.00

365

Rheumatic valve diseases

555

0.99

0.00

1.7

1.9

351.21

390.19

nmol/l

0.83

498

Osteochondrosis of ankle, juvenile

177

1.02

0.00

1.2

2.0

440.83

409.59

nmol/l

0.22

160

Dysplastic lesion of unknown severity of the cervix uteri

316

1.01

0.00

1.8

2.0

377.04

375.48

nmol/l

0.01

298

Balanced rearrangements and structural markers, not elsewhere classified

118

1.02

0.00

1.7

1.8

369.08

388.30

nmol/l

0.16

108

Cardiovascular disorders originating in the perinatal period

174

0.97

0.00

4.2

2.7

282.18

348.68

nmol/l

0.76

166

Other injuries involving multiple body regions, not elsewhere classified

1.02

0.00

2.2

1.8

368.40

390.05

nmol/l

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

2.9

—

377.78

—

Crushing injury of lower leg

0.97

0.00

1.4

1.8

322.43

365.47

nmol/l

—

Keratoderma in diseases classified elsewhere

0.00

0.0

1.2

—

447.00

—

Other specified/unspecified disorders of ear

0.99

0.00

3.3

2.1

272.50

386.47

nmol/l

—

Transient retinal artery occlusion

0.98

-0.00

4.7

2.0

267.50

405.59

nmol/l

—

Folliculitis decalvans

0.90

-0.00

1.2

2.0

300.50

359.64

nmol/l

—

Chondrosarcoma

0.99

-0.00

2.6

1.6

318.38

371.89

nmol/l

—

Thoracic root disorders

0.92

-0.00

3.0

1.9

568.80

406.69

nmol/l

—

Congenital syphilis

0.00

-0.00

0.0

2.3

—

336.00

—

Bilateral

0.00

-0.00

0.0

2.3

—

444.50

—

Testicular hypofunction, drug-induced

0.00

-0.00

0.0

1.3

—

307.83

—

Esophageal diverticulum (pouch)

0.90

-0.00

1.8

387.17

403.34

nmol/l

—

Accidental poisoning by and exposure to pesticides

0.85

-0.00

2.4

1.9

287.00

352.62

nmol/l

—

Acute necrotizing ulcerative gingivitis

0.00

-0.00

0.0

1.3

—

330.00

—

Cleft lip

1.00

-0.00

2.6

421.33

356.93

nmol/l

—

Foreign object accidentally left in body during surgical and medical care

0.98

-0.00

2.6

1.9

305.00

369.99

nmol/l

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

-0.00

0.0

2.0

—

541.17

—

Defects in glycoprotein degradation

0.00

-0.00

0.0

3.1

—

377.14

—

Ovarian dysfunction: androgen excess, drug-induced

0.00

-0.00

0.0

1.4

—

364.71

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

4.9

—

427.00

—

Upper arm

0.87

-0.00

1.3

2.0

284.17

406.35

nmol/l

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.98

-0.00

1.9

2.0

299.57

369.62

nmol/l

—

Small plaque parapsoriasis

0.92

-0.00

3.0

1.8

188.00

364.26

nmol/l

—

Frostbite involving multiple body regions and unspecified frostbite

0.93

-0.00

4.2

1.5

434.17

398.63

nmol/l

—

Radiological devices associated with adverse incidents

0.00

-0.00

0.0

3.1

—

311.71

—

Oher contracture of tendon (sheath)

1.01

-0.00

1.3

1.5

314.63

368.27

nmol/l

—

Intentional self-harm by smoke, fire and flames

0.96

-0.00

7.0

1.9

421.40

382.38

nmol/l

—

Pedestrian injured in collision with heavy transport vehicle or bus

1.01

-0.00

1.4

2.2

363.78

383.70

nmol/l

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

2.2

—

388.17

—

Tympanosclerosis

1.00

-0.00

2.3

1.6

435.50

381.98

nmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cortisol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS